{
    "testId": 396305147,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 123,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 0,
    "testModeName": "Timed",
    "questionModeId": 0,
    "questionModeName": "ALL",
    "testName": "",
    "totalQuestionCorrect": 4,
    "correctToIncorrect": 0,
    "incorrectToCorrect": 0,
    "incorrectToIncorrect": 0,
    "timeInSeconds": 3501,
    "averageTimeSpentInSeconds": 2,
    "otherAverageTimeSpentInSeconds": 59,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 40,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "1",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 4769,
            "questionIndex": 4769,
            "questionText": "<p>A 14-year-old girl is brought to the office due to heavy vaginal bleeding.&nbsp; Since menarche at age 13, menses have been irregular but not painful.&nbsp; Her previous menstrual period was 8 weeks ago, and current menses started 7 days ago.&nbsp; The patient is soaking through a thick pad every 2 or 3 hours and bled through her clothing overnight.&nbsp; She has no history of recurrent epistaxis or bruising and no chronic medical conditions or previous surgeries.&nbsp; Her mother required a blood transfusion with delivery but has experienced no other bleeding episodes.&nbsp; Blood pressure is 110/60 mm Hg and pulse is 65/min.&nbsp; The external genitalia are normal and consistent with sexual maturity rating (Tanner stage) 4 development.&nbsp; The abdomen is nontender and nondistended and has no masses.&nbsp; On pelvic examination, there is dark red bleeding from the cervical os.&nbsp; Urine pregnancy test is negative.&nbsp; Which of the following is the most likely cause of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"2990\" src=\"https://www.uworld.com/media/highresdefault/L24345.jpg\"  ></p><p>This patient has <strong>abnormal uterine bleeding (AUB)</strong>, defined during adolescence as menses &lt;21 days or &gt;45 days apart.&nbsp; In adolescents who have <strong>recently undergone menarche</strong>, the most common cause of AUB is <strong>immaturity of the hypothalamic-pituitary-ovarian (HPO) axis</strong>.&nbsp; An immature HPO axis fails to produce appropriate quantities and ratios of GnRH, and therefore LH and FSH, to induce ovulation.&nbsp; As a result, during the first few years after menarche, most menstrual cycles are <strong>anovulatory</strong> and present as <strong>painless, irregular, heavy bleeding</strong>.</p><p>During the menstrual cycle, the endometrium proliferates in response to estrogen stimulation.&nbsp; Normally, progesterone is produced by the corpus luteum following ovulation, and withdrawal of this progesterone (as the corpus luteum degenerates) results in synchronous endometrial shedding and menstrual bleeding.</p><p>However, during <a href=\"6928\">anovulatory cycles</a>, progesterone is not produced due to the lack of corpus luteum formation (which only occurs after release of the oocyte).&nbsp; Without progesterone, the endometrium continues to proliferate under unopposed estrogen and becomes structurally unstable, fragile (ie, outgrows its blood supply), and prone to random and asynchronous endometrial breakdown.&nbsp; Treatment of AUB is with either progestin only (to stabilize the endometrium) or combined oral contraceptive pills to help regulate menses.</p><p><strong>(Choice A)</strong>&nbsp; Adolescents are at higher risk for sexually transmitted infections, which cause cervical inflammation (ie, acute cervicitis).&nbsp; However, patients usually have intermenstrual or postcoital spotting rather than irregular, heavy menses.</p><p><strong>(Choice B)</strong>&nbsp; Adenomyosis, characterized by endometrial implantation within the myometrium, is a cause of heavy, painful, regular menses and chronic pelvic pain.&nbsp; Adenomyosis typically presents in parous women age &gt;40; it is unlikely in an adolescent with painless, irregular menses.</p><p><strong>(Choice D)</strong>&nbsp; Younger adolescents (eg, 1 year after menarche) with irregular menstrual cycles likely have AUB due to HPO axis immaturity and anovulation.&nbsp; In contrast, older adolescents who have established regular, ovulatory menstrual cycles but who continue to have heavy bleeding should be evaluated for disorders such as von Willebrand disease (eg, impaired platelet adhesion).&nbsp; Often, patients with von Willebrand disease have a history of recurrent epistaxis, easy bruising, and gingival bleeding, which are not seen in this patient.</p><p><strong>(Choice E)</strong>&nbsp; Monoclonal myometrial proliferation is the mechanism of leiomyoma (eg, uterine fibroid) formation.&nbsp; Patients with leiomyomas typically have heavy and prolonged but regular menses.</p><p><strong>Educational objective:</strong><br>Adolescents who have recently undergone menarche have an immature hypothalamic-pituitary-ovarian axis, which results in anovulatory menstrual cycles that commonly present as abnormal uterine bleeding (eg, heavy, irregular bleeding).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 17488,
            "topic": "Abnormal uterine bleeding",
            "titleId": 17488,
            "title": "Abnormal uterine bleeding",
            "topicAttributeId": 330800,
            "topicAttribute": "Menstrual disorders and contraception",
            "correctAnswer": "3",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cervical inflammation",
                    "choiceNumber": 1,
                    "correctTaken": 24,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometrial implantation within the myometrium",
                    "choiceNumber": 2,
                    "correctTaken": 236,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypothalamic-pituitary-ovarian axis immaturity",
                    "choiceNumber": 3,
                    "correctTaken": 3795,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Impaired platelet adhesion",
                    "choiceNumber": 4,
                    "correctTaken": 912,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Monoclonal myometrial proliferation",
                    "choiceNumber": 5,
                    "correctTaken": 147,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "32041387",
                    "mediaDataId": 0,
                    "title": "Approach to abnormal uterine bleeding in adolescents.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/32041387",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 2,
            "othersAvgTimeSpent": 77,
            "notes": null,
            "peopleTaken": 5114,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 74,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 2,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 2416,
            "questionIndex": 2416,
            "questionText": "<p>An 18-year-old, nulliparous woman comes to the office with lower abdominal pain, nausea, and vomiting for the past day.&nbsp; She has been unable to tolerate food or water for the past 8 hours.&nbsp; The patient is sexually active and uses oral contraceptive pills.&nbsp; She has had 3 lifetime sexual partners.&nbsp; Her last menstrual period was 15 days ago.&nbsp; The patient has no medication allergies.&nbsp; Temperature is 39 C (102.2 F), blood pressure is 100/70 mm Hg, and pulse is 110/min.&nbsp; Physical examination reveals dry mucous membranes and delayed capillary refill.&nbsp; The abdomen has diffuse tenderness over the lower quadrants.&nbsp; The external genitalia have no abnormalities; speculum examination shows purulent discharge from the cervical os.&nbsp; The uterus is small, anteverted, and tender to palpation and motion.&nbsp; The adnexa are markedly tender bilaterally, with no palpable masses.&nbsp; Cervical nucleic acid amplification testing is pending.&nbsp; Urine pregnancy test is negative.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">13.4 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">180,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">18,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neutrophils</td><td style=\"vertical-align:middle;\">80%</td></tr></tbody></table><p>Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T31458\"><table class=\"table-default-style\"><tbody><tr><td><p align=\"center\"><strong>Indications for hospitalization<br>for pelvic inflammatory disease</strong></p></td></tr><tr><td><ul><li>Pregnancy</li><li>Failed outpatient treatment</li><li>Inability to tolerate oral medications</li><li>Noncompliant with therapy</li><li>Severe presentation (eg, high fever, vomiting)</li><li>Complications (eg, tuboovarian abscess, perihepatitis)</li></ul></td></tr></tbody></table></div><p>This patient has fever, lower abdominal pain, purulent cervical discharge, and cervical motion and adnexal tenderness, findings consistent with <strong>pelvic inflammatory disease</strong> (PID).&nbsp; PID is typically preceded by cervicitis due to <em>Neisseria gonorrhoeae</em> or <em>Chlamydia trachomatis</em> infection, which disrupts the barrier to the upper genital tract (eg, uterus, fallopian tubes), allowing a <strong>polymicrobial infection</strong> to develop in a normally sterile area.</p><p>PID is treated with <strong>empiric, broad-spectrum antibiotics</strong>.&nbsp; The decision to treat either with inpatient or outpatient antibiotic therapy depends on several factors, including the following:</p><ul><li><p>Severity of presentation:&nbsp; Patients with <strong>high fever</strong>, severe pain, <strong>dehydration</strong> (eg, dry mucous membranes, delayed capillary refill), and <strong>inability to tolerate oral antibiotics</strong> (eg, nausea/vomiting) require <strong>inpatient treatment</strong>.&nbsp; In contrast, patients with a mild presentation (eg, no nausea/vomiting, pain manageable with over-the-counter medication) can be treated as an outpatient <strong>(Choices C, D, and E)</strong>.</p></li><li><p>Failure of outpatient therapy and/or presence of complications:&nbsp; PID can cause the formation of a <strong>tuboovarian abscess</strong> (eg, persistent fever, adnexal mass), <strong>perihepatitis</strong> (eg, new-onset pain in the right upper quadrant), or sepsis, all of which require inpatient treatment.</p></li><li><p>Patient compliance:&nbsp; Inpatient treatment may benefit patients at risk for nonadherence to outpatient treatment (eg, adolescents).</p></li></ul><p>Therefore, this patient requires hospitalization, fluid resuscitation, and intravenous antibiotic therapy because she cannot tolerate food or water.</p><p>A common regimen is an <strong>intravenous cephalosporin</strong> (eg, cefoxitin) <strong>plus oral doxycycline</strong>, which may require concomitant administration of an intravenous anti-nausea medication.&nbsp; Cephalosporins provide coverage for gram-negative bacilli (eg, <em>Escherichia coli</em>).&nbsp; Doxycycline treats gram-positive (eg, <em>Streptococcus</em>), gram-negative (eg, <em>N gonorrhoeae</em>), and atypical organisms (eg, <em>C trachomatis</em>, <em>Mycoplasma</em>).&nbsp; Metronidazole is added for additional anaerobic coverage when PID is complicated by a tuboovarian abscess.</p><p><strong>(Choice A)</strong>&nbsp; PID is typically polymicrobial and delayed treatment can increase the risk of severe and long-term complications (eg, perihepatitis, infertility).&nbsp; Therefore, both hospitalization and immediate broad-spectrum antibiotic treatment are required while nucleic acid amplification tests results are pending.</p><p><strong>Educational objective:</strong><br>Pelvic inflammatory disease may present with fever; diffuse lower abdominal pain; mucopurulent cervical discharge; and cervical motion, uterine, or adnexal tenderness.&nbsp; Indications for inpatient treatment with intravenous antibiotics include high fever, inability to tolerate oral antibiotics, and risk of nonadherence to outpatient treatment.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 8096,
            "topic": "Pelvic inflammatory disease",
            "titleId": 8096,
            "title": "Pelvic inflammatory disease",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "2",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Admit the patient and wait for nucleic acid amplification test results",
                    "choiceNumber": 1,
                    "correctTaken": 266,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inpatient treatment with cephalosporin plus doxycycline",
                    "choiceNumber": 2,
                    "correctTaken": 13591,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Outpatient treatment with cephalosporin plus doxycycline",
                    "choiceNumber": 3,
                    "correctTaken": 3096,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Outpatient treatment with metronidazole plus clindamycin",
                    "choiceNumber": 4,
                    "correctTaken": 305,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Outpatient treatment with metronidazole plus doxycycline",
                    "choiceNumber": 5,
                    "correctTaken": 551,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "43",
                    "mediaDataId": 0,
                    "title": "Pelvic inflammatory disease",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31524362",
                    "mediaDataId": 0,
                    "title": "Pelvic inflammatory disease: diagnosis, management, and prevention.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31524362",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23680907",
                    "mediaDataId": 0,
                    "title": "Clinician perspectives on management of adolescents with pelvic inflammatory disease using standardized patient scenarios.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23680907",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 4,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 17809,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 76,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 4,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 14128,
            "questionIndex": 15531,
            "questionText": "<p>A 16-year-old girl is brought to the office by her mother for evaluation of painful menstrual periods.&nbsp; Since menarche, the patient has had increasingly painful menses that now cause her to miss track practice a few days each month.&nbsp; Menstrual periods occur every 25-27 days with 5 days of moderate bleeding.&nbsp; For the first 4 days of her menses, the patient has cramping pain in the right lower quadrant that radiates to the right flank.&nbsp; The pain improves with ibuprofen and a heating pad.&nbsp; She has fatigue and nausea that start the day prior to menses and resolve when the pain stops.&nbsp; The patient has no chronic medical conditions and has had no surgeries.&nbsp; She is not sexually active.&nbsp; Her last menstrual period was 3 weeks ago.&nbsp; Blood pressure is 114/70 mm Hg and pulse is 68/min.&nbsp; BMI is 19 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Pelvic examination is deferred but physical examination is unremarkable.&nbsp; Which of the following findings is most concerning for a secondary cause of dysmenorrhea in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Dysmenorrhea</strong>, or painful menses, is common in reproductive-aged women and is divided into primary (physiologic) and secondary (pathologic) causes.&nbsp; Primary dysmenorrhea is the most common cause of painful menses and typically presents in adolescents after ovulatory, regular menstrual cycles are established <strong>(Choices A and D)</strong>.&nbsp; Patients typically have midline pelvic pain that can radiate to the bilateral legs or back as well as associated systemic symptoms such as fatigue, nausea, vomiting, and diarrhea <strong>(Choice B)</strong>.&nbsp; Primary dysmenorrhea can be diagnosed based on history alone and does not require physical examination.</p><p>In contrast, patients with any of the following clinical features should be evaluated for <strong>secondary causes of dysmenorrhea</strong>:</p><ul><li><p>Symptom onset at age &gt;25</p></li><li><p><strong>Unilateral (nonmidline) pelvic pain</strong> (as seen in this patient&#39;s right lower quadrant pain that radiates to the right flank)</p></li><li><p>No systemic symptoms (eg, fatigue, nausea) during menses</p></li><li><p>Abnormal uterine bleeding (eg, intermenstrual bleeding, postcoital spotting)</p></li></ul><p>These features are suggestive of a variety of <strong>pathologic causes</strong> of dysmenorrhea, including pelvic inflammatory disease, endometriosis, adnexal masses, and a uterine anomaly (eg, rudimentary uterine horn).&nbsp; Physical examination is performed to evaluate for these possible causes; patients with abnormal examination findings (eg, adnexal mass, cervical motion tenderness) may require additional imaging (eg, pelvic ultrasound) and possible surgery (eg, laparoscopy).</p><p><strong>(Choice E)</strong>&nbsp; Dysmenorrhea typically improves with nonsteroidal antiinflammatory drugs (NSAIDs) (eg, ibuprofen) because the pain results from an inflammatory response and increased prostaglandin release.&nbsp; Pain that does not improve with NSAIDs can be suggestive of a secondary cause of dysmenorrhea, though this is nonspecific, as many secondary causes of dysmenorrhea will improve with NSAIDs.</p><p><strong>Educational objective:</strong><br>Dysmenorrhea, or painful menses, is common in reproductive-aged women and is divided into primary (physiologic) and secondary (pathologic) causes.&nbsp; Clinical features suggestive of a secondary cause (eg, endometriosis) include age &gt;25 at onset, unilateral (nonmidline) pelvic pain, lack of systemic symptoms, and abnormal uterine bleeding.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 21040,
            "topic": "Dysmenorrhea",
            "titleId": 21040,
            "title": "Dysmenorrhea",
            "topicAttributeId": 330800,
            "topicAttribute": "Menstrual disorders and contraception",
            "correctAnswer": "3",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Age at onset",
                    "choiceNumber": 1,
                    "correctTaken": 620,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Associated symptoms",
                    "choiceNumber": 2,
                    "correctTaken": 1824,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Location of pain",
                    "choiceNumber": 3,
                    "correctTaken": 13313,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pattern of menstrual bleeding",
                    "choiceNumber": 4,
                    "correctTaken": 639,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Response to medication",
                    "choiceNumber": 5,
                    "correctTaken": 345,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "58",
                    "mediaDataId": 0,
                    "title": "Primary dysmenorrhea",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28944048",
                    "mediaDataId": 0,
                    "title": "Dysmenorrhea and related disorders.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28944048",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26841639",
                    "mediaDataId": 0,
                    "title": "Primary dysmenorrhea in adolescents: prevalence, impact and recent knowledge.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26841639",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 2,
            "othersAvgTimeSpent": 69,
            "notes": null,
            "peopleTaken": 16741,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 80,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 2,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 3339,
            "questionIndex": 3339,
            "questionText": "<p>A 32-year-old woman, gravida 1 para 1, comes to the office for a routine checkup 6 weeks after an uncomplicated vaginal delivery of a healthy boy.&nbsp; The patient has no concerns and would like to discuss contraception options.&nbsp; She was told by a friend that some options can make weight loss challenging, and she desires to return to her prepregnancy weight.&nbsp; Prior to pregnancy, the patient had regular monthly menses, with 5-7 days of heavy flow that caused mild iron deficiency anemia.&nbsp; Iron was prescribed, but she often forgot to take it.&nbsp; During pregnancy, the patient also inconsistently took prenatal vitamins.&nbsp; She is exclusively breastfeeding.&nbsp; BMI is 28 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Breast examination shows no masses, tenderness, or nipple injury.&nbsp; Pelvic examination reveals a small, mobile uterus with no abnormalities.&nbsp; The remainder of the physical examination is unremarkable.&nbsp; Which of the following is the most appropriate contraceptive option for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"2448\" src=\"https://www.uworld.com/media/highresdefault/L23853.jpg\"  ></p><p>For <strong>postpartum</strong> patients, early initiation of <strong>reliable contraception</strong> prevents short-interval pregnancy (ie, pregnancy within 6-18 months) and associated risks (eg, preterm delivery).&nbsp; The choice of method depends on future fertility plans, postpartum timing, breastfeeding status, and medical history.</p><p><strong>Progestin-only</strong> methods (eg, progestin-only pill, medroxyprogesterone injection, progestin-releasing intrauterine device [IUD]) are often used for <strong>breastfeeding patients</strong> because there is almost no effect on milk supply.&nbsp; These methods can be initiated either immediately after delivery (low thromboembolism risk with progestin-only methods) or at the postpartum visit (&#8805;4 weeks postpartum).</p><p>The <strong>progestin-releasing IUD</strong>, which may be inserted immediately after placental delivery or at &#8805;4 weeks postpartum, is an ideal contraceptive option for this patient because it is primarily a locally acting contraceptive with minimal systemic absorption.&nbsp; Therefore, the incidence of progesterone-related adverse effects (eg, mood changes, increased appetite leading to weight gain) is low.&nbsp; It is highly effective at preventing pregnancy, and its efficacy is not user-dependent (ie, no daily pills).&nbsp; It also has the added benefit of <strong>decreasing heavy menstrual bleeding</strong> by inducing <strong>amenorrhea</strong>.&nbsp; In addition, the lactational amenorrhea associated with exclusively breastfeeding an infant &lt;6 months will decrease this patient&#39;s risk of IUD expulsion from heavy menses.</p><p><strong>(Choice A)</strong>&nbsp; Combined estrogen/progestin oral contraceptive pills can be safely initiated &#8805;6 weeks postpartum because the risk of thromboembolisms has returned to baseline (ie, similar to risks outside the postpartum period) and lactogenesis is well established, minimizing the potential impact on milk production.&nbsp; However, this patient has inconsistent adherence taking daily pills, making this form of contraception unreliable for her.</p><p><strong>(Choice B)</strong>&nbsp; The copper-containing IUD is nonhormonal and does not affect lactation or body weight.&nbsp; However, it is associated with increased menstrual bleeding and dysmenorrhea and may exacerbate this patient&#39;s heavy menstrual bleeding and anemia.</p><p><strong>(Choice C)</strong>&nbsp; Medroxyprogesterone, a progestin, is a long-acting injectable contraceptive administered every 3 months.&nbsp; Because it induces anovulation by releasing high levels of progesterone (an appetite stimulant), it can be associated with weight gain and may make postpartum weight loss more challenging for this patient.</p><p><strong>(Choice D)</strong>&nbsp; Breastfeeding elevates prolactin levels, inhibiting GnRH and inducing anovulation.&nbsp; However, exclusive lactation is not recommended as contraception when other effective contraceptive options are readily available because resumption of ovulation is unpredictable (50% of patients resume ovulation after the first 6 months of breastfeeding).</p><p><strong>Educational objective:</strong><br>Progestin-only methods, such as the progestin-releasing intrauterine device (IUD), may be initiated any time after delivery.&nbsp; The progestin-releasing IUD has the added benefit of decreasing menstrual bleeding.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 17805,
            "topic": "Contraception",
            "titleId": 17805,
            "title": "Contraception",
            "topicAttributeId": 330800,
            "topicAttribute": "Menstrual disorders and contraception",
            "correctAnswer": "5",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Combined estrogen/progestin oral contraceptive pills",
                    "choiceNumber": 1,
                    "correctTaken": 568,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Copper intrauterine device",
                    "choiceNumber": 2,
                    "correctTaken": 2297,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medroxyprogesterone injection",
                    "choiceNumber": 3,
                    "correctTaken": 1484,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No contraception needed while breastfeeding",
                    "choiceNumber": 4,
                    "correctTaken": 1410,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Progestin-releasing intrauterine device",
                    "choiceNumber": 5,
                    "correctTaken": 10850,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "53",
                    "mediaDataId": 0,
                    "title": "Contraception",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25861205",
                    "mediaDataId": 0,
                    "title": "Levonorgestrel intrauterine system (Mirena): an emerging tool for conservative treatment of abnormal uterine bleeding.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25861205",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 2,
            "othersAvgTimeSpent": 48,
            "notes": null,
            "peopleTaken": 16609,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 2,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 3757,
            "questionIndex": 3757,
            "questionText": "<p>A 34-year-old woman comes to the office for evaluation of vulvar lesions that have worsened over the past 3 months.&nbsp; She has had 2 sexual partners in the last year.&nbsp; Medical history includes genital infection with herpes simplex virus diagnosed at age 23; when she was 25, her sexual partner was diagnosed with syphilis.&nbsp; Cervical cancer screening last year revealed atypical squamous cells of undetermined significance, with negative testing for high-risk human papillomavirus.&nbsp; The patient smokes cigarettes but does not use alcohol or illicit drugs.&nbsp; Examination reveals multiple nontender, fleshy, verrucous growths clustered at the vestibule of the vulva and over the labia majora.&nbsp; A few lesions are friable and bleed on manipulation.&nbsp; The remainder of the physical examination is normal.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t44026\"><table class=\"table-default-style table-header-footer-style\" style=\"width:540px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Genital warts (condylomata acuminata)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>HPV 6, 11&nbsp;&amp; other low-risk strains</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Pink, skin-colored, hyperpigmented lesions</li><li>Smooth or cauliflower-like papules/nodules</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Lesions &lt;1 cm: imiquimod, cryotherapy, sinecatechins, podophyllotoxin, trichloroacetic acid</li><li>Lesions &gt;1 cm: excision, laser therapy, electrosurgery</li><li>Screen for other STIs</li><li>Recurrence is common</li></ul></td></tr><tr><td><p align=\"center\"><strong>Prevention</strong></p></td><td><ul><li>Vaccination</li><li>Barrier contraception</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>HPV</strong> = human papillomavirus; <strong>STIs</strong> = sexually transmitted infections.</p></td></tr></tbody></table></div><p>This patient most likely has <strong>condylomata acuminata</strong> (anogenital warts) caused by human papillomavirus (HPV), a common sexually transmitted infection.&nbsp; Condyloma acuminata occur due to persistent infection with <strong>low-risk HPV strains 6 and 11</strong>, and patients with chronic tobacco use (as in this patient) or immunosuppression (eg, HIV) have an elevated risk.&nbsp; Anogenital warts typically appear as clusters of soft, pink or <strong>skin-colored (fleshy) lesions</strong> in the internal or external vaginal, vulvar, and anal regions in women.&nbsp; Most lesions are exophytic, dry-appearing, and <strong>verrucous</strong> (ie, cauliflower-like), although some may appear sessile and flat.&nbsp; Genital warts are typically asymptomatic and nontender, although <strong>pruritic, friable lesions</strong> (eg, those that bleed with manipulation) may occur.</p><p>Diagnosis is primarily clinical, based on the characteristic appearance of the lesions.&nbsp; Small anogenital warts are treated with topical agents that either chemically injure the lesion (eg, trichloroacetic acid, podophyllin resin) or stimulate an immune response to it (eg, imiquimod).&nbsp; Surgical excision may be required for larger lesions.&nbsp; Recurrence rates are high, regardless of treatment modality.</p><p><strong>(Choice B)</strong>&nbsp; Condylomata lata, caused by secondary syphilis, are raised, gray-white lesions that develop on mucosal surfaces (eg, mouth, perineum).&nbsp; In contrast to condylomata acuminata, condylomata lata typically have a broader base and a smooth, rather than a verrucous, surface.</p><p><strong>(Choice C)</strong>&nbsp; <a href=\"2847\">Herpes simplex virus</a> presents as tender ulcerative blisters or pustules, not fleshy, verrucous growths.</p><p><strong>(Choice D)</strong>&nbsp; Vulvar lichen planus creates pruritic, glassy, bright red-purple lesions with overlying white reticular lines (ie, &#x22;Wickham striae&#x22;).</p><p><strong>(Choice E)</strong>&nbsp; <a href=\"2178\">Vulvar lichen sclerosus</a> presents as pruritic, white labial lesions that appear thin and wrinkled and result in obliteration of the normal vulvar architecture.</p><p><strong>(Choice F)</strong>&nbsp; <a href=\"2101\">Molluscum contagiosum</a>, caused by a poxvirus, is characterized by small, painless, &#x22;pearly&#x22; (eg, smooth, firm) nodules with central dimpling.</p><p><strong>(Choice G)</strong>&nbsp; Smokers are at increased risk for vulvar cancer, which can present as a single friable, fleshy vulvar lesion.&nbsp; Vulvar cancer is associated with high-risk HPV strains (eg, types 16 and 18), making this diagnosis unlikely in this patient with recent negative high-risk HPV testing.</p><p><strong>Educational objective:</strong><br>Condylomata acuminata, or anogenital warts, are caused by the low-risk strains of human papillomavirus (eg, types 6 and 11) and typically present as nontender, verrucous genital lesions that may be friable.&nbsp; Treatment is with topical medications (eg, trichloroacetic acid) or surgical excision.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 9031,
            "topic": "Warts",
            "titleId": 9031,
            "title": "Warts",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "1",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Condylomata acuminata",
                    "choiceNumber": 1,
                    "correctTaken": 10530,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Condylomata lata",
                    "choiceNumber": 2,
                    "correctTaken": 3397,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Genital herpes",
                    "choiceNumber": 3,
                    "correctTaken": 571,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lichen planus",
                    "choiceNumber": 4,
                    "correctTaken": 113,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lichen sclerosus",
                    "choiceNumber": 5,
                    "correctTaken": 71,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Molluscum contagiosum",
                    "choiceNumber": 6,
                    "correctTaken": 561,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vulvar cancer",
                    "choiceNumber": 7,
                    "correctTaken": 1364,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "388",
                    "mediaDataId": 0,
                    "title": "Human papillomavirus (HPV)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "45",
                    "mediaDataId": 0,
                    "title": "Condyloma acuminata",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24559567",
                    "mediaDataId": 0,
                    "title": "Genital warts and other HPV infections: established and novel therapies.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24559567",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25251091",
                    "mediaDataId": 0,
                    "title": "Management of external genital warts.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25251091",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27034016",
                    "mediaDataId": 0,
                    "title": "Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27034016",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 3,
            "othersAvgTimeSpent": 56,
            "notes": null,
            "peopleTaken": 16607,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 3,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 13935,
            "questionIndex": 15333,
            "questionText": "<p>A 32-year-old woman comes to the office for evaluation of absent menses.&nbsp; The patient had a vaginal delivery 4 months ago and has not yet had a menstrual period.&nbsp; Her postpartum course was complicated by a retained placenta and postpartum hemorrhage that required a blood transfusion and emergency suction and sharp curettage.&nbsp; At her postpartum visit 2 months ago, the patient was given a prescription for combination oral contraceptive pills; she has had no vaginal bleeding or spotting during her week of placebo pills.&nbsp; Prior to this pregnancy, she had regular monthly menstrual cycles with 3-4 days of moderate bleeding.&nbsp; The patient has had increased fatigue since returning to work.&nbsp; She elected to formula-feed exclusively after delivery.&nbsp; The patient has had no headaches, galactorrhea, or hot flashes.&nbsp; Vital signs are normal.&nbsp; BMI is 31 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Pelvic examination shows clear vaginal discharge throughout the vault and a well-rugated vagina.&nbsp; The uterus is small and anteverted, and both ovaries are small and nontender.&nbsp; Urine pregnancy test is negative.&nbsp; FSH and TSH levels are normal.&nbsp; Which of the following is the most likely cause of this patient&#39;s clinical presentation?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T43083\" style=\"overflow-x:auto;\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Intrauterine adhesions</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Infection (eg, septic abortion, endometritis)</li><li>Intrauterine surgery (eg, curettage, myomectomy)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Abnormal uterine bleeding</li><li>Amenorrhea</li><li>Infertility</li><li>Cyclic pelvic pain</li><li>Recurrent pregnancy loss</li></ul></td></tr><tr><td><p align=\"center\"><strong>Evaluation</strong></p></td><td><ul><li>Hysteroscopy</li></ul></td></tr></tbody></table></div><p>This patient has <strong>Asherman syndrome</strong>, the formation of <strong>intrauterine adhesions</strong> that can follow intrauterine surgery.&nbsp; It occurs most often after <strong>suction and sharp curettage</strong> for delivery complications (eg, postpartum hemorrhage, endometritis).&nbsp; Because the postpartum uterus is soft and enlarged, curettage might be unintentionally aggressive.&nbsp; The basalis layer of the endometrium can be injured inadvertently, creating a denuded, adherent intrauterine surface prone to synechiae and endometrial cavity obliteration.</p><p>Because of complete or partial <strong>obliteration of the endometrium</strong>, patients typically have very light menses or <strong>secondary amenorrhea</strong> that does not respond to a <a href=\"67928\">progesterone challenge</a>, as evidenced by <strong>no withdrawal bleeding</strong> during the placebo week of oral contraceptive pills.&nbsp; Asherman syndrome is a structural cause of amenorrhea; therefore, patients have normal FSH and TSH levels.&nbsp; Diagnosis and treatment are performed via hysteroscopy to identify and lyse the adhesions.</p><p><strong>(Choice B)</strong>&nbsp; Gestational trophoblastic disease (eg, choriocarcinoma) can cause abnormal uterine bleeding after pregnancy.&nbsp; The persistent trophoblastic tissue secretes hCG; the patient has a negative pregnancy test, making this diagnosis unlikely.</p><p><strong>(Choice C)</strong>&nbsp; Postpartum thyroiditis is an autoimmune transient thyroid disorder that can occur within a year after delivery.&nbsp; Symptoms can include abnormal uterine bleeding and fatigue; however, an abnormal TSH level would be expected.</p><p><strong>(Choice D)</strong>&nbsp; Because of low estrogen levels, primary ovarian insufficiency can cause secondary amenorrhea and no withdrawal bleeding during the placebo week of oral contraceptive pills.&nbsp; However, these patients have elevated FSH levels.</p><p><strong>(Choice E)</strong>&nbsp; Sheehan syndrome can occur as a complication of postpartum hemorrhage, particularly if associated with massive hemorrhage requiring blood transfusion and emergency suction curettage.&nbsp; Patients can have amenorrhea, fatigue, and inability to breastfeed; however, low FSH and TSH levels would be expected due to panhypopituitarism.&nbsp; In addition, fatigue is a nonspecific symptom common in patients with infants at home.</p><p><strong>Educational objective:</strong><br>Asherman syndrome, the formation of intrauterine adhesions, occurs most often following intrauterine surgery (eg, suction curettage).&nbsp; Patients with Asherman syndrome typically have amenorrhea that does not respond to a progesterone challenge due to obliteration of the endometrium.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 23429,
            "topic": "Amenorrhea",
            "titleId": 23429,
            "title": "Amenorrhea",
            "topicAttributeId": 330800,
            "topicAttribute": "Menstrual disorders and contraception",
            "correctAnswer": "1",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Asherman syndrome",
                    "choiceNumber": 1,
                    "correctTaken": 10836,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Gestational trophoblastic disease",
                    "choiceNumber": 2,
                    "correctTaken": 151,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Postpartum thyroiditis",
                    "choiceNumber": 3,
                    "correctTaken": 816,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Primary ovarian insufficiency",
                    "choiceNumber": 4,
                    "correctTaken": 878,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sheehan syndrome",
                    "choiceNumber": 5,
                    "correctTaken": 3909,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "64",
                    "mediaDataId": 0,
                    "title": "Intrauterine adhesions",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "700",
                    "mediaDataId": 0,
                    "title": "Evaluation of secondary amenorrhea",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21437822",
                    "mediaDataId": 0,
                    "title": "Asherman&#39;s syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21437822",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28582327",
                    "mediaDataId": 0,
                    "title": "A comprehensive review of Asherman&#39;s syndrome: causes, symptoms and treatment options.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28582327",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29024798",
                    "mediaDataId": 0,
                    "title": "Hysteroscopic management of Asherman&#39;s syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29024798",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 2,
            "othersAvgTimeSpent": 72,
            "notes": null,
            "peopleTaken": 16617,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 2,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 11060,
            "questionIndex": 12201,
            "questionText": "<p>A 23-year-old woman comes to the office due to 3 days of fever and dysuria.&nbsp; The patient has also had a pruritic, erythematous vulvar rash that is particularly painful during urination.&nbsp; She is sexually active with one partner, and they use condoms inconsistently.&nbsp; Temperature is 38.7 C (101.7 F), blood pressure is 120/80 mm Hg, and pulse is 84/min.&nbsp; There is suprapubic fullness on abdominal examination.&nbsp; Pelvic examination shows several shallow,&nbsp;small, and tender ulcerated lesions with circular borders on the inside of the left labium minus.&nbsp; Speculum examination reveals no cervical friability or mucopurulent discharge.&nbsp; The left inguinal lymph nodes are enlarged and tender.&nbsp; Urethral catheterization is performed due to difficulty with spontaneous voiding.&nbsp; Urinalysis results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Leukocyte esterase</td><td style=\"vertical-align:middle;\">positive</td></tr><tr><td style=\"vertical-align:middle;\">Nitrites</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">Bacteria</td><td style=\"vertical-align:middle;\">none</td></tr><tr><td style=\"vertical-align:middle;\">White blood cells</td><td style=\"vertical-align:middle;\">15/hpf</td></tr></tbody></table><p>Urine pregnancy test is negative.&nbsp; Which of the following tests would most likely establish this patient&#39;s diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T34255\" style=\"overflow-x:auto;\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\" style=\"width:47.0%;\"><p align=\"center\"><strong>Infectious genital ulcers</strong></p></td></tr><tr><td rowspan=\"2\" style=\"width:18.0%;\"><p align=\"center\" style=\"margin-left:22.5pt;\"><strong>Painful</strong></p></td><td style=\"width:35.0%;\"><p align=\"center\" style=\"margin-left:22.3pt;\">Herpes simplex virus</p></td><td style=\"width:47.0%;\"><ul><li>Pustules, vesicles, or small ulcers on erythematous base</li><li>Tender lymphadenopathy</li><li>Systemic symptoms common</li></ul></td></tr><tr><td style=\"width:35.0%;\"><p align=\"center\"><em>Haemophilus ducreyi</em> (chancroid)</p></td><td style=\"width:47.0%;\"><ul><li>Larger, deep ulcers with gray/yellow exudate</li><li>Well-demarcated borders &amp; soft, friable base</li><li>Severe lymphadenopathy that may suppurate</li></ul></td></tr><tr><td rowspan=\"2\" style=\"width:18.0%\"><p align=\"center\"><strong>Painless</strong></p></td><td style=\"width:35.0%\"><p align=\"center\"><em>Treponema pallidum</em> (syphilis)</p></td><td style=\"width:47.0%\"><ul><li>Usually single ulcer (chancre)</li><li>Indurated borders &amp; hard, nonpurulent base</li></ul></td></tr><tr><td style=\"width:35.0%;\"><p align=\"center\"><em>Chlamydia trachomatis</em> serovars L1-L3 (lymphogranuloma venereum)</p></td><td style=\"width:47.0%;\"><ul><li>Initial small, shallow ulcers (often missed)</li><li>Then painful &amp; fluctuant adenitis (buboes)</li></ul></td></tr></tbody></table></div><p>This patient&#39;s multiple, painful genital ulcers likely indicates genital <strong>herpes simplex virus (HSV)</strong> infection.&nbsp; Patients with a <strong>primary</strong> infection often have <strong>systemic symptoms</strong> (eg, fever) and develop <strong>tender inguinal lymphadenopathy</strong>.</p><p>HSV evolves from <strong>multiple, painful, pruritic</strong>&nbsp;vesicles to open ulcers; patients with <strong>ulcers</strong> often have associated dysuria and <strong>sterile pyuria</strong> (eg, pyuria = white blood cells [WBCs] on urinalysis, sometimes with corresponding positive leukocyte esterase; sterile = no bacteria on urinalysis) due to urethral and vulvar inflammation and passage of urine over the open lesion.&nbsp; In addition, some patients may develop <strong>acute urinary retention</strong> (eg, suprapubic fullness) due to reluctance to urinate secondary to pain or lumbosacral neuropathy.</p><p>The appearance of genital <a href=\"14017\">HSV lesions</a> can vary and mimic other disease processes as the lesions change from vesicles to ulcers.&nbsp; Therefore, a suspected clinical diagnosis of genital HSV requires laboratory confirmation via <strong>viral culture</strong> or <strong>PCR</strong> testing.&nbsp; Viral culture is most effective in patients with active HSV lesions, such as this woman, but has lower sensitivity as lesions heal.</p><p><strong>(Choice A)</strong>&nbsp; <em>Haemophilus ducreyi</em>&nbsp;(a gram negative rod) causes chancroid, a very rare sexually transmitted infection that can present as genital ulcers.&nbsp; However, chancroid usually causes &#8805;1 papules that develop into pustules then large, deep genital ulcers (vs small and shallow in this patient) with a gray/yellow exudate and a friable base.&nbsp; In addition, chancroid-associated regional lymphadenopathy (less common in women) is often fluctuant and suppurative; and intense pruritus and systemic symptoms are more likely with HSV.</p><p><strong>(Choice B)</strong>&nbsp; KOH wet mount microscopy is used to diagnose vulvovaginal candidiasis, which can present with a pruritic, erythematous vulvar rash and dysuria; however, there are no associated genital ulcers.</p><p><strong>(Choice C)</strong>&nbsp; <em>Chlamydia trachomatis</em> can cause dysuria and sterile pyuria (ie, WBCs but no bacteria) due to urethritis, but patients typically have concomitant acute cervicitis (eg, cervical friability, mucopurulent discharge).&nbsp; Lymphogranuloma venereum is caused by <em>C trachomatis</em> serovars L1-L3 and presents with small, painless ulcers followed several weeks later by painful, suppurative inguinal lymphadenopathy (buboes).</p><p><strong>(Choice D)</strong>&nbsp; Nontreponemal serologic testing (ie, rapid plasma reagin) is used for the evaluation of syphilis; primary syphilis typically presents with a single painless ulcer (ie, chancre) and bilateral, nontender lymphadenopathy.</p><p><strong>Educational objective:</strong><br>Genital herpes simplex virus infection can present with painful, pruritic, vesicular, or ulcerative lesions; dysuria; and inguinal lymphadenopathy.&nbsp; Clinical diagnosis requires confirmation with laboratory testing via a viral culture or PCR.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 11819,
            "topic": "HSV infection",
            "titleId": 11819,
            "title": "HSV infection",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "5",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Gram stain and culture of the lesion for <em>Haemophilus ducreyi</em>",
                    "choiceNumber": 1,
                    "correctTaken": 3458,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "KOH wet mount microscopy for <em>Candida albicans</em>",
                    "choiceNumber": 2,
                    "correctTaken": 131,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nucleic acid amplification testing for <em>Chlamydia trachomatis</em>",
                    "choiceNumber": 3,
                    "correctTaken": 1745,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rapid plasma reagin testing for <em>Treponema pallidum</em>",
                    "choiceNumber": 4,
                    "correctTaken": 405,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Viral culture of the lesion for herpes simplex virus",
                    "choiceNumber": 5,
                    "correctTaken": 7973,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "387",
                    "mediaDataId": 0,
                    "title": "Herpes simplex virus (HSV)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "46",
                    "mediaDataId": 0,
                    "title": "Infectious genital ulcers",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24131689",
                    "mediaDataId": 0,
                    "title": "Light microscopy, culture, molecular, and serologic methods for detection of herpes simplex virus.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24131689",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24885431",
                    "mediaDataId": 0,
                    "title": "Diagnosis of genital herpes simplex virus infection in the clinical laboratory.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24885431",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 2,
            "othersAvgTimeSpent": 63,
            "notes": null,
            "peopleTaken": 13712,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 58,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 2,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 14053,
            "questionIndex": 15456,
            "questionText": "<p>An 8-year-old girl is brought to the office after her mother noticed bloody spotting in the girl&#39;s underwear.&nbsp; The patient has no chronic medical conditions and is up to date on her vaccinations.&nbsp; She plays soccer with her elementary school team, and her parents are divorced.&nbsp; Vital signs are normal.&nbsp; Height and weight are at the 40th percentile.&nbsp; Physical examination reveals sexual maturity rating (Tanner) stage 1 breast development and no acne or axillary hair.&nbsp; Pelvic examination shows multiple 2-mm, raised, fleshy papules on the vulva and anus that bleed on contact with a cotton swab.&nbsp; Which of the following is the best next step in evaluation of this patient&#39;s lesions?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t47341\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Anogenital warts (condyloma acuminata) in children</strong></p></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>Human papillomavirus infection</li></ul></td></tr><tr><td><p align=\"center\"><strong>Transmission</strong></p></td><td><ul><li>Sexual abuse</li><li>Autoinoculation from other sites</li><li>Prenatal or perinatal</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Pink/flesh-colored, verrucous papules &amp; plaques</li><li>Asymptomatic (most common)</li><li>Pruritic, friable lesions</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Sexual abuse assessment, especially age &ge;4</li></ul></td></tr></tbody></table></div><p>This patient&#39;s multiple, flesh-colored, raised papules along the vulva and anus are consistent with <strong>condyloma acuminata</strong> (ie, anogenital warts).&nbsp; Most lesions are asymptomatic, but they can become pruritic and friable, which can cause bloody spotting in patients&#39; underwear.&nbsp; Condyloma acuminata are due to infection with low-risk <strong>human papillomavirus</strong> (HPV) types 6 and 11, which are typically transmitted via direct contact.</p><p>HPV can be transmitted via nonsexual contact such as vertical transmission during delivery, autoinfection from other areas of the body, or heteroinoculation from a caregiver (eg, diaper changes).&nbsp; However, because of the association with transmission via <strong>direct genital contact</strong>, an assessment for <strong>sexual abuse</strong>&nbsp;is required in all children, particularly those age &#8805;4.</p><p>Anogenital warts in children are often self-resolving; therefore, asymptomatic patients typically require only observation.&nbsp; For those with symptomatic or unresolved disease, management options include topical treatments (eg, podophyllotoxin) and surgical removal.</p><p><strong>(Choice A)</strong>&nbsp; The scotch tape test is used to diagnose&nbsp;pinworms (<em>Enterobius vermicularis</em>), which can cause anal pruritus and bloody spotting (secondary to scratching); however, pinworms do not cause skin lesions.</p><p><strong>(Choice B)</strong>&nbsp; Poor vulvar hygiene is a risk factor for nonspecific vulvovaginitis (particularly in prepubertal girls), which can present with vulvovaginal pruritus, erythema, and bleeding.&nbsp; Poor vulvar hygiene does not cause raised vulvar lesions.</p><p><strong>(Choices C and D)</strong>&nbsp; The poor glycemic control and immunosuppression associated with diabetes mellitus (ie, elevated hemoglobin A1c) can cause recurrent vulvovaginal candidiasis and candidal intertrigo.&nbsp; Patients typically have vulvovaginal pruritus and a thick, white vaginal discharge (vulvovaginal candidiasis) or a bright-red lesion over skinfolds (intertrigo).&nbsp; There are no associated multiple, raised, fleshy papules.</p><p><strong>(Choice F)</strong>&nbsp; Vulvar cancer is also caused by HPV infection but is rare in children.&nbsp; It typically presents as a single vulvar mass rather than multiple masses.&nbsp; Because it is associated with infection, family history does not help with the diagnosis.</p><p><strong>Educational objective:</strong><br>Condyloma acuminata (anogenital warts) occur due to infection with human papillomavirus and can present as friable, raised papules.&nbsp; Although many cases in children are due to nonsexual contact (eg, autoinoculation), the association with disease transmission via direct genital contact requires assessment for sexual abuse.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 9031,
            "topic": "Warts",
            "titleId": 9031,
            "title": "Warts",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "5",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Administer scotch tape test",
                    "choiceNumber": 1,
                    "correctTaken": 277,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ask about vulvar hygiene",
                    "choiceNumber": 2,
                    "correctTaken": 2150,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Measure hemoglobin A1c",
                    "choiceNumber": 3,
                    "correctTaken": 94,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform wet mount microscopy",
                    "choiceNumber": 4,
                    "correctTaken": 520,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Question about sexual abuse",
                    "choiceNumber": 5,
                    "correctTaken": 12397,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Review family history for malignancy",
                    "choiceNumber": 6,
                    "correctTaken": 970,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "566",
                    "mediaDataId": 0,
                    "title": "Nonaccidental trauma in children",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26658657",
                    "mediaDataId": 0,
                    "title": "Sexually transmitted infections in children as a marker of child sexual abuse and direction of future research.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26658657",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29166505",
                    "mediaDataId": 0,
                    "title": "Anogenital warts in pediatric population.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29166505",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29962062",
                    "mediaDataId": 0,
                    "title": "Anogenital warts in children: analysis of a cohort of 34 prepubertal children.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29962062",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 3,
            "othersAvgTimeSpent": 46,
            "notes": null,
            "peopleTaken": 16408,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 76,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 3,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 13374,
            "questionIndex": 14752,
            "questionText": "<p>A 44-year-old woman comes to the office for evaluation of abnormal uterine bleeding.&nbsp; The patient has had intermenstrual bleeding over the past 3 months.&nbsp; Most of the time, she has had only spotting with wiping, but last week, she had slightly heavier bleeding that required her to use a menstrual pad.&nbsp; In addition to this intermenstrual bleeding, the patient also has monthly menses with 4-5 days of moderate bleeding and slight cramping on the first 2 days that typically resolves with ibuprofen.&nbsp; She has no chronic medical conditions and takes no daily medications.&nbsp; The patient had a bilateral tubal ligation after her last delivery at age 31.&nbsp; Vital signs are normal.&nbsp; BMI is 22 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Speculum examination reveals a multiparous cervix with a small amount of bright red blood at the os and no visible cervical or vaginal lesions.&nbsp; On bimanual pelvic examination, the uterus is small, mobile, and nontender.&nbsp; No adnexal masses are palpated.&nbsp; FSH, TSH, and prolactin levels are normal.&nbsp; Urine pregnancy test is negative.&nbsp; Which of the following is the most likely cause of this patient&#39;s abnormal uterine bleeding?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"4775\" src=\"https://www.uworld.com/media/L29448.jpg\" ></p><p>This premenopausal patient with regular monthly menses and intermenstrual bleeding most likely has an <strong>endometrial polyp</strong>.&nbsp; Endometrial polyps are common, well-vascularized, hyperplastic endometrial gland growths that extend into the uterine cavity.&nbsp; Endometrial polyps typically develop in women in their 30s and 40s.</p><p>Most endometrial polyps are benign and asymptomatic, but they can cause <strong>abnormal uterine bleeding (AUB)</strong> in some patients due to their friability and vascularity.&nbsp; Because endometrial polyps do not affect ovulation, patients typically have <strong>regular monthly menses</strong> with painless, light <strong>intermenstrual bleeding</strong>.&nbsp; Endometrial polyps typically remain intracavitary; therefore, patients typically have a small, nontender uterus with no visible cervical or vaginal lesions.</p><p>Treatment of symptomatic endometrial polyps is with hysteroscopic polypectomy.</p><p><strong>(Choice A)</strong>&nbsp; Although <a href=\"1210\">adenomyosis</a> is a common cause of heavy, painful menses in women age &gt;40, affected patients have regular (ie, ovulatory) menses with no intermenstrual bleeding.&nbsp; In addition, patients with adenomyosis typically have a boggy, uniformly enlarged uterus.</p><p><strong>(Choice B)</strong>&nbsp; Endometrial hyperplasia typically presents as irregular, anovulatory menses in women with risk factors for excess unopposed estrogen (eg, obesity, tamoxifen).&nbsp; This patient has a normal BMI and regular menses, making this diagnosis less likely.</p><p><strong>(Choice D)</strong>&nbsp; Invasive <a href=\"8311\">cervical cancer</a> can cause irregular spotting or heavy vaginal bleeding due to cervical friability from a mass.&nbsp; This patient has no visible cervical or vaginal lesions, making this diagnosis unlikely.</p><p><strong>(Choice E)</strong>&nbsp; This patient has regular, monthly menses with molimina (eg, cramping) and a normal FSH level, making perimenopause an unlikely cause of her AUB.</p><p><strong>(Choice F)</strong>&nbsp; <a href=\"14699\">Uterine leiomyomas (fibroids)</a> typically cause regular (ie, ovulatory) but heavy, prolonged menses and an irregularly enlarged, bulky uterus, which are not seen in this patient.</p><p><strong>Educational objective:</strong><br>Endometrial polyps typically present with regular monthly menses and additional intermenstrual bleeding.&nbsp; Symptomatic endometrial polyps are treated with hysteroscopic polypectomy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 17488,
            "topic": "Abnormal uterine bleeding",
            "titleId": 17488,
            "title": "Abnormal uterine bleeding",
            "topicAttributeId": 330800,
            "topicAttribute": "Menstrual disorders and contraception",
            "correctAnswer": "3",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adenomyosis",
                    "choiceNumber": 1,
                    "correctTaken": 905,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometrial hyperplasia",
                    "choiceNumber": 2,
                    "correctTaken": 3263,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometrial polyp",
                    "choiceNumber": 3,
                    "correctTaken": 7372,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Invasive cervical cancer",
                    "choiceNumber": 4,
                    "correctTaken": 426,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perimenopause",
                    "choiceNumber": 5,
                    "correctTaken": 3915,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine leiomyomas",
                    "choiceNumber": 6,
                    "correctTaken": 1045,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "79",
                    "mediaDataId": 0,
                    "title": "Endometrial polyp",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "15749501",
                    "mediaDataId": 0,
                    "title": "Hysteroscopic polypectomy in 240 premenopausal and postmenopausal women.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/15749501",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21783430",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of endometrial polyps: a critical review of the literature.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21783430",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26803558",
                    "mediaDataId": 0,
                    "title": "Abnormal uterine bleeding.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26803558",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 2,
            "othersAvgTimeSpent": 88,
            "notes": null,
            "peopleTaken": 16926,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 44,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 2,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 10916,
            "questionIndex": 12052,
            "questionText": "<p>A 60-year-old woman, gravida 3 para 3, comes to the office due to progressive bloating.&nbsp; The patient has noticed that she cannot fit into any of her pants despite recent nausea and a decreased appetite.&nbsp; She feels full quickly with meals and has increasing constipation.&nbsp; Menopause was at age 51, and she has had no postmenopausal bleeding or hormone replacement therapy.&nbsp; The patient has had no surgeries and all of her children were born via spontaneous vaginal delivery.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 120/70 mm Hg, and pulse is 88/min.&nbsp; Cardiopulmonary examination is unremarkable.&nbsp; The abdomen is nontender and mildly distended.&nbsp; Bowel sounds are normal and there is no fluid wave.&nbsp; Pelvic examination reveals a firm, immobile mass in the left adnexa and rectovaginal nodularity.&nbsp; A pelvic ultrasound and CT scan of the abdomen and pelvis confirm the physical examination findings.&nbsp; CA-125 is 57 U/mL (normal: &lt;35 U/mL).&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32688\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Epithelial ovarian carcinoma</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><ul><li>Asymptomatic: incidental adnexal mass</li><li>Subacute: pelvic/abdominal pain, bloating, early satiety</li><li>Acute: dyspnea, obstipation/constipation, abdominal distension</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Family history</li><li>Genetic mutations (<em>BRCA1</em>,<em> BRCA2</em>)</li><li>Age &ge;50</li><li>Endometriosis</li><li>Infertility</li><li>Early menarche/late menopause</li></ul></td></tr><tr><td><p align=\"center\"><strong>Protective factors</strong></p></td><td><ul><li>Oral contraceptive pills</li><li>Multiparity</li><li>Breastfeeding</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>&uarr;CA-125</li></ul></td></tr><tr><td><p align=\"center\"><strong>Ultrasound findings</strong></p></td><td><ul><li>Solid, complex mass</li><li>Thick septations</li><li>Ascites</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Surgical exploration</li><li>&plusmn; Chemotherapy</li></ul></td></tr></tbody></table></div><p><strong>Epithelial ovarian cancer</strong> (EOC) occurs primarily in postmenopausal women and most often presents with advanced disease because the earliest symptoms of disease are vague and nonspecific (eg, constipation, bloating).&nbsp; This postmenopausal woman&#39;s firm, nonmobile <strong>pelvic mass with nodularity</strong> is concerning for EOC that has extended beyond the adnexa.</p><p>Initial evaluation of postmenopausal women with suspected EOC is with pelvic imaging (eg, ultrasound), which identifies mass characteristics (eg, thick septations, increased vascularity), and CA-125, which is released by cells from the peritoneum, uterus, and fallopian tubes, all of which are in close proximity to the rapidly growing ovary (ie, malignancy).&nbsp; In postmenopausal women with a malignant-appearing mass, CA-125 aids in disease monitoring and response to treatment (ie, chemotherapy).&nbsp; In contrast, in postmenopausal women with a benign-appearing mass, CA-125 stratifies the risk for cancer.</p><p>Additional imaging (eg, CT scan) is performed in patients with suspected EOC to evaluate for distant metastases and for surgical planning.&nbsp; In the absence of distant metastases, suspected EOC is treated with <strong>exploratory laparotomy</strong> and <strong>surgical staging and tumor debulking</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Colorectal cancer symptoms overlap with those of ovarian cancer (eg, bloating, constipation, rectovaginal nodularity).&nbsp; However, this patient has a fixed adnexal mass with an elevated CA-125 more likely indicating ovarian cancer.&nbsp; Colorectal cancer often presents with an elevated CEA.</p><p><strong>(Choice B)</strong>&nbsp; Estrogen and FSH levels are not routinely used to evaluate for EOC because the malignant cells do not alter hormonal secretion.&nbsp; However, they can be helpful in patients with an adnexal mass and signs of hyperestrogenism (eg, postmenopausal bleeding, breast tenderness) to evaluate for a suspected granulosa cell tumor, which causes high levels of estradiol and inhibin (which typically inhibits FSH).</p><p><strong>(Choice D)</strong>&nbsp; Image-guided biopsy is contraindicated in patients with suspected EOC because biopsy can lead to rupture of the mass and result in spreading of the cancerous cells throughout the abdomen, significantly increasing the disease stage.&nbsp; Ideally, the mass is removed intact during exploratory laparotomy.</p><p><strong>(Choice E)</strong>&nbsp; A small bowel follow-through can evaluate for small intestine function, obstruction, or masses in patients with suspected obstruction.&nbsp; Nausea/vomiting and early satiety can be symptoms of partial obstruction; however, this diagnosis is less likely in a patient with a nontender abdomen and normal bowel sounds.</p><p><strong>Educational objective:</strong><br>Advanced ovarian cancer may present in postmenopausal women with an immobile pelvic mass.&nbsp; Suspected ovarian cancer with no distant metastases is managed with exploratory laparotomy, staging, and tumor debulking.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3170,
            "topic": "Ovarian cancer",
            "titleId": 3170,
            "title": "Ovarian cancer",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "3",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Colonoscopy",
                    "choiceNumber": 1,
                    "correctTaken": 938,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Estrogen and FSH levels",
                    "choiceNumber": 2,
                    "correctTaken": 686,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Exploratory laparotomy",
                    "choiceNumber": 3,
                    "correctTaken": 8732,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Image-guided biopsy of pelvic mass",
                    "choiceNumber": 4,
                    "correctTaken": 6180,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Small bowel follow-through",
                    "choiceNumber": 5,
                    "correctTaken": 109,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "52",
                    "mediaDataId": 0,
                    "title": "Epithelial ovarian cancer",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27141074",
                    "mediaDataId": 0,
                    "title": "Optimal primary therapy of ovarian cancer.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27141074",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 2,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 16645,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 52,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 2,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 4158,
            "questionIndex": 4158,
            "questionText": "<p>A 22-year-old nulligravid woman comes to the office for her first gynecologic examination and to discuss contraception options.&nbsp; Menarche was at age 13.&nbsp; Her last menses was 2 weeks ago; periods occur every 30 days and last for 4 days.&nbsp; The patient has no dysuria, urinary frequency, vaginal discharge, postcoital spotting, or abdominal pain.&nbsp; She became sexually active a few months ago with her boyfriend; she is monogamous and currently uses condoms for contraception.&nbsp; The patient takes no medications and has no allergies.&nbsp; She does not use tobacco, alcohol, or illicit drugs.&nbsp; The patient has received all recommended vaccinations except for the human papillomavirus series.&nbsp; Her mother was diagnosed with ovarian cancer at age 46 and is currently undergoing chemotherapy.&nbsp; Vital signs are normal.&nbsp; Complete physical examination, including pelvic examination, shows no abnormalities.&nbsp; A urine pregnancy test is negative.&nbsp; In addition to her first Pap test, which of the following is the best recommendation for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31462\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Chlamydia &amp; gonorrhea in women</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors </strong></p></td><td><ul><li>Age &lt;25</li><li>High-risk sexual behavior</li></ul></td></tr><tr><td><p align=\"center\"><strong>Manifestations </strong></p></td><td><ul><li>Asymptomatic (most common)</li><li>Cervicitis</li><li>Urethritis</li><li>Perihepatitis (Fitz-Hugh&ndash;Curtis syndrome)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis </strong></p></td><td><ul><li>Nucleic acid amplification testing</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment </strong></p></td><td><ul><li>Empiric: ceftriaxone + doxycycline*</li><li>Confirmed chlamydia: doxycycline*</li><li>Confirmed gonorrhea: ceftriaxone</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications </strong></p></td><td><ul><li>Pelvic inflammatory disease</li><li>Ectopic pregnancy</li><li>Infertility</li><li>Pharyngitis</li></ul></td></tr><tr><td colspan=\"2\"><p>*Azithromycin in pregnancy.</p></td></tr></tbody></table></div><p><em><strong>Chlamydia trachomatis</strong></em> and <em><strong>Neisseria gonorrhoeae</strong></em> are the 2 most common bacterial sexually transmitted infections and have a <strong>high prevalence</strong> in women age &lt;25.&nbsp; However, these infections often have <strong>no symptoms</strong>.&nbsp; Due to the lack of symptoms (and subsequent lack of treatment) and high prevalence, patients are at risk of ascending infection (eg, pelvic inflammatory disease) that can result in long-term sequelae (eg, infertility, ectopic pregnancy) due to tubal scarring.</p><p>Therefore, all <strong>sexually active women age &lt;25</strong> are recommended <strong>annual screening</strong> for <em>C trachomatis</em> and <em>N gonorrhoeae</em>, including those with low-risk sexual behavior (eg, monogamous, condom use) such as this patient.&nbsp; The <strong>nucleic acid amplification test</strong> (NAAT) is the gold standard for screening and diagnosis due to its high sensitivity and specificity.</p><p><strong>(Choice A)</strong>&nbsp; Cervical cancer screening most commonly begins at age 21 with cervical cytology (ie, Pap test).&nbsp; However, routine human papillomavirus (HPV) cotesting is not recommended in patients age &lt;30 because most HPV infections are transient and spontaneously clear in younger patients.&nbsp; Unnecessary cotesting increases the risk of cervical procedures, which can lead to obstetric complications (eg, preterm birth).&nbsp; Instead, this patient should be offered the HPV vaccination series, which can be initiated at age &lt;26, regardless of sexual activity.</p><p><strong>(Choice C)</strong>&nbsp; Clean-catch urinalysis is used to evaluate for cystitis in patients with symptoms (eg, dysuria, hematuria).&nbsp; This patient is asymptomatic, and screening for cystitis in asymptomatic patients is generally not recommended.</p><p><strong>(Choice E)</strong>&nbsp; Routine syphilis screening (eg, nontreponemal serology) is recommended in asymptomatic patients with a prior sexually transmitted infection, &gt;1 sexual partner in the last 6 months, high-risk populations (eg, men who have sex with men), and pregnant patients due to the risk of congenital syphilis.&nbsp; This patient does not meet the criteria for testing (ie, no symptoms of syphilis [eg, chancre, maculopapular rash]) or routine screening.</p><p><strong>(Choice F)</strong>&nbsp; Wet mount microscopy evaluates for bacterial vaginosis, candidiasis, and trichomoniasis, all of which typically present with vaginal discharge.&nbsp; In contrast, this asymptomatic patient would likely have normal vaginal flora on microscopy, making this test unnecessary.</p><p><strong>Educational objective:</strong><br>All sexually active women age &lt;25 are recommended annual screening for <em>Chlamydia trachomatis</em> and <em>Neisseria gonorrhoeae</em> due to high rates of asymptomatic infection and risk of long-term sequelae (eg, infertility).&nbsp; Nucleic acid amplification testing is the gold standard testing method.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 8096,
            "topic": "Pelvic inflammatory disease",
            "titleId": 8096,
            "title": "Pelvic inflammatory disease",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cervical human papillomavirus testing",
                    "choiceNumber": 1,
                    "correctTaken": 3922,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cervical swab for chlamydia and gonorrhea",
                    "choiceNumber": 2,
                    "correctTaken": 11784,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Clean-catch urinalysis",
                    "choiceNumber": 3,
                    "correctTaken": 476,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No additional testing needed",
                    "choiceNumber": 4,
                    "correctTaken": 3784,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nontreponemal serology for syphilis",
                    "choiceNumber": 5,
                    "correctTaken": 227,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Wet mount microscopy of cervical mucus",
                    "choiceNumber": 6,
                    "correctTaken": 83,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "42",
                    "mediaDataId": 0,
                    "title": "Acute cervicitis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24622331",
                    "mediaDataId": 0,
                    "title": "Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae—2014.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24622331",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26042815",
                    "mediaDataId": 0,
                    "title": "Sexually transmitted diseases treatment guidelines, 2015.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26042815",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "33332296",
                    "mediaDataId": 0,
                    "title": "Update to CDC&#39;s treatment guidelines for gonococcal infection, 2020.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/33332296",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 2,
            "othersAvgTimeSpent": 58,
            "notes": null,
            "peopleTaken": 20276,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 58,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 2,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 18482,
            "questionIndex": 19952,
            "questionText": "<p>A 58-year-old woman, gravida 2 para 2, comes to the office for evaluation of increased urinary frequency and painful urination.&nbsp; The patient developed these symptoms 2 days ago, and they did not improve despite increasing fluid intake and voiding regularly.&nbsp; She has had 2 other episodes of acute simple cystitis in the past 8 months, which resolved with antibiotics.&nbsp; The patient underwent menopause at age 53 and has had no episodes of postmenopausal bleeding.&nbsp; BMI is 28 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Vital signs are normal.&nbsp; Physical examination shows mild suprapubic tenderness and no costovertebral tenderness.&nbsp; Pelvic examination shows thin vulvar tissue but no excoriations or lesions.&nbsp; Urinalysis is positive for leukocyte esterase and nitrites.&nbsp; The patient is prescribed a course of antibiotics and is asymptomatic a week later.&nbsp; Which of the following is the best next step in management of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33193\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Recurrent urinary tract infection</strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td><ul><li>&ge;2 infections in 6 months</li><li>&ge;3 infections in 1 year</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>History of cystitis at age &le;15</li><li>Spermicide use</li><li>New sexual partner</li><li>Postmenopausal status</li></ul></td></tr><tr><td><p align=\"center\"><strong>Evaluation</strong></p></td><td><ul><li>Urinalysis</li><li>Urine culture</li></ul></td></tr><tr><td><p align=\"center\"><strong>Prevention</strong></p></td><td><ul><li>Behavior modification</li><li>Postcoital or daily antibiotic prophylaxis</li><li>Topical vaginal estrogen for postmenopausal patients&nbsp; &nbsp;</li></ul></td></tr></tbody></table></div><p>This patient has <strong>recurrent urinary tract infections</strong> (UTI), defined as <strong>&#8805;3 episodes in a year</strong> (or &#8805;2 episodes in 6 months) of simple cystitis (eg, leukocyte esterase and nitrites on urinalysis with no costovertebral tenderness).&nbsp; Women are at increased risk for cystitis due to the proximity of the urethra to the vagina and rectum.&nbsp; In <strong>postmenopausal women</strong>, the risk increases further due to <strong>estrogen deficiency</strong>, which causes:</p><ul><li><p>vulvovaginal atrophy (eg, thin vulvar tissue).</p></li></ul><ul><li><p>decreased bulk and elasticity of the bladder trigone and urethra, resulting in an increased risk for ascending infection.</p></li></ul><ul><li><p>decreased vaginal lactobacilli levels and an <strong>elevated vaginal pH</strong>, leading to an increased rate of vaginal <em>Escherichia coli</em> colonization.</p></li></ul><p>Therefore, in addition to behavioral changes (eg, increased fluid intake), treatment of postmenopausal women with recurrent UTI is with topical <strong>vaginal estrogen</strong>.&nbsp; Topical estrogen can improve genitourinary atrophy and prevent future UTI episodes.&nbsp; In addition to vaginal estrogen, antibiotic prophylaxis (daily or postcoital) can be considered.</p><p><strong>(Choices A and E)</strong>&nbsp; Cystoscopy and urine cytology can evaluate for bladder cancer, which may present with recurrent UTIs; however, bladder cancer is typically associated with gross hematuria or red blood cells on urinalysis, which are not seen in this patient.&nbsp; In addition, she has no significant risk factors (eg, tobacco use, prior pelvic radiation).</p><p><strong>(Choice B)</strong>&nbsp; Daily probiotic consumption has not been shown to increase vaginal <em>Lactobacillus</em> colonization or decrease the risk of recurrent cystitis.</p><p><strong>(Choice C)</strong>&nbsp; Pelvic ultrasonography may be indicated in patients with abnormal uterine bleeding (eg, postmenopausal bleeding) or a pelvic mass; it is not used to evaluate recurrent cystitis.</p><p><strong>(Choice D)</strong>&nbsp; Topical corticosteroids can treat vulvar <a href=\"38669\">lichen planus</a> and lichen sclerosus, which may present in postmenopausal patients with dyspareunia and atrophic vulvar tissue.&nbsp; However, patients typically have visible lesions (ie, plaques) or excoriations due to vulvar pruritus, which are not seen in this patient.</p><p><strong>Educational objective:</strong><br>Recurrent urinary tract infections (&#8805;3 episodes in a year or &#8805;2 episodes in 6 months) commonly occur in postmenopausal patients due to estrogen deficiency, which causes vulvovaginal atrophy, decreased bulk and elasticity of the bladder trigone and urethra, and increased vaginal pH.&nbsp; Treatment is with vaginal estrogen.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 19887,
            "topic": "Urinary tract infection",
            "titleId": 19887,
            "title": "Urinary tract infection",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "6",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cystoscopy",
                    "choiceNumber": 1,
                    "correctTaken": 4157,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Daily probiotic consumption",
                    "choiceNumber": 2,
                    "correctTaken": 1651,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pelvic ultrasound",
                    "choiceNumber": 3,
                    "correctTaken": 2491,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Topical corticosteroids",
                    "choiceNumber": 4,
                    "correctTaken": 173,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urine cytology",
                    "choiceNumber": 5,
                    "correctTaken": 1637,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vaginal estrogen",
                    "choiceNumber": 6,
                    "correctTaken": 9063,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "57",
                    "mediaDataId": 0,
                    "title": "Genitourinary syndrome of menopause",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27472999",
                    "mediaDataId": 0,
                    "title": "Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27472999",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 5,
            "othersAvgTimeSpent": 69,
            "notes": null,
            "peopleTaken": 19172,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 47,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 5,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 3656,
            "questionIndex": 3656,
            "questionText": "<p>A 52-year-old woman comes to the office due to a pruritic rash on the inguinal region and vulva.&nbsp; Over the last 2 weeks the patient&#39;s inguinal and vulvar skin has become increasingly irritated and pruritic, particularly after she wears tight clothing.&nbsp; Application of an over-the-counter moisturizing cream has not improved the symptoms.&nbsp; The patient was recently hospitalized for an asthma exacerbation and treated with inhaled bronchodilators and systemic corticosteroids.&nbsp; She underwent a cervical conization at age 36 for dysplasia; all subsequent Pap tests have been normal.&nbsp; The patient has been sexually active with a new partner for the past few months, but the pruritus has prevented intercourse.&nbsp; Her last menstrual period was 8 months ago.&nbsp; BMI is 32 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Vital signs are normal.&nbsp; Examination of the patient is seen in the <a href=\"17332\">exhibit</a>.&nbsp; Which of the following is the most appropriate treatment for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"17335\" src=\"https://www.uworld.com/media/L16937.jpg\" ></p><p>This patient&#39;s <strong>erythematous (&#x22;beefy red&#x22;) plaques</strong> within the inguinal folds are consistent with <strong>intertrigo</strong>, a dermatitis that typically occurs within the inguinal, axillary, gluteal, and inframammary folds.&nbsp; Patients with intertrigo typically have erythematous plaques in a symmetric &#x22;kissing&#x22; or &#x22;mirror image&#x22; pattern across the skinfold and multiple <strong>satellite lesions</strong> near the primary infection.</p><p>The most common cause of intertrigo is <strong><em>Candida albicans</em></strong>, a part of the normal flora of the urogenital and gastrointestinal tracts.&nbsp; Patients at risk for candida intertrigo include those with impaired immunity (eg, <strong>systemic corticosteroid use</strong>, diabetes mellitus), particularly when associated with increased skin moisture or friction (eg, obesity, tight-fitting clothing), which can cause skin maceration and trauma.</p><p>Diagnosis is typically clinical but can be confirmed by visualization of hyphae or pseudohyphae on microscopic examination of skin scrapings from affected areas.&nbsp; Treatment is typically with <strong>topical azoles</strong> (eg, <strong>clotrimazole</strong>, ketoconazole), which help decrease the spread of infection and have some anti-inflammatory and antibacterial properties.</p><p><strong>(Choice B)</strong>&nbsp; Doxycycline is used for the treatment of <a href=\"8128\">hidradenitis suppurativa</a>, which commonly occurs in intertriginous areas.&nbsp; Patients typically have tender inflammatory nodules, often with associated sinus tract formation and multiple open comedones.</p><p><strong>(Choice C)</strong>&nbsp; Estrogen cream is indicated for the treatment of vulvovaginal atrophy (ie, genitourinary syndrome of menopause).&nbsp; Patients with vulvovaginal atrophy typically have thinned, hypopigmented skin with decreased moisture.</p><p><strong>(Choice D)</strong>&nbsp; Trichloroacetic acid is indicated in the management of condyloma acuminata (seen in a man in this <a href=\"2309\">exhibit</a>), which are associated with persistent human papillomavirus infection.&nbsp; However, they typically appear as soft, verrucous growths in the anogenital region.</p><p><strong>(Choice E)</strong>&nbsp; Trimethoprim-sulfamethoxazole is a treatment option for cellulitis.&nbsp; In contrast to this patient, those with cellulitis typically have a unilateral, rather than bilateral, lesion.</p><p><strong>Educational objective:</strong><br>Intertrigo typically presents erythematous plaques with associated satellite lesions within intertriginous areas (eg, inguinal and axillary folds).&nbsp; A common cause is an overgrowth of <em>Candida albicans</em>, which often occurs during times of immunosuppression (eg, systemic corticosteroid use).&nbsp; Treatment includes topical azoles (eg, clotrimazole, ketoconazole).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 22504,
            "topic": "Vulvovaginitis",
            "titleId": 22504,
            "title": "Vulvovaginitis",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "1",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Clotrimazole ointment",
                    "choiceNumber": 1,
                    "correctTaken": 14010,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Doxycycline",
                    "choiceNumber": 2,
                    "correctTaken": 214,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Estrogen cream",
                    "choiceNumber": 3,
                    "correctTaken": 771,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Trichloroacetic acid",
                    "choiceNumber": 4,
                    "correctTaken": 1043,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Trimethoprim-sulfamethoxazole",
                    "choiceNumber": 5,
                    "correctTaken": 145,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "715",
                    "mediaDataId": 0,
                    "title": "Candida infections",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26051058",
                    "mediaDataId": 0,
                    "title": "Fungal infections of the folds (intertriginous areas).",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26051058",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24695603",
                    "mediaDataId": 0,
                    "title": "Intertrigo and secondary skin infections.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24695603",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 3,
            "othersAvgTimeSpent": 51,
            "notes": null,
            "peopleTaken": 16200,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 86,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 3,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 3365,
            "questionIndex": 3365,
            "questionText": "<p>A 27-year-old nulligravid woman comes to the office with her husband due to inability to conceive.&nbsp; The patient and her husband stopped using barrier contraception a year ago and have intercourse every other day.&nbsp; Her menses occur every 28 days and last 5 days with 2 days of heavy bleeding and moderate cramping.&nbsp; She has bloating the day before her menses start, but no pain with intercourse.&nbsp; In her late teens, the patient was hospitalized for a pelvic infection; during that time, she had pain with intercourse, vaginal discharge, and fever.&nbsp; She has no other medical or surgical history.&nbsp; Family history is significant for a sister with polycystic ovary syndrome.&nbsp; The patient&#39;s husband has no children from prior relationships, and his semen analysis is normal.&nbsp; BMI is 30 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Blood pressure is 128/76 mm Hg and pulse is 82/min.&nbsp; Physical examination, including pelvic examination, shows no abnormalities.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"49027\" src=\"https://www.uworld.com/media/highresdefault/L77244.jpg\"  ></p><p>This patient has <strong>primary infertility</strong>, or failure to conceive after 12 months of unprotected sexual intercourse in nulliparous women age &lt;35 (or after 6 months at age &#8805;35).&nbsp; A normal semen analysis makes female factor infertility most likely.&nbsp; Female factor infertility is generally categorized into:</p><ul><li><strong>anatomic</strong> disorders (eg, fallopian tube obstruction)</li><li><strong>ovulatory</strong> dysfunction (eg, anovulation)</li><li><strong>endocrine</strong> disorders (eg, hyperprolactinemia).</li></ul><p><strong>Patient history</strong> helps to identify the most likely underlying etiology.</p><p>This patient&#39;s regular menses (eg, every 28 days) and classic molimina symptoms (eg, bloating), which are caused by increasing progesterone during the luteal phase of the menstrual cycle, make ovulatory dysfunction and endocrine disorders unlikely.&nbsp; However, her hospitalization in adolescence for <strong>fever, dyspareunia, and vaginal discharge</strong> is consistent with prior <strong>pelvic inflammatory disease</strong> (PID), a common cause of infertility due to <strong>tubal scarring and obstruction</strong>.</p><p>The first-line test for suspected <strong>tubal factor infertility</strong> is a <strong>hysterosalpingogram</strong> (HSG), which infuses radiocontrast into the uterus under fluoroscopy.&nbsp; Because the uterus is contiguous with the fallopian tubes and thus the peritoneal cavity, HSGs in patients with normal, patent fallopian tubes show bilateral intraperitoneal spill of contrast.&nbsp; <strong>No intraperitoneal spill of contrast</strong> from 1 or both tubes is consistent with tubal factor infertility.</p><p><strong>(Choice A)</strong>&nbsp; Laparoscopy, which visualizes the peritoneal cavity, is indicated in patients with infertility and suspected peritoneal adhesions or endometriosis.&nbsp; However, these patients typically have a history of abdominal surgery or recurring pain with intercourse, both of which are not present in this patient.</p><p><strong>(Choice C)</strong>&nbsp; A mid-cycle LH level (to confirm LH surge 36 hours prior to ovulation) is obtained in patients with infertility and suspected ovulatory dysfunction (eg, irregular menses, no molimina symptoms).&nbsp; This patient has regular menses and classic molimina symptoms; therefore, an LH level would not be useful.</p><p><strong>(Choice D)</strong>&nbsp; <a href=\"67928\">Progesterone challenge tests</a> are indicated in patients with secondary amenorrhea (ie, no bleeding after progesterone administration indicates low estrogen).&nbsp; This test is not indicated in patients with regular menses.</p><p><strong>(Choice E)</strong>&nbsp; FSH, TSH, and testosterone levels are obtained if an endocrine disorder (primary ovarian insufficiency, hypothyroidism, and polycystic ovary syndrome, respectively) is suspected.&nbsp; However, endocrine disorders severe enough to cause infertility are characterized by irregular menses (eg, oligomenorrhea) and usually associated with additional symptoms (eg, hot flashes, hirsutism).&nbsp; These laboratory studies are not necessary in this patient with regular, ovulatory menses and a history strongly suggestive of PID.</p><p><strong>Educational objective:</strong><br>Infertility is failure to conceive after 12 months of unprotected sexual intercourse in women age &lt;35.&nbsp; A hysterosalpingogram is used to diagnose an anatomic cause of infertility such as tubal obstruction from prior pelvic infection.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 7389,
            "topic": "Infertility",
            "titleId": 7389,
            "title": "Infertility",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "2",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Diagnostic laparoscopy",
                    "choiceNumber": 1,
                    "correctTaken": 493,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hysterosalpingogram",
                    "choiceNumber": 2,
                    "correctTaken": 10442,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Mid-cycle LH level",
                    "choiceNumber": 3,
                    "correctTaken": 1742,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Progesterone challenge test",
                    "choiceNumber": 4,
                    "correctTaken": 545,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum FSH, TSH, and testosterone levels",
                    "choiceNumber": 5,
                    "correctTaken": 3502,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "632",
                    "mediaDataId": 0,
                    "title": "Infertility",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28007229",
                    "mediaDataId": 0,
                    "title": "Sexually transmitted diseases and infertility.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28007229",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25822387",
                    "mediaDataId": 0,
                    "title": "Evaluation and treatment of infertility.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25822387",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 3,
            "othersAvgTimeSpent": 57,
            "notes": null,
            "peopleTaken": 16724,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 3,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 14048,
            "questionIndex": 15451,
            "questionText": "<p>A 16-year-old girl is brought to the office for evaluation of vulvar bumps.&nbsp; The bumps have been present for the past 4 months but are not painful or itchy.&nbsp; She stopped shaving when she noticed that they were increasing in number and size.&nbsp; The patient is currently sexually active with one partner, and she consistently uses condoms for contraception.&nbsp; BMI is 35 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The lesions are shown in the <a href=\"69478\">exhibit</a>.&nbsp; Which of the following would have been most effective in preventing this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T100429\" style=\"overflow-x:auto;\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Genital warts (condylomata acuminata)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>HPV 6 &amp; 11</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Multiple pink or skin-colored lesions</li><li>Lesions ranging from smooth, flattened papules<br>to exophytic/cauliflower-like growths</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Chemical: podophyllin resin, trichloroacetic acid</li><li>Immunologic: imiquimod</li><li>Surgical: cryotherapy, laser therapy, excision</li></ul></td></tr><tr><td><p align=\"center\"><strong>Prevention</strong></p></td><td><ul><li>Vaccination</li><li>Barrier contraception</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>HPV</strong> = human papillomavirus.</p></td></tr></tbody></table></div><p>This patient has <strong>anogenital warts</strong> (condylomata acuminata) caused by <strong>low-risk human papillomavirus (HPV)</strong>, typically types 6 and 11.&nbsp; HPV enters the epidermis through <strong>sexual contact</strong> (ie, microabrasions), causing soft, <a href=\"37353\">fleshy, verrucous bumps</a> that progress over several months.&nbsp; Once present, anogenital warts can worsen or regress spontaneously (ie, immune clearance).&nbsp; Most patients are <strong>asymptomatic</strong> but some may develop pruritus or friability (spotting with wiping).</p><p>HPV infection, particularly with high-risk types 16 and 18, is also associated with anogenital (eg, cervical, anal) and oropharyngeal cancers.&nbsp; The <strong>most effective preventive strategy</strong> for both low-risk and high-risk types is <strong>HPV vaccination</strong>, ideally prior to initial sexual contact (ie, first HPV exposure).&nbsp; Barrier contraceptive use is also protective (although skin contact beyond barrier protection may still permit viral transmission).</p><p>Small anogenital warts (ie, &lt;1 cm) are treated with <strong>topical agents</strong> that can decrease wart size or induce regression by either chemical injury (eg, <strong>trichloroacetic acid</strong>, podophyllin resin) or immunomodulation (eg, imiquimod).&nbsp; Surgical excision may be indicated for bulky, extensive lesions.&nbsp; Recurrence rates are high regardless of treatment modality.</p><p><strong>(Choice A)</strong>&nbsp; Pseudofolliculitis barbae (ie, &#x22;razor bumps&#x22;) develop following hair removal, most often because of shaving.&nbsp; Inflamed <a href=\"49421\">follicular papules</a> develop in response to entrapped, recently trimmed hairs.&nbsp; This patient has verrucous, fleshy lesions from low-risk HPV infection instead of inflamed papules related to shaving.</p><p><strong>(Choices B and E)</strong>&nbsp; Avoiding tight-fitting clothing and maintaining proper vulvar hygiene (eg, wiping front to back) help prevent nonspecific vulvovaginitis, a common cause of itching and vulvar irritation in adolescents.&nbsp; However, these measures do not prevent HPV exposure and the development of anogenital warts.</p><p><strong>(Choice D)</strong>&nbsp; An elevated BMI is associated with acrochordons (skin tags) in areas of friction and <a href=\"545\">acanthosis nigricans</a> (a sign of insulin resistance).&nbsp; There is no association between BMI and anogenital warts.</p><p><strong>Educational objective:</strong><br>Condylomata acuminata, or anogenital warts, are caused by infection with low-risk human papillomavirus (HPV) (eg, types 6 and 11) and typically present as nontender, smooth, or verrucous anogenital lesions that may be asymptomatic, friable, or pruritic.&nbsp; The most effective preventive strategy against developing condylomata acuminata is HPV vaccination.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 9031,
            "topic": "Warts",
            "titleId": 9031,
            "title": "Warts",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Avoiding shaving",
                    "choiceNumber": 1,
                    "correctTaken": 677,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Avoiding tight-fitting clothing",
                    "choiceNumber": 2,
                    "correctTaken": 517,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Completing vaccination schedule",
                    "choiceNumber": 3,
                    "correctTaken": 14713,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maintaining a normal BMI",
                    "choiceNumber": 4,
                    "correctTaken": 984,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Performing proper vulvar hygiene",
                    "choiceNumber": 5,
                    "correctTaken": 331,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "388",
                    "mediaDataId": 0,
                    "title": "Human papillomavirus (HPV)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "45",
                    "mediaDataId": 0,
                    "title": "Condyloma acuminata",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30062377",
                    "mediaDataId": 0,
                    "title": "Epidemiology and prevention of human papillomavirus.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30062377",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31415491",
                    "mediaDataId": 0,
                    "title": "Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31415491",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 2,
            "othersAvgTimeSpent": 30,
            "notes": null,
            "peopleTaken": 17222,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 85,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 2,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 18965,
            "questionIndex": 20446,
            "questionText": "<p>A 29-year-old woman comes to the office for a well-woman visit.&nbsp; The patient has no concerns today.&nbsp; Her menses occur monthly with 5 days of light to moderate bleeding.&nbsp; The patient has no midcycle bleeding, pelvic pain, or vaginal discharge.&nbsp; She has no chronic medical conditions, and her only medication is an oral contraceptive.&nbsp; The patient is in a long-term monogamous relationship with a male partner.&nbsp; Her last menstrual period was 2 weeks ago.&nbsp; Vitals signs are normal.&nbsp; The abdomen is soft and nontender.&nbsp; On pelvic examination, there is scant clear discharge in the vaginal vault.&nbsp; The uterus and bilateral adnexa are mobile and nontender.&nbsp; The remainder of the physical examination is unremarkable.&nbsp; Pap testing from today&#39;s visit is negative for intraepithelial malignancy and shows abundant clue cells.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient has abundant clue cells on Pap testing consistent with <strong>bacterial vaginosis</strong> (BV).&nbsp; Although anaerobic bacteria (eg, <em>Gardnerella vaginalis</em>) can be present in normal vaginal flora, BV occurs due to a shift in the microbiota with overgrowth of anaerobic bacteria and loss of lactobacilli.&nbsp; However, <strong>Pap test cytology</strong> has <strong>low sensitivity and specificity</strong> for identifying BV; therefore, further evaluation is warranted.</p><p>Patients with BV on cytology results should be asked about symptoms (eg, malodorous vaginal discharge).&nbsp; Symptomatic patients should undergo further evaluation with wet mount microscopy and potassium hydroxide whiff testing and receive treatment (eg, metronidazole, clindamycin) if the diagnosis is confirmed.</p><p>In contrast, <strong>asymptomatic</strong> patients (such as this one) <strong>do not require treatment</strong> due to the limitations of cytology results for identifying infections (ie, high false positive rate).&nbsp; Furthermore, treatment of asymptomatic BV is typically avoided because it may resolve spontaneously, and treatment can lead to symptomatic vaginal candidiasis.</p><p><strong>(Choice A)</strong>&nbsp; Gonorrhea and chlamydia testing is indicated in patients with symptoms (eg, abnormal vaginal discharge, postcoital bleeding) or risk factors (eg, age &lt;25, multiple partners, new partner), none of which are seen in this patient.</p><p><strong>(Choice B)</strong>&nbsp; Although BV is associated with sexual activity, partner treatment (eg, metronidazole) does not reduce the risk of BV symptoms or recurrence and therefore is not indicated.</p><p><strong>(Choice D)</strong>&nbsp; Because <em>Gardnerella vaginalis</em> is normally present in the vaginal flora of healthy, asymptomatic patients, a vaginal culture is not diagnostic and therefore not performed.</p><p><strong>Educational objective:</strong><br>Patients with cytology results that show bacterial vaginosis on Pap testing should be asked about symptoms (eg, malodorous vaginal discharge).&nbsp; Symptomatic patients are screened (eg, wet mount microscopy, potassium hydroxide whiff testing) and treated if the diagnosis is confirmed.&nbsp; Asymptomatic patients do not require treatment.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 22504,
            "topic": "Vulvovaginitis",
            "titleId": 22504,
            "title": "Vulvovaginitis",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "3",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Gonorrhea and chlamydia testing",
                    "choiceNumber": 1,
                    "correctTaken": 2173,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Metronidazole therapy for patient and partner",
                    "choiceNumber": 2,
                    "correctTaken": 6288,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No additional management indicated",
                    "choiceNumber": 3,
                    "correctTaken": 6820,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vaginal culture for <em>Gardnerella vaginalis</em>",
                    "choiceNumber": 4,
                    "correctTaken": 5094,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "41",
                    "mediaDataId": 0,
                    "title": "Bacterial vaginosis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 3,
            "othersAvgTimeSpent": 51,
            "notes": null,
            "peopleTaken": 20375,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 33,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 3,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 13721,
            "questionIndex": 15111,
            "questionText": "<p>A 16-year-old girl is brought to the office because she has not started her menstrual period.&nbsp; The patient&#39;s 14-year-old sister underwent menarche a few months ago and her mother began menstruating at age 13.&nbsp; The girl has had no headaches, changes in vision, weight gain, nipple discharge, or abdominal pain.&nbsp; She has no chronic medical conditions and has had no surgeries.&nbsp; The patient is not sexually active and is not on contraception.&nbsp; She plays basketball for her high school team.&nbsp; Height is at the 85th percentile and weight is at the 25th percentile for age.&nbsp; Vital signs are normal.&nbsp; Breast, axillary, and pubic hair development are sexual maturity rating (Tanner stage) IV.&nbsp; The abdomen is soft, nontender, and has no palpable masses.&nbsp; On pelvic examination, the external genitalia appear normal, but a cervix cannot be visualized.&nbsp; Pelvic ultrasound reveals bilateral ovaries but no uterus or cervix.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t41477\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>M&uuml;llerian agenesis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>M&uuml;ller duct system defect</li><li>Abnormal development of uterus, cervix &amp; upper third of vagina</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Primary amenorrhea</li><li>Normal female external genitalia</li><li>Blind vaginal pouch</li><li>Absent or rudimentary uterus</li><li>Bilateral functioning ovaries (normal FSH)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Evaluate for renal tract abnormalities (eg, renal ultrasonography)</li><li>Vaginal dilation (surgical or nonsurgical)</li></ul></td></tr></tbody></table></div><p>This patient&#39;s primary amenorrhea, normal secondary sexual characteristics, and <strong>absent uterus</strong> are consistent with <strong>m&uuml;llerian agenesis</strong> (also known as Mayer-Rokitansky-K&uuml;ster-Hauser syndrome).&nbsp; During development, the m&uuml;llerian (ie, paramesonephric) duct develops into the uterus, cervix, and upper 1/3 of the vagina.&nbsp; Patients with agenesis do not develop these structures and so have <strong>amenorrhea</strong>.&nbsp; M&uuml;llerian duct development does not affect ovarian development; therefore, patients have <strong>bilateral ovaries</strong>, normal estrogen levels, and <strong>normal secondary sexual characteristics</strong> (eg, breast development, normal stature).&nbsp; In addition, the external genitalia develop from a different precursor (ie, genital tubercle) and patients have normal female external genitalia and lower 2/3 of the vagina (ie, <strong>blind vaginal pouch</strong>).</p><p>Due to the association with renal development, patients with m&uuml;llerian agenesis may have renal system abnormalities (eg, duplicated ureters) that require evaluation (eg, renal ultrasound).&nbsp; Treatment of m&uuml;llerian agenesis includes vaginal dilation to create a functional vagina for sexual intercourse.</p><p><strong>(Choice A)</strong>&nbsp; Androgen insensitivity syndrome occurs in genotypical males (46,XY) who have defective androgen receptor function.&nbsp; These patients appear phenotypically female and have primary amenorrhea, tall stature, and an absent uterus.&nbsp; However, they have minimal pubic/axillary hair (no peripheral effect of testosterone) and have male gonads (ie, testes).</p><p><strong>(Choice B)</strong>&nbsp; Constitutional delay of puberty is a delay in thelarche (breast development), adrenarche (eg, pubic and axillary hair development), and menarche in patients with a uterus.&nbsp; This patient has breast and pubic hair development, making this diagnosis unlikely.</p><p><strong>(Choice C)</strong>&nbsp; Functional hypothalamic amenorrhea can present in athletes with primary amenorrhea.&nbsp; However, patients have breast atrophy secondary to low estrogen.&nbsp; There is no association with an absent uterus.</p><p><strong>(Choices D and F)</strong>&nbsp; Patients with an imperforate hymen or transverse vaginal septum may have primary amenorrhea.&nbsp; However, both are isolated genital outflow tract defects in patients who have a uterus.</p><p><strong>(Choice G)</strong>&nbsp; Patients with Turner syndrome (45,XO) can have primary amenorrhea due to decreased ovarian function (ie, gonadal dysgenesis), not an absent uterus.&nbsp; Due to low estrogen levels from the nonfunctioning ovaries, patients typically have short stature and minimal breast development, which are not seen in this patient.</p><p><strong>Educational objective:</strong><br>Patients with m&uuml;llerian agenesis have primary amenorrhea due to an absent uterus, cervix, and upper 1/3 of the vagina (ie, blind vaginal pouch).&nbsp; However, because the ovaries and external female genitalia develop independently of the m&uuml;llerian duct system, patients have normal external genitalia and secondary sexual characteristics.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 23429,
            "topic": "Amenorrhea",
            "titleId": 23429,
            "title": "Amenorrhea",
            "topicAttributeId": 330800,
            "topicAttribute": "Menstrual disorders and contraception",
            "correctAnswer": "5",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Androgen insensitivity syndrome",
                    "choiceNumber": 1,
                    "correctTaken": 911,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Constitutional delay of puberty",
                    "choiceNumber": 2,
                    "correctTaken": 13,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Functional hypothalamic amenorrhea",
                    "choiceNumber": 3,
                    "correctTaken": 79,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Imperforate hymen",
                    "choiceNumber": 4,
                    "correctTaken": 51,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "M&uuml;llerian agenesis",
                    "choiceNumber": 5,
                    "correctTaken": 15545,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transverse vaginal septum",
                    "choiceNumber": 6,
                    "correctTaken": 38,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Turner syndrome",
                    "choiceNumber": 7,
                    "correctTaken": 114,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "65",
                    "mediaDataId": 0,
                    "title": "Müllerian agenesis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29527097",
                    "mediaDataId": 0,
                    "title": "Clinical and genetic aspects of Mayer-Rokitansky-K&amp;#252;ster-Hauser syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29527097",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29266078",
                    "mediaDataId": 0,
                    "title": "ACOG Committee opinion: no. 728:  M&amp;#252;llerian agenesis: diagnosis, management, and treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29266078",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 2,
            "othersAvgTimeSpent": 49,
            "notes": null,
            "peopleTaken": 16751,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 93,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 2,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 11323,
            "questionIndex": 12476,
            "questionText": "<p>A 20-year-old woman comes to the office due to dysuria for the past 2 days.&nbsp; She also has had urinary frequency but no fever, chills, nausea, or hematuria.&nbsp; The patient became sexually active with her boyfriend 6 months ago.&nbsp; Since then, she has had 3 episodes of cystitis.&nbsp; The patient voids following intercourse and has increased her daily water intake without any improvement.&nbsp; She has no other medical conditions and no prior surgery.&nbsp; She uses a subdermal progestin implant for contraception, and her last menstrual period was 2 weeks ago.&nbsp; Temperature is 37.2 C (99 F).&nbsp; On abdominal examination, there is mild suprapubic tenderness.&nbsp; No costovertebral or flank tenderness is present.&nbsp; Antibiotic therapy is prescribed.&nbsp; A urine culture grows <em>Escherichia coli</em>.&nbsp; When the patient is called with the results, she reports complete resolution of her symptoms.&nbsp; Repeat urine culture 2 weeks later is negative.&nbsp; Which of the following is the best next step in management of this patient&#39;s recurrent cystitis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T31768\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Recurrent cystitis in women</strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td><ul><li>&#8805;2 infections in 6 months</li><li>&#8805;3 infections in a year</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Sexually active</li><li>Postmenopausal</li><li>1st UTI at age &lt;15</li><li>Spermicide use</li></ul></td></tr><tr><td><p align=\"center\"><strong>Prevention</strong></p></td><td><ul><li>Daily antibiotic prophylaxis</li><li>Postcoital prophylaxis</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>UTI</strong> = urinary tract infection.</p></td></tr></tbody></table></div><p>Women are at increased risk for cystitis, a lower <strong>urinary tract infection</strong>, due to the proximity of the rectum to the vagina and urethra.&nbsp; A significant <strong>risk factor</strong> is <strong>sexual intercourse</strong>, as in this patient.&nbsp; During intercourse, enteric bacteria (most commonly <em>Escherichia coli</em>) are introduced into the vagina and periurethral area.&nbsp; Because the female urethra is short, these bacteria can readily ascend to the bladder and cause cystitis and associated symptoms (eg, dysuria, urinary frequency).&nbsp; Other risk factors include conditions that alter the normal urogenital flora (eg, recent antibiotic use, spermicide use).</p><p>This patient has <strong>recurrent cystitis</strong>, defined as <strong>&#8805;2 episodes in 6 months</strong> (or &#8805;3 episodes in a year).&nbsp; Patients with recurrent cystitis are at increased risk for repeat episodes.&nbsp; Prevention is first focused on behavior modifications, which include increasing daily fluid intake, changing contraception method (eg, stop using spermicide or diaphragm), and voiding after sexual intercourse (unproven benefit but possibly helpful).&nbsp; If these measures fail, low-dose antibiotic prophylaxis can be considered, although this has inherent risks related to continuous antibiotic exposure.&nbsp; Therefore, in women with cystitis episodes clearly linked to intercourse, <strong>postcoital antibiotics</strong> (eg, nitrofurantoin, trimethoprim-sulfamethoxazole) are preferred because they can prevent recurrence while reducing the risks associated with long-term antibiotic use (eg, antibiotic resistance, toxicity).</p><p><strong>(Choice A)</strong>&nbsp; <a href=\"4856\">Cystoscopy</a> is typically performed for suspected bladder cancer (eg, persistent or unexplained hematuria) or urinary tract injury (eg, postoperative).&nbsp; Recurrent cystitis that responds appropriately to antibiotic therapy (eg, negative repeat urine culture, as in this patient) does not require cystoscopy.</p><p><strong>(Choice B)</strong>&nbsp; Although increased daily fluid intake (eg, 2-3 L) is recommended for patients with recurrent cystitis, cranberry juice has not been demonstrated to decrease the incidence of infection.</p><p><strong>(Choice D)</strong>&nbsp; Renal ultrasonography is indicated in patients with recurrent cystitis when repeat urine cultures are persistently positive or demonstrate atypical pathogens (eg, <em>Proteus</em>), which may indicate an underlying structural anomaly or nephrolithiasis.&nbsp; In contrast, this patient has a negative repeat urine culture and a common pathogen (ie, <em>E coli</em>).</p><p><strong>Educational objective:</strong><br>A significant risk factor for recurrent cystitis (ie, &#8805;2 episodes in 6 months or &#8805;3 episodes in a year) in women is sexual intercourse.&nbsp; Postcoital antibiotic prophylaxis (eg, nitrofurantoin, trimethoprim-sulfamethoxazole) can reduce the rate of recurrence.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 19887,
            "topic": "Urinary tract infection",
            "titleId": 19887,
            "title": "Urinary tract infection",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cystoscopy",
                    "choiceNumber": 1,
                    "correctTaken": 5146,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Daily cranberry juice",
                    "choiceNumber": 2,
                    "correctTaken": 2350,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Postcoital antibiotics",
                    "choiceNumber": 3,
                    "correctTaken": 9810,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Renal ultrasonography",
                    "choiceNumber": 4,
                    "correctTaken": 2937,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "547",
                    "mediaDataId": 0,
                    "title": "Urinary tract infections (UTIs), including pyelonephritis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25410372",
                    "mediaDataId": 0,
                    "title": "Recurrent urinary tract infections in women.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25410372",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 3,
            "othersAvgTimeSpent": 50,
            "notes": null,
            "peopleTaken": 20251,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 3,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 11326,
            "questionIndex": 12479,
            "questionText": "<p>A 25-year-old woman comes to the office for evaluation of increasing amounts of malodorous vaginal discharge over the past 4 days.&nbsp; The patient has no postcoital spotting or intermenstrual bleeding.&nbsp; Her last menstrual period was 3 weeks ago.&nbsp; She has been sexually active with a new partner for the past month, and they use condoms intermittently.&nbsp; She has no chronic medical conditions or previous surgeries.&nbsp; The patient takes no daily medications.&nbsp; She has a history of chlamydial cervicitis at age 19.&nbsp; Vitals signs are normal.&nbsp; Physical examination shows no vulvar or vaginal erythema or lesions.&nbsp; There is an off-white discharge throughout the vaginal vault with no discharge from the cervical os.&nbsp; The uterus is mobile and nontender with no adnexal masses.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"2216\" src=\"https://www.uworld.com/media/highresdefault/L21422.jpg\"  ></p><p><strong>Bacterial vaginosis</strong> (BV) is a common cause of vaginal discharge and occurs due to an <strong>imbalance in vaginal flora</strong>.&nbsp; In patients with BV, the physiologic lactobacilli colonization of the vagina decreases, leading to an increased pH and overgrowth of anaerobic bacteria (eg, <em>Gardnerella vaginalis</em>).&nbsp; The increased pH and bacterial overgrowth lead to increasing malodorous (ie, fishy) vaginal discharge.&nbsp; Risk factors for BV include women having sex with women, douching, and tobacco use.</p><p>Patients with BV typically have a <strong>malodorous</strong>, <strong>thin</strong>, <strong>off-white vaginal discharge</strong> with <strong>no associated vulvovaginal inflammation</strong> (eg, pruritus, erythema).&nbsp; Therefore, patients have no vulvar erythema, cervical discharge, or friability.&nbsp; Evaluation of vaginal discharge reveals a <strong>pH &gt;4.5</strong>, an <strong>amine odor</strong> with the addition of potassium hydroxide (whiff test), and <a href=\"1112\">clue cells</a> on microscopy (eg, Amsel criteria).&nbsp; Treatment is with <strong>metronidazole</strong> or clindamycin.</p><p><strong>(Choice A)</strong>&nbsp; Acute cervicitis, due to <em>Neisseria gonorrhoeae</em> and <em>Chlamydia trachomatis</em>, presents with postcoital or intermenstrual bleeding.&nbsp; Physical examination reveals mucopurulent cervical discharge and a friable cervix, which are not seen in this patient.</p><p><strong>(Choice C)</strong>&nbsp; Patients using condoms for contraception may have a latex allergy.&nbsp; The typical presentation is a pruritic, erythematous, vesicular rash at the area of contact.&nbsp; There is no associated malodorous vaginal discharge, making this diagnosis unlikely.</p><p><strong>(Choice D)</strong>&nbsp; Physiologic leukorrhea is a white, odorless discharge that typically occurs midcycle and resolves spontaneously.</p><p><strong>(Choice E)</strong>&nbsp; <em>Trichomonas</em> vaginitis presents with a malodorous, yellow-green vaginal discharge and vaginal erythema on examination.&nbsp; In some cases, punctate hemorrhages may be visualized on the cervix (eg, &#x22;strawberry cervix&#x22;).</p><p><strong>(Choice F)</strong>&nbsp; Vaginal candidiasis presents with a thick, white discharge and vaginal pruritus; vulvar erythema and excoriations are typically present on examination.</p><p><strong>Educational objective:</strong><br>Bacterial vaginosis typically presents with malodorous, thin, white vaginal discharge in the absence of vulvovaginal inflammation.&nbsp; It is characterized by a vaginal pH &gt;4.5, a positive whiff test, and clue cells on microscopic examination.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 22504,
            "topic": "Vulvovaginitis",
            "titleId": 22504,
            "title": "Vulvovaginitis",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "2",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute cervicitis",
                    "choiceNumber": 1,
                    "correctTaken": 151,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bacterial vaginosis",
                    "choiceNumber": 2,
                    "correctTaken": 10343,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Latex allergy",
                    "choiceNumber": 3,
                    "correctTaken": 59,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Physiologic leukorrhea",
                    "choiceNumber": 4,
                    "correctTaken": 799,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<em>Trichomonas</em> vaginitis",
                    "choiceNumber": 5,
                    "correctTaken": 200,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vaginal candidiasis",
                    "choiceNumber": 6,
                    "correctTaken": 1103,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "41",
                    "mediaDataId": 0,
                    "title": "Bacterial vaginosis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27396541",
                    "mediaDataId": 0,
                    "title": "Bacterial vaginosis: a critical analysis of current knowledge.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27396541",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 3,
            "othersAvgTimeSpent": 51,
            "notes": null,
            "peopleTaken": 14348,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 72,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 3,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 11278,
            "questionIndex": 12433,
            "questionText": "<p>A 15-year-old girl comes to the office due to yellow vaginal discharge for the past 2 days.&nbsp; The patient has also had bleeding between menstrual periods for the past 2 months.&nbsp; She has no fevers, chills, or pelvic pain.&nbsp; She is sexually active.&nbsp; The patient&#39;s parents are at work and she comes to the appointment alone.&nbsp; She does not have any medical conditions, takes no medications, and has no allergies.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 110/70 mm Hg, and pulse is 78/min.&nbsp; Physical examination shows a nontender abdomen.&nbsp; Pelvic examination reveals mucopurulent discharge at the cervical os; there is no cervical motion or adnexal tenderness.&nbsp; Urine pregnancy test is negative.&nbsp; The patient is prescribed the appropriate treatment and leaves the office.&nbsp; Several hours later, the patient&#39;s mother comes to the office asking for an explanation for the visit and for the antibiotic prescription.&nbsp; Which of the following is the most appropriate response?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31862\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Exceptions to informed consent by parent/guardian in minors</strong></p></td></tr><tr><td><p align=\"center\"><strong>Emergency care</strong></p></td><td><ul><li>Condition in which treatment delay<br />can cause serious impairment or death&nbsp;</li></ul></td></tr><tr><td><p align=\"center\"><strong>Emancipated minor<br />(adolescents)</strong></p></td><td><ul><li>Parent</li><li>Married</li><li>Military service</li><li>Financially independent</li><li>High school graduate</li><li>Homeless</li></ul></td></tr><tr><td><p align=\"center\"><strong>Specific medical care<br />(adolescents)</strong></p></td><td><ul><li>Sexually transmitted infection</li><li>Substance use disorder (most states)</li><li>Pregnancy care (most states)</li><li>Contraception</li></ul></td></tr></tbody></table></div><p>This patient has <strong>acute cervicitis</strong> (eg, mucopurulent cervical discharge, vaginal spotting), a cause by a sexually transmitted infection (eg, <em>Neisseria gonorrhoeae</em>, <em>Chlamydia trachomatis</em>).</p><p><strong>Minors</strong> (<strong>age &lt;18</strong>) may be treated without parental consent for a variety of medical conditions, including sexually transmitted infections.&nbsp; In addition to appropriate medical care, this patient also has the right to <strong>confidential treatment</strong>; her personal health information cannot be disclosed without the <strong>patient&#39;s permission</strong>.&nbsp; Maintaining patient confidentiality establishes a trusting relationship between the minor and the health care provider.&nbsp; This allows the minor to seek and access treatment for sensitive health concerns (eg, sexually transmitted infections, pregnancy) without embarrassment or fear of retribution.</p><p><strong>(Choices A and C)</strong>&nbsp; Although encouraging open communication within the family is appropriate, the direct inquiry from the patient&#39;s mother needs to be addressed, rather than evading the question.</p><p><strong>(Choice D)</strong>&nbsp; Another appointment may be appropriate for consultation and education purposes but may be scheduled only after the patient gives permission to share the information with her parent.</p><p><strong>(Choice E)</strong>&nbsp; A minor has the same right to privacy as an adult, and privileged information (eg, diagnosis, treatment) may not be shared without the patient&#39;s permission, including with the patient&#39;s parents.</p><p><strong>Educational objective:</strong><br>Patients age &lt;18 may be treated for sexually transmitted infections without parental consent.&nbsp; Confidentiality should be maintained, and details of the visit cannot be shared with others without the patient&#39;s permission.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 8096,
            "topic": "Pelvic inflammatory disease",
            "titleId": 8096,
            "title": "Pelvic inflammatory disease",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "2",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "&#x22;Can you explain to me what you think is going on with your daughter?&#x22;",
                    "choiceNumber": 1,
                    "correctTaken": 1882,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;I need your daughter&#39;s permission before I discuss her care with you.&#x22;",
                    "choiceNumber": 2,
                    "correctTaken": 11563,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;I recommend you discuss this diagnosis with your daughter.&#x22;",
                    "choiceNumber": 3,
                    "correctTaken": 1360,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Let&#39;s schedule another appointment with your daughter to discuss the results together.&#x22;",
                    "choiceNumber": 4,
                    "correctTaken": 1059,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Your daughter has a cervical infection and I prescribed antibiotics.&#x22;",
                    "choiceNumber": 5,
                    "correctTaken": 452,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "649",
                    "mediaDataId": 0,
                    "title": "Informed consent in medicine",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "684",
                    "mediaDataId": 0,
                    "title": "Patient confidentiality and privacy",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26024938",
                    "mediaDataId": 0,
                    "title": "Physician knowledge and attitudes around confidential care for minor patients.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26024938",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 3,
            "othersAvgTimeSpent": 44,
            "notes": null,
            "peopleTaken": 16316,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 3,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 21,
            "questionId": 11154,
            "questionIndex": 12303,
            "questionText": "<p>A 19-year-old woman comes to the office due to severe acne.&nbsp; She had expected the acne to improve after high school, but instead, it is worsening.&nbsp; The patient has tried multiple remedies without significant improvement.&nbsp; She is concerned that the acne is scarring her face.&nbsp; Since the patient started college last year, she has gained 13.6 kg (30 lb).&nbsp; She sings in a local church choir and has not noticed any voice changes.&nbsp; The patient has no chronic medical conditions, has had no surgeries, and takes no medications.&nbsp; BMI is 29 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination shows nodulocystic acne on the face, arms, back, and forehead.&nbsp; The scalp is normal, with no alopecia.&nbsp; Tanner stage is 5.&nbsp; There is no skin discoloration or striae.&nbsp; No masses are palpable on abdominal examination.&nbsp; A urine pregnancy test is negative.&nbsp; Which of the following additional information is required to establish the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T58021\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hyperandrogenism</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Hirsutism</li><li>Nodulocystic acne</li><li>Androgenic alopecia</li><li>&#8593; Serum testosterone</li></ul></td></tr><tr><td><p align=\"center\"><strong>Differential diagnosis</strong></p></td><td><ul><li>Polycystic ovary syndrome</li><li>Androgen-secreting tumor</li><li>Cushing syndrome</li><li>Nonclassical CAH</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>CAH</strong> = congenital adrenal hyperplasia.</p></td></tr></tbody></table></div><p><a href=\"5964\">Severe nodulocystic acne</a> occurring on the arms and upper back is a sign of <strong>hyperandrogenism</strong>.&nbsp; A common cause of hyperandrogenism in young women, particularly in conjunction with obesity, is <strong>polycystic ovary syndrome (PCOS)</strong>.&nbsp; In addition to either clinical (eg, severe acne, hirsutism, androgenic alopecia) or laboratory (eg, elevated serum testosterone) evidence of hyperandrogenism, the diagnosis of PCOS requires a history of <strong>irregular menses</strong> indicating anovulation and/or <strong>polycystic ovaries on ultrasound</strong>.&nbsp; When 2 of these 3 criteria are met and other causes of hyperandrogenism (eg, Cushing syndrome, nonclassical congenital adrenal hyperplasia) are excluded, the diagnosis of PCOS is established.</p><p><strong>(Choice A)</strong>&nbsp; Autoimmune hypothyroidism is linked to family history and may cause irregular menses and weight gain.&nbsp; Typical skin findings are coarse hair, skin discoloration, and, occasionally, alopecia, not nodulocystic acne.</p><p><strong>(Choices B and C)</strong>&nbsp; Patients with eating disorders do not typically have signs of hyperandrogenism.&nbsp; In addition, there is no established causal relationship between certain foods and acne.</p><p><strong>(Choice D)</strong>&nbsp; Intravenous drug use may cause localized skin infections (eg, folliculitis) but not diffuse nodulocystic acne.</p><p><strong>(Choice F)</strong>&nbsp; The number of lifetime sexual partners is used to assess the risk for cervical dysplasia and sexually transmitted infections; it is not relevant in the differential diagnosis of acne.</p><p><strong>Educational objective:</strong><br>Severe nodulocystic acne may be the initial sign of hyperandrogenism in patients with polycystic ovary syndrome.&nbsp; The diagnosis is based on the presence of 2 of 3 manifestations: clinical or laboratory evidence of hyperandrogenism, menstrual irregularities, and polycystic ovaries on ultrasound.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 8274,
            "topic": "Polycystic ovary disease",
            "titleId": 8274,
            "title": "Polycystic ovary disease",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "5",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Family history of hypothyroidism",
                    "choiceNumber": 1,
                    "correctTaken": 35,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Food intake diary",
                    "choiceNumber": 2,
                    "correctTaken": 152,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "History of an eating disorder",
                    "choiceNumber": 3,
                    "correctTaken": 17,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intravenous drug use",
                    "choiceNumber": 4,
                    "correctTaken": 5,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Menstrual history",
                    "choiceNumber": 5,
                    "correctTaken": 1679,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Number of lifetime sexual partners",
                    "choiceNumber": 6,
                    "correctTaken": 0,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "503",
                    "mediaDataId": 0,
                    "title": "Acne vulgaris",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "60",
                    "mediaDataId": 0,
                    "title": "Polycystic ovary syndrome",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27423183",
                    "mediaDataId": 0,
                    "title": "Genetic, hormonal and metabolic aspects of PCOS: an update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27423183",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 2,
            "othersAvgTimeSpent": 68,
            "notes": null,
            "peopleTaken": 1888,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 89,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 2,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 22,
            "questionId": 17496,
            "questionIndex": 18953,
            "questionText": "<p>A 29-year-old woman comes to the office and says, &#x22;my interstitial cystitis is getting worse.&#x22;&nbsp; Six months ago, the patient developed chronic urinary frequency and suprapubic pain relieved with voiding.&nbsp; She was diagnosed with interstitial cystitis and prescribed amitriptyline, which initially improved her symptoms.&nbsp; However, for the past week, the patient has had worsening urinary urgency and pain with voiding.&nbsp; She has no other chronic medical conditions and has no medication allergies.&nbsp; The patient recently started a relationship with a male partner and uses oral contraceptives.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 126/74 mm Hg, and pulse is 88/min.&nbsp; The abdomen is soft with diffuse lower abdominal discomfort to deep palpation.&nbsp; A clean-catch urinalysis shows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Leukocyte esterase</td><td style=\"vertical-align:middle;\">positive</td></tr><tr><td style=\"vertical-align:middle;\">Nitrites</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">Bacteria</td><td style=\"vertical-align:middle;\">none</td></tr><tr><td style=\"vertical-align:middle;\">White blood cells</td><td style=\"vertical-align:middle;\">40/hpf</td></tr><tr><td style=\"vertical-align:middle;\">Red blood cells</td><td style=\"vertical-align:middle;\">none</td></tr></tbody></table><p>Urine culture and pregnancy testing are negative.&nbsp; Which of the following is best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31462\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Chlamydia &amp; gonorrhea in women</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors </strong></p></td><td><ul><li>Age &lt;25</li><li>High-risk sexual behavior</li></ul></td></tr><tr><td><p align=\"center\"><strong>Manifestations </strong></p></td><td><ul><li>Asymptomatic (most common)</li><li>Cervicitis</li><li>Urethritis</li><li>Perihepatitis (Fitz-Hugh&ndash;Curtis syndrome)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis </strong></p></td><td><ul><li>Nucleic acid amplification testing</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment </strong></p></td><td><ul><li>Empiric: ceftriaxone + doxycycline*</li><li>Confirmed chlamydia: doxycycline*</li><li>Confirmed gonorrhea: ceftriaxone</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications </strong></p></td><td><ul><li>Pelvic inflammatory disease</li><li>Ectopic pregnancy</li><li>Infertility</li><li>Pharyngitis</li></ul></td></tr><tr><td colspan=\"2\"><p>*Azithromycin in pregnancy.</p></td></tr></tbody></table></div><p>This patient has interstitial cystitis (ie, painful bladder syndrome), a chronic pain disorder classically characterized by suprapubic pain that worsens with bladder filling and is relieved with voiding, resulting in increased urinary frequency.&nbsp; Interstitial cystitis is often treated with amitriptyline, and those with worsening symptoms may require an increased dose <strong>(Choice A)</strong>.&nbsp; However, this patient&#39;s new-onset <strong>pain with urination</strong> (ie, dysuria) is atypical for interstitial cystitis and requires evaluation for other disorders <strong>(Choice B)</strong>.</p><p>The most common causes of dysuria in young sexually active women are cystitis and urethritis, and initial evaluation is with urinalysis and urine culture.&nbsp; This patient&#39;s urinalysis reveals sterile pyuria (positive leukocytes but no bacteria), and she has a negative urine culture.&nbsp; This combination of <strong>dysuria</strong> and <strong>sterile pyuria</strong> is a common presentation of <em><strong>Chlamydia trachomatis</strong></em>&ndash;associated <strong>urethritis</strong> in women (up to 25% of patients).&nbsp; Therefore, the best next step in management is <strong>nucleic acid amplification testing</strong> for chlamydia; testing for gonorrhea is typically added because co-infection is common.&nbsp; A first-catch urine sample can be used in women; however, because most women have concomitant cervical infection, a vaginal or cervical swab may also be performed.</p><p><strong>(Choice C)</strong>&nbsp; CT scan of the abdomen and pelvis can be used to evaluate for renal pathology.&nbsp; However, an acute onset of sterile pyuria alone (ie, no associated casts or red blood cells) is an uncommon presentation for renal disease.</p><p><strong>(Choice E)</strong>&nbsp; Nitrofurantoin is used to treat acute cystitis, which has symptoms (eg, urinary frequency, urgency, dysuria) similar to acute urethritis.&nbsp; Although this patient&#39;s urinalysis reveals pyuria (ie, urine leukocytes, leukocyte esterase), her urine culture is negative, making cystitis unlikely.</p><p><strong>Educational objective:</strong><br>The combination of dysuria and sterile pyuria is a common presentation for <em>Chlamydia trachomatis</em> urethritis in sexually active women.&nbsp; Patients with this clinical presentation require nucleic acid amplification testing for chlamydia and gonorrhea.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 8096,
            "topic": "Pelvic inflammatory disease",
            "titleId": 8096,
            "title": "Pelvic inflammatory disease",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "4",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Increase the dose of amitriptyline",
                    "choiceNumber": 1,
                    "correctTaken": 321,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Observation and reassurance only",
                    "choiceNumber": 2,
                    "correctTaken": 396,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Order a CT scan of the abdomen and pelvis",
                    "choiceNumber": 3,
                    "correctTaken": 959,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform chlamydia and gonorrhea nucleic acid amplification testing",
                    "choiceNumber": 4,
                    "correctTaken": 10699,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe a course of nitrofurantoin",
                    "choiceNumber": 5,
                    "correctTaken": 4287,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "534",
                    "mediaDataId": 0,
                    "title": "Interstitial cystitis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "637",
                    "mediaDataId": 0,
                    "title": "Chlamydia trachomatis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24622331",
                    "mediaDataId": 0,
                    "title": "Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae—2014.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24622331",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26554471",
                    "mediaDataId": 0,
                    "title": "Dysuria: evaluation and differential diagnosis in adults.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26554471",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "33332296",
                    "mediaDataId": 0,
                    "title": "Update to CDC&#39;s treatment guidelines for gonococcal infection, 2020.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/33332296",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 4,
            "othersAvgTimeSpent": 63,
            "notes": null,
            "peopleTaken": 16662,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 64,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 4,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 23,
            "questionId": 11149,
            "questionIndex": 12296,
            "questionText": "<p>A 29-year-old woman comes to the office due to painful sores on her labia.&nbsp; The patient first noticed the sores 3 days ago and has not had these symptoms before.&nbsp; She has also had a headache and intermittent fever for the past 5 days that transiently improve with acetaminophen.&nbsp; The patient recently became sexually active with a new male partner and uses a progestin-containing intrauterine device for contraception.&nbsp; She has no chronic medical conditions and takes no medications.&nbsp; Temperature is 38.4 C (101.2 F), blood pressure is 110/70 mm Hg, and pulse is 88/min.&nbsp; Physical examination shows several clusters of multiple small, vesicular lesions on the right labium minora and tender inguinal lymphadenopathy on the right side.&nbsp; Speculum examination is normal.&nbsp; Urine pregnancy test is negative.&nbsp; If left untreated, this patient&#39;s clinical course would most likely result in which of the following?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34255\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\" style=\"width:47.0%;\"><p align=\"center\"><strong>Infectious genital ulcers</strong></p></td></tr><tr><td rowspan=\"2\" style=\"width:18.0%;\"><p align=\"center\" style=\"margin-left:22.5pt;\"><strong>Painful</strong></p></td><td style=\"width:35.0%;\"><p align=\"center\" style=\"margin-left:22.3pt;\">Herpes simplex virus</p></td><td style=\"width:47.0%;\"><ul><li>Pustules, vesicles, or small ulcers on erythematous base</li><li>Tender lymphadenopathy</li><li>Systemic symptoms common</li></ul></td></tr><tr><td style=\"width:35.0%;\"><p align=\"center\"><em>Haemophilus ducreyi</em> (chancroid)</p></td><td style=\"width:47.0%;\"><ul><li>Larger, deep ulcers with gray/yellow exudate</li><li>Well-demarcated borders &amp; soft, friable base</li><li>Severe lymphadenopathy that may suppurate</li></ul></td></tr><tr><td rowspan=\"2\" style=\"width:18.0%\"><p align=\"center\"><strong>Painless</strong></p></td><td style=\"width:35.0%\"><p align=\"center\"><em>Treponema pallidum</em> (syphilis)</p></td><td style=\"width:47.0%\"><ul><li>Usually single ulcer (chancre)</li><li>Indurated borders &amp; hard, nonpurulent base</li></ul></td></tr><tr><td style=\"width:35.0%;\"><p align=\"center\"><em>Chlamydia trachomatis</em> serovars L1-L3 (lymphogranuloma venereum)</p></td><td style=\"width:47.0%;\"><ul><li>Initial small, shallow ulcers (often missed)</li><li>Then painful &amp; fluctuant adenitis (buboes)</li></ul></td></tr></tbody></table></div><p>This patient&#39;s painful, vesicular lesions with associated tender lymphadenopathy are due to genital <strong>herpes simplex virus</strong> (HSV) infection.&nbsp; Primary HSV outbreaks are often associated with systemic symptoms (eg, fever, headache), more painful lesions that persist for a longer duration, and concomitant urinary retention.</p><p>Without treatment, most immunocompetent patients with primary HSV have <strong>spontaneous resolution of symptoms within a week</strong>.&nbsp; However, many patients will experience disease recurrence, particularly during the first year after primary infection.&nbsp; Afterward, recurrence becomes less frequent due to improved cell-mediated immunity.&nbsp; Antivirals (eg, <strong>acyclovir</strong>, valacyclovir) are used to <strong>reduce symptom duration</strong> and <strong>frequency of recurrences</strong> but do not eliminate recurrences.</p><p><strong>(Choice A)</strong>&nbsp; Development of a maculopapular rash that includes the palms and soles occurs in secondary syphilis.&nbsp; In contrast to this patient, those with primary syphilis have a single, painless ulcer (ie, chancre) with bilateral, nontender, inguinal lymphadenopathy.</p><p><strong>(Choice B)</strong>&nbsp; Inflammation of the liver capsule and resultant perihepatitis (ie, Fitz-Hugh&ndash;Curtis syndrome) occurs secondary to <em>Chlamydia trachomatis</em> serovars A-K and <em>Neisseria gonorrhoeae</em> infection.&nbsp; Patients with either infection can have systemic symptoms (eg, fever) when associated with pelvic inflammatory disease; however, neither infection causes vulvar lesions.</p><p><strong>(Choice C)</strong>&nbsp; Persistent lesions with no additional sequelae can occur with condyloma acuminata (ie, genital warts) from human papillomavirus infection.&nbsp; Condyloma acuminata are sexually transmitted but appear as nonpainful, pedunculated, verrucous lesions rather than painful vesicles.</p><p><strong>(Choice D)</strong>&nbsp; Patients with an HSV outbreak who are immunocompromised may occasionally develop CNS complications (eg, aseptic meningitis, transverse myelitis), but this is very uncommon in an otherwise healthy individual.&nbsp; HSV establishes life-long infection in peripheral nerve ganglia, not the CNS.</p><p><strong>(Choice F)</strong>&nbsp; Suppuration of inguinal lymph nodes and formation of buboes can develop with lymphogranuloma venereum (<em>C trachomatis</em> serovars L1-3) or chancroid (<em>Haemophilus ducreyi</em>).&nbsp; Chancroid typically produces ulcers with a yellow-gray exudate, and lymphogranuloma venereum typically produces painless ulcers&mdash;neither of which are seen in this patient.</p><p><strong>Educational objective:</strong><br>Herpes simplex virus (HSV) infection typically resolves spontaneously within a week of lesion development.&nbsp; However, HSV is associated with recurrent disease, which can become less frequent over time.&nbsp; Antivirals (eg, acyclovir, valacyclovir) are used to decrease symptom duration and the number of recurrences.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 11819,
            "topic": "HSV infection",
            "titleId": 11819,
            "title": "HSV infection",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "5",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Development of maculopapular rash that includes the palms and soles",
                    "choiceNumber": 1,
                    "correctTaken": 348,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inflammation of the liver capsule and resultant perihepatitis",
                    "choiceNumber": 2,
                    "correctTaken": 224,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Persistent lesions with no additional sequelae",
                    "choiceNumber": 3,
                    "correctTaken": 2290,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Progression to CNS infection",
                    "choiceNumber": 4,
                    "correctTaken": 2527,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Spontaneous resolution of symptoms within the next week",
                    "choiceNumber": 5,
                    "correctTaken": 8027,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Suppuration of inguinal lymph nodes and formation of buboes",
                    "choiceNumber": 6,
                    "correctTaken": 840,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "387",
                    "mediaDataId": 0,
                    "title": "Herpes simplex virus (HSV)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "46",
                    "mediaDataId": 0,
                    "title": "Infectious genital ulcers",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27281837",
                    "mediaDataId": 0,
                    "title": "Genital herpes: a review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27281837",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27575957",
                    "mediaDataId": 0,
                    "title": "Interventions for men and women with their first episode of genital herpes.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27575957",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 2,
            "othersAvgTimeSpent": 52,
            "notes": null,
            "peopleTaken": 14256,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 56,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 2,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 24,
            "questionId": 7005,
            "questionIndex": 7005,
            "questionText": "<p>A 32-year-old woman comes to the office due to several days of vaginal itching and discharge.&nbsp; She also has pain with sexual intercourse.&nbsp; The patient has had no fever, chills, abdominal pain, urinary frequency, or dysuria.&nbsp; In the past year she has had 2 new male sexual partners.&nbsp; The patient takes oral contraceptive pills and uses condoms on most occasions.&nbsp; She has no chronic medical conditions and has had no surgeries.&nbsp; The patient takes no other daily medications.&nbsp; She drinks several glasses of wine each week but does not smoke or use recreational drugs.&nbsp; Her last menstrual period was 3 weeks ago.&nbsp; Temperature is 36.7 C (98.1 F) and blood pressure is 100/60 mm Hg.&nbsp; Pelvic examination shows vulvar and vaginal erythema and a small amount of vaginal discharge with a pH of 4.&nbsp; Which of the following is the most likely causal organism?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"2216\" src=\"https://www.uworld.com/media/highresdefault/L21422.jpg\"  ></p><p>This patient&#39;s <strong>vulvovaginal erythema</strong> and <strong>vaginal discharge</strong> are consistent with <strong>candida vulvovaginitis</strong>, an infection typically due to overgrowth of <em><strong>Candida albicans</strong></em>.&nbsp; <em>C albicans</em> is part of the normal vaginal flora in women; however, symptomatic infection can be triggered by alterations in the vaginal flora balance, allowing abnormal <em>Candida</em> proliferation.&nbsp; These alterations can occur sporadically without any identifiable precursor, as seen in this patient.&nbsp; However, there are well-known factors that predispose to candidiasis, including increased estrogen levels (eg, pregnancy), recent antibiotic use, immunosuppression (eg, systemic corticosteroids), and diabetes mellitus (particularly if poorly controlled).</p><p>With <em>Candida</em> overgrowth, patients develop vaginal discharge (classically white and thick but can range in presentation to include scant, thin, and even watery) and vulvovaginal inflammation that can result in <strong>vulvar pruritus</strong> (sometimes with excoriations), dyspareunia, and dysuria.&nbsp; <em>Candida</em> does not alter the acidity of the vagina; therefore, the discharge has a <strong>normal vaginal pH (3.8-4.5)</strong>.&nbsp; Pseudohyphae, hyphae, and budding yeast are typically visualized on wet mount microscopy; however, microscopy can be negative.&nbsp; In these patients, a vaginal culture can be used for diagnosis.&nbsp; Treatment options include oral (eg, fluconazole) and intravaginal (eg, clotrimazole) antifungals.</p><p><strong>(Choices B, D, and E)</strong>&nbsp; <em>Chlamydia trachomatis</em>, <em>Mycoplasma genitalium</em>, and <em>Neisseria gonorrhoeae</em> are causes of <a href=\"2342\">acute cervicitis</a>, which can present with dyspareunia and discharge.&nbsp; However, patients typically have a mucopurulent cervical discharge that may be accompanied by dysuria (eg, urethritis) or abdominal pain (ie, pelvic inflammatory disease).&nbsp; There is no associated vulvovaginal erythema.</p><p><strong>(Choice C)</strong>&nbsp; <em>Gardnerella vaginalis</em>, a cause of bacterial vaginosis, presents with vaginal discharge; however, it is typically a thin, gray, &#x22;fishy-smelling&#x22; discharge that has a pH &gt;4.5.&nbsp; There is no associated dyspareunia or vulvovaginal erythema.</p><p><strong>(Choice F)</strong>&nbsp; <em>Trichomonas vaginalis</em> is a unicellular, flagellated protozoan that causes vaginal discharge; however, it is typically a green, frothy discharge with a pH &gt;4.5.</p><p><strong>Educational objective:</strong><br>Candida vulvovaginitis is caused by overgrowth of <em>Candida albicans</em> and typically presents with vulvovaginal erythema, vaginal pruritus, and discharge with a normal vaginal pH (3.8-4.5).&nbsp; Treatment options include oral (eg, fluconazole) and intravaginal (eg, clotrimazole) antifungals.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 22504,
            "topic": "Vulvovaginitis",
            "titleId": 22504,
            "title": "Vulvovaginitis",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "1",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "<em>Candida albicans</em>",
                    "choiceNumber": 1,
                    "correctTaken": 8900,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<em>Chlamydia trachomatis</em>",
                    "choiceNumber": 2,
                    "correctTaken": 1329,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<em>Gardnerella vaginalis</em>",
                    "choiceNumber": 3,
                    "correctTaken": 2729,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<em>Mycoplasma genitalium</em>",
                    "choiceNumber": 4,
                    "correctTaken": 611,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<em>Neisseria gonorrhoeae</em>",
                    "choiceNumber": 5,
                    "correctTaken": 459,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<em>Trichomonas vaginalis</em>",
                    "choiceNumber": 6,
                    "correctTaken": 2656,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "44",
                    "mediaDataId": 0,
                    "title": "Vulvovaginal candidiasis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "715",
                    "mediaDataId": 0,
                    "title": "Candida infections",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "805",
                    "mediaDataId": 0,
                    "title": "Evaluation of vaginal discharge",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26690853",
                    "mediaDataId": 0,
                    "title": "Vulvovaginal candidiasis:  epidemiology, microbiology and risk factors.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26690853",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28499528",
                    "mediaDataId": 0,
                    "title": "Vaginitis: beyond the basics.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28499528",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29671516",
                    "mediaDataId": 0,
                    "title": "Vaginitis: diagnosis and treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29671516",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 2,
            "othersAvgTimeSpent": 60,
            "notes": null,
            "peopleTaken": 16684,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 53,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 2,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 25,
            "questionId": 11353,
            "questionIndex": 12507,
            "questionText": "<p>A 52-year-old woman comes to the office due to vulvar pruritus for the past week.&nbsp; The patient also reports frequent urination, dysuria, and nocturia.&nbsp; She has had similar symptoms 4 times in the past 3 months.&nbsp; Each time previously, over-the-counter suppositories provided symptom relief.&nbsp; However, the symptoms recurred within 1-2 weeks.&nbsp; The patient had irregular, heavy periods that improved after insertion of a progestin-containing intrauterine device.&nbsp; She has no other medical conditions or previous surgeries.&nbsp; The patient is sexually active and in a long-term, monogamous relationship.&nbsp; She does not use tobacco and drinks alcohol socially.&nbsp; Blood pressure is 130/80 mm Hg and pulse is 84/min.&nbsp; BMI is 25 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Pelvic examination shows vulvar erythema and multiple excoriations.&nbsp; There is thick, white discharge throughout the vaginal vault.&nbsp; No cervical or vaginal lesions are noted.&nbsp; Microscopy reveals pseudohyphae and no motile organisms.&nbsp; Which of the following additional tests should be performed in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"8320\" src=\"https://www.uworld.com/media/highresdefault/L31895.jpg\"  ></p><p>This patient has <strong>vulvovaginal candidiasis</strong>, characterized by <strong>thick, white vaginal discharge</strong> and <strong>vulvovaginal pruritus</strong>, typically due to an overgrowth of <em>Candida albicans</em>.&nbsp; Other clinical features include dysuria and vulvar irritation, leading to vulvar and <a href=\"6086\">vaginal erythema</a> and excoriations seen on physical examination.&nbsp; Further evaluation of the discharge typically reveals a normal pH; budding yeast and <a href=\"31186\">pseudohyphae</a> are present on microscopy.</p><p>Risk factors for vulvovaginal candidiasis include antibiotic use, pregnancy, immunosuppression, and <strong>diabetes mellitus</strong>.&nbsp; Diabetes mellitus increases the risk for candidiasis because glucose facilitates the adhesion of <em>Candida</em> to the epithelial surface.&nbsp; Therefore, women with <strong>recurrent vulvovaginal candidiasis infections</strong> (&#8805;3 episodes in a year) and other signs of diabetes mellitus (eg, <strong>nocturia</strong>, <strong>urinary frequency</strong>) should be evaluated with a <strong>hemoglobin A1c</strong>.&nbsp; Fluconazole is the treatment for vulvovaginal candidiasis, and improved glycemic control can reduce the risk of recurrence.</p><p><strong>(Choice A)</strong>&nbsp; Nucleic acid amplification testing can be used to diagnose <em>Chlamydia trachomatis</em> or <em>Neisseria gonorrhoeae</em> cervicitis.&nbsp; Acute cervicitis presents with intermenstrual or postcoital spotting.&nbsp; Examination reveals mucopurulent discharge and cervical friability, which are not seen in this patient.</p><p><strong>(Choice B)</strong>&nbsp; Patients with long-term intrauterine devices (IUDs) are at increased risk for <em>Actinomyces</em> infection because this bacterium can ascend to the upper genital tract to colonize an indwelling IUD.&nbsp; However, there is not a strong association between IUD use and recurrent vulvovaginal candidiasis; therefore, culture of the IUD is not necessary.</p><p><strong>(Choice C)</strong>&nbsp; FSH level may help in the diagnosis of menopause.&nbsp; The genitourinary syndrome of menopause (eg, vulvovaginal atrophy) may present with vaginal pruritus, dysuria, nocturia, and urinary frequency.&nbsp; However, examination reveals an atrophic vulva and thinning vaginal mucosa with minimal rugation.</p><p><strong>(Choice E)</strong>&nbsp; A vulvar biopsy may be indicated in patients with vulvar lesions unresponsive to therapy.&nbsp; Although this patient has recurrent candidiasis, previous infections resolved with over-the-counter suppositories.&nbsp; If her current symptoms do not resolve after management of diabetes mellitus and treatment of candidiasis, a biopsy may be performed to exclude other etiologies (eg, malignancy, lichen sclerosus).</p><p><strong>Educational objective:</strong><br>Vulvovaginal candidiasis is characterized by thick, white vaginal discharge, pruritus, erythema, and excoriations.&nbsp; Risk factors include diabetes mellitus, immunosuppression, and antibiotic use.&nbsp; Recurrent candidiasis warrants evaluation for diabetes mellitus.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 22504,
            "topic": "Vulvovaginitis",
            "titleId": 22504,
            "title": "Vulvovaginitis",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "4",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Chlamydia and gonorrhea nucleic acid amplification testing",
                    "choiceNumber": 1,
                    "correctTaken": 499,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Culture of the intrauterine device",
                    "choiceNumber": 2,
                    "correctTaken": 631,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "FSH level",
                    "choiceNumber": 3,
                    "correctTaken": 330,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hemoglobin A1c",
                    "choiceNumber": 4,
                    "correctTaken": 3142,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vulvar biopsy",
                    "choiceNumber": 5,
                    "correctTaken": 401,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "44",
                    "mediaDataId": 0,
                    "title": "Vulvovaginal candidiasis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "36159646",
                    "mediaDataId": 0,
                    "title": "Management of recurrent vulvovaginal candidosis: narrative review of the literature and European expert panel opinion.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/36159646",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "35538480",
                    "mediaDataId": 0,
                    "title": "Survey of incidence, lifetime prevalence, and treatment of self-reported vulvovaginal candidiasis, United States, 2020.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/35538480",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 3,
            "othersAvgTimeSpent": 81,
            "notes": null,
            "peopleTaken": 5003,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 3,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 26,
            "questionId": 11193,
            "questionIndex": 12343,
            "questionText": "<p>A 22-year-old woman comes to the emergency department with right upper quadrant pain that has worsened over the past day.&nbsp; The pain initially began in the lower abdomen 5 days ago, after she returned from a trip to South America.&nbsp; The right upper quadrant pain increases with deep breathing.&nbsp; She now has fevers, chills, and vomiting.&nbsp; The patient has no diarrhea, constipation, or changes in stool color.&nbsp; She has no medical conditions or previous surgeries.&nbsp; The patient is sexually active with a male partner and does not use contraception.&nbsp; She is currently on her menstrual period but reports increasingly irregular menses over the last 3 months, with occasional spotting.&nbsp; The patient does not use tobacco, alcohol, or illicit drugs.&nbsp; Temperature is 38.9 C (102 F), blood pressure is 100/70 mm Hg, and pulse is 104/min.&nbsp; BMI is 21 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Examination shows right upper quadrant tenderness, and the lower abdomen is diffusely tender without guarding.&nbsp; Bowel sounds are present.&nbsp; There is no costovertebral angle tenderness.&nbsp; Skin is normal without rash.&nbsp; A urine pregnancy test is negative.&nbsp; Which of the following is the most likely diagnosis for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T32055\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Pelvic inflammatory disease</strong></p></td></tr><tr><td><p align=\"center\"><strong>Symptoms</strong></p></td><td><ul><li>Lower abdominal pain</li><li>Abnormal bleeding</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk<br>factors</strong></p></td><td><ul><li>Multiple sexual partners</li><li>Age 15-25</li><li>Previous pelvic inflammatory disease</li><li>Inconsistent barrier contraception use</li><li>Partner with sexually transmitted infection</li></ul></td></tr><tr><td><p align=\"center\"><strong>Physical<br>examination</strong></p></td><td><ul><li>Fever &gt;38.3 C (&gt;100.9 F)</li><li>Cervical motion, uterine, or adnexal tenderness</li><li>Mucopurulent cervical discharge</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Inpatient: IV broad-spectrum antibiotics</li><li>Outpatient: PO broad-spectrum antibiotics</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Tuboovarian abscess</li><li>Infertility</li><li>Ectopic pregnancy</li><li>Perihepatitis</li></ul></td></tr></tbody></table></div><p>This young woman has fever, chills, and right upper quadrant pain, findings that suggest hepatic infection or inflammation.&nbsp; The additional history of intermenstrual spotting and lower abdominal pain makes the most likely diagnosis <strong>pelvic inflammatory disease</strong> (PID) complicated by <strong>perihepatitis</strong> (also known as Fitz-Hugh&ndash;Curtis syndrome).</p><p>In women, the initial infection of the cervix with <em>Neisseria gonorrhoeae</em> or <em>Chlamydia trachomatis</em> can be asymptomatic or subtle (eg, <strong>irregular intermenstrual bleeding</strong>).&nbsp; Untreated cervicitis allows polymicrobial vaginal flora to ascend into the upper reproductive tract (eg, uterus, fallopian tubes), causing <strong>fever</strong> and <strong>lower abdominal pain</strong>, as in this patient.&nbsp; As the infection spreads farther into the intraperitoneal cavity, it can cause inflammation of the liver capsule (ie, perihepatitis or Fitz-Hugh&ndash;Curtis syndrome in 6%-10% of patients), resulting in <strong>vomiting</strong> and <strong>right upper quadrant tenderness</strong>.&nbsp; The pain is often pleuritic (ie, worsened with inspiration) due to fibrinous adhesion formation on the anterior liver surface.</p><p>Treatment of PID complicated by perihepatitis includes hospitalization and broad-spectrum intravenous antibiotics (eg, cefoxitin plus doxycycline).</p><p><strong>(Choice A)</strong>&nbsp; Appendicitis can cause fever, vomiting, and lower abdominal pain; however, patients typically have periumbilical pain that migrates to the right lower (not right upper) quadrant.&nbsp; In addition, appendicitis is not associated with intermenstrual spotting.</p><p><strong>(Choice B)</strong>&nbsp; Acute cholecystitis can cause fever and localized right upper quadrant tenderness; it is not typically associated with diffuse lower abdominal pain or abnormal vaginal bleeding.&nbsp; In addition, affected women are typically age &gt;40 and obese, in contrast to this patient.</p><p><strong>(Choice C)</strong>&nbsp; Acute viral hepatitis can cause fever, vomiting, and right upper quadrant pain in patients with recent travel to endemic regions.&nbsp; However, patients typically develop jaundice and changes in stool color, and there is no association with intermenstrual spotting.</p><p><strong>(Choice E)</strong>&nbsp; Ruptured ectopic pregnancy can cause diffuse lower abdominal pain, but an acute abdomen (eg, rebound, guarding) usually develops due to hemoperitoneum.&nbsp; This diagnosis is unlikely in this patient with a negative pregnancy test.</p><p><strong>(Choice F)</strong>&nbsp; Ruptured ovarian cysts typically cause sudden-onset, severe, lower abdominal pain provoked by activity.&nbsp; However, ruptured ovarian cysts typically occur in the middle of the menstrual cycle (this patient is menstruating) and do not cause a high fever.</p><p><strong>Educational objective:</strong><br>Pelvic inflammatory disease (PID) can spread to the intraperitoneal cavity and cause perihepatitis (ie, Fitz-Hugh&ndash;Curtis syndrome).&nbsp; PID complicated by perihepatitis typically causes fever, vomiting, and pain in the right upper quadrant and lower abdomen.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 8096,
            "topic": "Pelvic inflammatory disease",
            "titleId": 8096,
            "title": "Pelvic inflammatory disease",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "4",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute appendicitis",
                    "choiceNumber": 1,
                    "correctTaken": 619,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Acute cholecystitis",
                    "choiceNumber": 2,
                    "correctTaken": 2168,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Acute viral hepatitis",
                    "choiceNumber": 3,
                    "correctTaken": 3264,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pelvic inflammatory disease",
                    "choiceNumber": 4,
                    "correctTaken": 8018,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ruptured ectopic pregnancy",
                    "choiceNumber": 5,
                    "correctTaken": 572,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ruptured ovarian cyst",
                    "choiceNumber": 6,
                    "correctTaken": 2036,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "43",
                    "mediaDataId": 0,
                    "title": "Pelvic inflammatory disease",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22665342",
                    "mediaDataId": 0,
                    "title": "Clinical features of Fitz-Hugh-Curtis syndrome in the emergency department.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22665342",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28057084",
                    "mediaDataId": 0,
                    "title": "Chlamydia trachomatis–induced Fitz-Hugh-Curtis syndrome: a case report.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28057084",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "32670702",
                    "mediaDataId": 0,
                    "title": "Chlamydia trachomatis–induced Fitz-Hugh-Curtis syndrome presenting as inspiratory dyspnea.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/32670702",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 2,
            "othersAvgTimeSpent": 84,
            "notes": null,
            "peopleTaken": 16677,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 2,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 27,
            "questionId": 11327,
            "questionIndex": 12480,
            "questionText": "<p>A 17-year-old girl comes to the office for evaluation of vaginal discharge requiring the use of a panty liner.&nbsp; She has had this discharge intermittently for the past few months and notices it returns after menses end.&nbsp; The last menstrual period ended a week ago.&nbsp; For the last 6 months, she has been sexually active with a new partner and uses condoms for contraception.&nbsp; The patient has no medical problems or previous surgeries.&nbsp; She takes no medications and does not use tobacco, alcohol, or illicit drugs.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 110/70 mm Hg, and pulse is 78/min.&nbsp; On pelvic examination, the external genitalia have no erythema or edema.&nbsp; There is copious white, mucoid, odorless vaginal discharge.&nbsp; Microscopic examination reveals a predominance of squamous cells and rare polymorphonuclear leukocytes.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p><img id=\"8316\" src=\"https://www.uworld.com/media/L31938.png\"  draggable=\"false\" ></p><p><strong>Physiologic leukorrhea</strong> is a white, odorless <strong>cervical discharge</strong> composed of cervical mucus, normal vaginal flora, and vaginal squamous epithelium.&nbsp; Increasing amounts of this normal vaginal discharge typically occurs <strong>midcycle</strong> (eg, 10-14 days after previous menses) as estrogen levels increase prior to ovulation, and then regresses (as seen in this patient).&nbsp; Physiologic leukorrhea presents <strong>without manifestations of infection</strong> such as pruritus, erythema, pain, or a malodorous discharge.</p><p>Prior to the diagnosis of physiologic leukorrhea, other causes of increasing vaginal discharge must be excluded.&nbsp; Polymorphonuclear leukocytes on microscopic examination are evidence of a local immune response (eg, inflammation) to infection.&nbsp; This patient has <strong>rare polymorphonuclear leukocytes</strong> on microscopy, ruling out all infectious etiologies as the cause of her discharge.</p><p><strong>(Choice A)</strong>&nbsp; Bacterial vaginosis is characterized by a malodorous discharge that is noted after menses or intercourse.&nbsp; Wet mount microscopy typically reveals squamous epithelial cells with adherent bacteria (eg, <a href=\"1112\">clue cells</a>).</p><p><strong>(Choice B)</strong>&nbsp; Candidiasis presents with white vaginal discharge, vulvar pruritus, and <a href=\"6086\">erythema</a> on examination.&nbsp; <a href=\"6250\">Hyphae</a> are present on microscopy with potassium hydroxide preparation of the discharge.</p><p><strong>(Choices C and D)</strong>&nbsp; Acute cervicitis is typically caused by <em>Chlamydia trachomatis</em> and <em>Neisseria gonorrhoeae</em>.&nbsp; When symptomatic, patients have intermenstrual or postcoital spotting and a mucopurulent cervical discharge.&nbsp; Microscopy shows abundant, rather than rare, polymorphonuclear leukocytes.</p><p><strong>(Choice F)</strong>&nbsp; Trichomoniasis typically presents with vulvovaginal pruritus in addition to a malodorous, green vaginal discharge.&nbsp; Motile <a href=\"1154\">protozoa</a> and an abundance of polymorphonuclear leukocytes are visualized on microscopy.</p><p><strong>Educational objective:</strong><br>Physiologic leukorrhea is a white, odorless mucoid cervical discharge that typically occurs midcycle due to increasing estrogen levels prior to ovulation.&nbsp; Microscopic examination of the discharge reveals no evidence of inflammation or infection (eg, rare polymorphonuclear leukocytes).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 22504,
            "topic": "Vulvovaginitis",
            "titleId": 22504,
            "title": "Vulvovaginitis",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "5",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bacterial vaginosis",
                    "choiceNumber": 1,
                    "correctTaken": 1226,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Candidiasis",
                    "choiceNumber": 2,
                    "correctTaken": 1859,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Gonococcal cervicitis",
                    "choiceNumber": 3,
                    "correctTaken": 1086,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Non-gonococcal cervicitis",
                    "choiceNumber": 4,
                    "correctTaken": 733,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Physiologic leukorrhea",
                    "choiceNumber": 5,
                    "correctTaken": 11590,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<em>Trichomonas</em>\n vaginitis",
                    "choiceNumber": 6,
                    "correctTaken": 161,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "805",
                    "mediaDataId": 0,
                    "title": "Evaluation of vaginal discharge",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25415165",
                    "mediaDataId": 0,
                    "title": "Management of persistent vaginitis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25415165",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 4,
            "othersAvgTimeSpent": 56,
            "notes": null,
            "peopleTaken": 16655,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 70,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 4,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 28,
            "questionId": 17870,
            "questionIndex": 19330,
            "questionText": "<p>A 49-year-old woman comes to the office for evaluation of decreased interest in sexual intercourse for the past 6 months.&nbsp; The patient has been married for 24 years and states that this is becoming a problem in her marriage.&nbsp; She has had a decreased libido for the past 6 months, and more recently, is also having pain with intercourse.&nbsp; The last few attempts at intercourse were so painful that the patient is now avoiding all sexual intimacy.&nbsp; Her only surgery was a laparoscopic hysterectomy at age 29 for severe endometriosis.&nbsp; She takes no daily medications and drinks a glass of wine most nights.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 120/70 mm Hg, and pulse is 78/min.&nbsp; BMI is 23 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; On pelvic examination, the vulva has scant pubic hair, and the vulvovaginal mucosa is pale, with clear vaginal discharge.&nbsp; The cervix and uterus are surgically absent, and the ovaries are small and nontender bilaterally.&nbsp; The remainder of the examination is unremarkable.&nbsp; Which of the following is most likely to establish the diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31500\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Menopause </strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features </strong></p></td><td><ul><li>Vasomotor symptoms</li><li>Oligomenorrhea/amenorrhea</li><li>Sleep disturbances</li><li>Decreased libido</li><li>Depression</li><li>Cognitive decline</li><li>Vaginal atrophy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis </strong></p></td><td><ul><li>Clinical manifestations</li><li>&uarr; FSH</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment </strong></p></td><td><ul><li>Topical vaginal estrogen</li><li>Systemic hormone&nbsp;replacement therapy</li></ul></td></tr></tbody></table></div><p>This patient has 6 months of decreased sexual libido and <strong>dyspareunia</strong> (ie, pain with intercourse), which may have various medical or psychosocial etiologies.&nbsp; These symptoms, along with the pale vaginal mucosa (consistent with <strong>vulvovaginal atrophy</strong>), are most likely due to <strong>menopause</strong>.&nbsp; Most women undergo menopause around age 51 due to age-related ovarian follicle depletion and decreased estrogen levels, resulting in vasomotor symptoms (eg, hot flashes, night sweats), vulvovaginal atrophy, and amenorrhea.</p><p>In general, menopause is a clinical diagnosis defined as cessation of menses for &#8805;12 months in women with previously regular menstrual cycles.&nbsp; In women with typical menopausal symptoms and cessation of menses for &#8805;12 months, no additional evaluation is required.&nbsp; However, in women <strong>without previously normal menstrual cycles</strong> (eg, prior hysterectomy, endometrial ablation), the diagnosis of menopause cannot be made clinically because vasomotor symptoms and vulvovaginal atrophy can be due to other etiologies (eg, thyroid disorder, malignancy).&nbsp; Therefore, these patients require an <strong>elevated serum FSH level</strong> for the diagnosis of menopause.</p><p><strong>(Choice A)</strong>&nbsp; Diagnostic laparoscopy is indicated in patients with dyspareunia due to suspected endometriosis (eg, dysmenorrhea, pain with defecation).&nbsp; This patient&#39;s dyspareunia is more likely due to vulvovaginal atrophy related to menopause.</p><p><strong>(Choice B)</strong>&nbsp; The Patient Health Questionnaire-9 depression screen assesses for depression, which is a common cause of decreased libido.&nbsp; However, depression would not explain this patient&#39;s vulvovaginal atrophy.</p><p><strong>(Choice D)</strong>&nbsp; Serum testosterone level does not affect menopausal status and does not correlate with sexual function in women; therefore, it is not measured in patients with menopausal symptoms or decreased libido.</p><p><strong>(Choice E)</strong>&nbsp; Vulvar biopsy is used to evaluate for possible vulvar cancer in patients with vulvar lesions (that may be associated with dyspareunia).&nbsp; This patient has no vulvar lesions.</p><p><strong>(Choice F)</strong>&nbsp; Wet mount microscopy is used to evaluate abnormal (eg, malodorous, bloody) vaginal discharge in patients with vaginitis, which can cause dyspareunia.&nbsp; This patient&#39;s clear vaginal discharge is normal.</p><p><strong>Educational objective:</strong><br>Menopause is a clinical diagnosis (ie, cessation of menses for &#8805;12 months) that usually does not require further evaluation in patients with previously normal menses and typical menopausal symptoms (eg, dyspareunia due to vulvovaginal atrophy).&nbsp; Diagnosis in women without previously normal menses (eg, prior hysterectomy) is confirmed by an elevated serum FSH level.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3188,
            "topic": "Menopause",
            "titleId": 3188,
            "title": "Menopause",
            "topicAttributeId": 330800,
            "topicAttribute": "Menstrual disorders and contraception",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Diagnostic laparoscopy",
                    "choiceNumber": 1,
                    "correctTaken": 348,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Patient Health Questionnaire-9 depression screen",
                    "choiceNumber": 2,
                    "correctTaken": 1071,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum FSH level",
                    "choiceNumber": 3,
                    "correctTaken": 14032,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum testosterone level",
                    "choiceNumber": 4,
                    "correctTaken": 559,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vulvar biopsy",
                    "choiceNumber": 5,
                    "correctTaken": 686,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Wet mount microscopy",
                    "choiceNumber": 6,
                    "correctTaken": 103,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "56",
                    "mediaDataId": 0,
                    "title": "Menopause",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "57",
                    "mediaDataId": 0,
                    "title": "Genitourinary syndrome of menopause",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28697291",
                    "mediaDataId": 0,
                    "title": "Genitourinary syndrome of menopause.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28697291",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30401552",
                    "mediaDataId": 0,
                    "title": "Female sexual function at midlife and beyond.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30401552",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 8,
            "othersAvgTimeSpent": 60,
            "notes": null,
            "peopleTaken": 16799,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 84,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 8,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 29,
            "questionId": 4791,
            "questionIndex": 4791,
            "questionText": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td id=\"vignettedescriptor\">The following vignette applies to the next <strong>2</strong> items.&nbsp; The items in the set must be answered in sequential order.&nbsp; Once you click <strong>Proceed to Next Item</strong>, you will not be able to add or change an answer.</td></tr></tbody></table><p>A 26-year-old woman comes to the office due to a vulvar lesion that she noticed 2 days ago.&nbsp; The lesion began as a papule, but this morning it developed a small ulcer in the center.&nbsp; The patient has mild burning with urination but no fever, abnormal vaginal discharge, or oral ulcers.&nbsp; She is sexually active and has had 5 male partners over the past year.&nbsp; Her only medication is an oral contraceptive.&nbsp; The patient smokes 1 pack of cigarettes daily but does not use alcohol or illicit drugs.&nbsp; Vital signs are normal.&nbsp; Vulvar examination shows a 2-cm ulcer with a nonexudative base and a raised, indurated margin.&nbsp; There is no tenderness with palpation.&nbsp; Moderate, painless bilateral inguinal lymphadenopathy is present.</p><p><strong>Item 1 of 2</strong></p><p>Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T63437\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"4\"><p align=\"center\"><strong>Characteristics of ulcerative sexually transmitted diseases</strong></p></td></tr><tr><td><p align=\"center\"><strong>Disease</strong></p></td><td><p align=\"center\"><strong>Causative agent</strong></p></td><td><p align=\"center\"><strong>Features of primary lesion</strong></p></td><td><p align=\"center\"><strong>Initial lesion painful?</strong></p></td></tr><tr><td><p align=\"center\">Chancroid</p></td><td><p align=\"center\"><em>Haemophilus ducreyi</em></p></td><td><ul><li>Multiple &amp; deep ulcers</li><li>Base may have gray to yellow exudate</li><li>Organisms often clump in long parallel strands (&#x22;school of fish&#x22;)</li></ul></td><td><p align=\"center\">Yes</p></td></tr><tr><td><p align=\"center\">Genital herpes</p></td><td><p align=\"center\">Herpes simplex virus 1 &amp; 2</p></td><td><ul><li>Multiple, small, grouped ulcers</li><li>Shallow with erythematous base</li><li>Multinucleated giant cells &amp; intranuclear inclusions (Cowdry type A)</li></ul></td><td><p align=\"center\">Yes</p></td></tr><tr><td><p align=\"center\">Granuloma inguinale (donovanosis)</p></td><td><p align=\"center\"><em>Klebsiella granulomatis</em></p></td><td><ul><li>Extensive &amp; progressive ulcerative lesions without lymphadenopathy</li><li>Base may have granulation-like tissue</li><li>Deeply staining gram-negative intracytoplasmic cysts (Donovan bodies)</li></ul></td><td><p align=\"center\">No</p></td></tr><tr><td><p align=\"center\">Syphilis</p></td><td><p align=\"center\"><em>Treponema pallidum</em></p></td><td><ul><li>Single, indurated, well-circumscribed ulcer</li><li>Nonexudative base</li><li>Painless inguinal lymphadenopathy</li><li>Thin, delicate, corkscrew-shaped organisms on dark-field microscopy</li></ul></td><td><p align=\"center\">No</p></td></tr><tr><td><p align=\"center\">Lymphogranuloma venereum</p></td><td><p align=\"center\"><em>Chlamydia trachomatis</em></p></td><td><ul><li>Small &amp; shallow ulcers</li><li>Large, painful, coalesced inguinal lymph nodes (&#x22;buboes&#x22;)</li><li>Intracytoplasmic chlamydial inclusion bodies in epithelial cells &amp; leukocytes</li></ul></td><td><p align=\"center\">No</p></td></tr></tbody></table></div><p>Patients with multiple sexual partners are at high risk for sexually transmitted infections.&nbsp; This patient has classic symptoms of <strong>primary syphilis</strong>: a painless <strong>genital chancre</strong> and painless, bilateral inguinal lymphadenopathy.&nbsp; Syphilitic chancres form at the site of direct inoculation with <em><strong>Treponema pallidum</strong></em>.&nbsp; After exposure (3-60 days), patients develop a <strong>single papule</strong> that turns into a shallow, <strong>painless, nonexudative ulcer</strong> with indurated edges.&nbsp; Mild to moderate bilateral <strong>inguinal lymphadenopathy</strong> can develop.&nbsp; Syphilitic chancres are exceedingly infectious, with rates of <em>T pallidum</em> transmission as high as 30%.&nbsp; If untreated, most chancres resolve spontaneously in 6-8 weeks, but the systemic spread of <em>T pallidum</em> results in continued infection.</p><p><strong>(Choices A, B, and C)</strong>&nbsp; Beh&ccedil;et syndrome, chancroid, and genital herpes are characterized by multiple, painful genital lesions, not a single, painless lesion.&nbsp; Chancroid, caused by <em>Haemophilus ducreyi</em>, is most common in developing regions and is rare in the United States.&nbsp; Beh&ccedil;et syndrome, most likely a form of vasculitis, is marked by recurrent oral aphthous ulcers, often with other systemic findings (eg, fever, uveitis, arthritis).</p><p><strong>(Choice D)</strong>&nbsp; Granuloma inguinale is caused by <em>Klebsiella granulomatis</em> and is marked by extensive, progressive, and painless genital ulcers, usually without lymphadenopathy.&nbsp; In the United States, &lt;100 infections occur annually, mostly in patients who have traveled internationally (eg, India, Guyana).</p><p><strong>(Choice F)</strong>&nbsp; Vulvar carcinoma usually presents with a vulvar plaque, ulcer, or mass, often with significant pruritus.&nbsp; Vulvar cancer would evolve over weeks or months, not 2 days.</p><p><strong>Educational objective:</strong><br>Primary syphilis is marked by the formation of a single, painless chancre that begins as a papule and becomes a nonexudative ulcer with indurated borders.&nbsp; Mild to moderate, painless, bilateral lymphadenopathy is often present.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 15559,
            "topic": "Syphilis",
            "titleId": 15559,
            "title": "Syphilis",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "5",
            "userAnswer": "0",
            "parentQuestionId": 4791,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 1,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Beh&ccedil;et syndrome",
                    "choiceNumber": 1,
                    "correctTaken": 103,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Chancroid",
                    "choiceNumber": 2,
                    "correctTaken": 1998,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Genital herpes",
                    "choiceNumber": 3,
                    "correctTaken": 1323,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Granuloma inguinale",
                    "choiceNumber": 4,
                    "correctTaken": 2110,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Syphilis",
                    "choiceNumber": 5,
                    "correctTaken": 11760,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vulvar carcinoma",
                    "choiceNumber": 6,
                    "correctTaken": 639,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 6,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "46",
                    "mediaDataId": 0,
                    "title": "Infectious genital ulcers",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "601",
                    "mediaDataId": 0,
                    "title": "Syphilis:  Treponema pallidum infection",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31253629",
                    "mediaDataId": 0,
                    "title": "Syphilis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31253629",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 4,
            "othersAvgTimeSpent": 57,
            "notes": null,
            "peopleTaken": 17933,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 66,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 4,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 30,
            "questionId": 4792,
            "questionIndex": 4792,
            "questionText": "<p><strong>Item 2 of 2</strong></p><p>Serum rapid plasma reagin and herpes simplex virus PCR testing are negative.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t63438\"><table class=\"table-default-style table-footer-only-style\" style=\"width:612px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Syphilis: diagnostic serology</strong></p></td></tr><tr><td><p align=\"center\"><strong>Nontreponemal</strong></p><p align=\"center\"><strong>(RPR, VDRL)</strong></p></td><td><ul><li>Antibody to cardiolipin-cholesterol-lecithin antigen</li></ul><ul><li>Quantitative (titers)</li><li>Possible negative result in early infection</li><li>Decrease in titers confirms treatment</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treponemal</strong></p><p align=\"center\"><strong>(FTA-ABS, TP-EIA)</strong></p></td><td><ul><li>Antibody to treponemal antigens</li><li>Qualitative (reactive/nonreactive)</li><li>Greater sensitivity in early infection</li><li>Positive even after treatment</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>FTA-ABS</strong> = fluorescent treponemal antibody absorption; <strong>RPR</strong> = rapid plasma reagin;<br /><strong>TP-EIA</strong> = <em>Treponema pallidum</em> enzyme immunoassay.</p></td></tr></tbody></table></div><p>This patient with a <strong>painless genital ulcer</strong> (ie, chancre) and bilateral inguinal lymphadenopathy almost certainly has <strong>primary syphilis</strong>, despite negative serology testing.&nbsp; Two types of syphilis serologic tests are usually used in combination for diagnosis:</p><ul><li>Nontreponemal (eg, rapid plasma reagin [RPR])</li><li>Treponemal (eg, fluorescent treponemal antibody absorption [FTA-ABS])</li></ul><p>In general, <strong>nontreponemal testing</strong> (eg, <strong>RPR</strong>) is obtained first due to low cost and availability.&nbsp; An initial RPR titer can also be used later to monitor response to treatment (ie, decreasing titers).&nbsp; However, nontreponemal testing has a higher rate of <strong>false-negative results</strong> (20%-30%), particularly for primary syphilis.&nbsp; This is because testing depends on the patient&#39;s development of antibodies, which may be absent or low in patients with <strong>early infection</strong> or severe immunosuppression.</p><p>This patient could undergo treponemal testing, which is more sensitive, but her <strong>classic clinical presentation</strong> for primary syphilis is a strong indication for <strong>empiric treatment</strong> with <strong>intramuscular benzathine penicillin G</strong>.&nbsp; Empiric treatment reduces the risk of transmission.&nbsp; Repeat nontreponemal serology is performed in 2-4 weeks to establish baseline titers for treatment monitoring; a 4-fold titer decrease at 6-12 months confirms adequate treatment.</p><p><strong>(Choices A and B)</strong>&nbsp; Acyclovir can treat genital herpes outbreaks caused by herpes simplex virus (HSV).&nbsp; HSV tends to cause multiple, painful ulcers, but this patient has a single, painless lesion with negative HSV PCR testing.&nbsp; Azithromycin can be used to treat chlamydial infections, including lymphogranuloma venereum, which causes multiple genital ulcers and large, painful inguinal lymphadenopathy (ie, buboes), which are not seen in this patient.</p><p><strong>(Choice D)</strong>&nbsp; Treatment should not be delayed because transmission risk is high with an active syphilitic chancre.&nbsp; In addition, patients may not return for treatment because untreated chancres resolve spontaneously; however, syphilis infection may persist and can spread systemically.</p><p><strong>(Choice E)</strong>&nbsp; Topical corticosteroids are used to treat vulvar lichen planus and lichen sclerosus; however, these conditions usually do not present as a painless ulcer and are unlikely in this young patient.</p><p><strong>(Choice F)</strong>&nbsp; A wide local excision may be indicated for vulvar cancer, which can present as a single vulvar ulcer.&nbsp; In contrast to this patient, vulvar cancer typically causes pruritic, friable lesions over the course of months, not days.</p><p><strong>Educational objective:</strong><br>False-negative nontreponemal serology (eg, rapid plasma reagin) is common in primary syphilis.&nbsp; Patients with negative serology and strong clinical evidence (eg, chancre) of primary syphilis are treated empirically with intramuscular benzathine penicillin G.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 15559,
            "topic": "Syphilis",
            "titleId": 15559,
            "title": "Syphilis",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "3",
            "userAnswer": "0",
            "parentQuestionId": 4791,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 2,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 1,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Empiric acyclovir",
                    "choiceNumber": 1,
                    "correctTaken": 189,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Empiric azithromycin",
                    "choiceNumber": 2,
                    "correctTaken": 1319,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Empiric penicillin G",
                    "choiceNumber": 3,
                    "correctTaken": 15122,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassurance and follow-up in 2 months",
                    "choiceNumber": 4,
                    "correctTaken": 366,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Topical corticosteroids",
                    "choiceNumber": 5,
                    "correctTaken": 196,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Wide local excision",
                    "choiceNumber": 6,
                    "correctTaken": 739,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 6,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": true,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "46",
                    "mediaDataId": 0,
                    "title": "Infectious genital ulcers",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "601",
                    "mediaDataId": 0,
                    "title": "Syphilis:  Treponema pallidum infection",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25428245",
                    "mediaDataId": 0,
                    "title": "Recent trends in the serologic diagnosis of syphilis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25428245",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 15,
            "notes": null,
            "peopleTaken": 17931,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 84,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 31,
            "questionId": 3371,
            "questionIndex": 3371,
            "questionText": "<p>A 28-year-old nulligravid woman comes to the office due to infertility.&nbsp; She feels well but has been trying to conceive for the past 12 months without success.&nbsp; The patient has had sexual intercourse with her husband 3 or 4 times a week without contraception.&nbsp; Her menses are irregular with frequent missed periods.&nbsp; For every missed period, home pregnancy tests are negative.&nbsp; She has frequent migraines and often takes a triptan for abortive therapy along with metoclopramide to relieve the accompanying nausea; she has had no surgeries.&nbsp; Vital signs are normal.&nbsp; There is no excess hair on physical examination.&nbsp; Breast examination shows no masses or nipple discharge.&nbsp; The abdomen is soft and without masses.&nbsp; Pelvic examination shows normal external genitalia and a small, mobile uterus.&nbsp; Pelvic ultrasonography shows a normal uterus and bilateral ovaries.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\"></td><td style=\"vertical-align:middle;\"><strong>Result</strong></td><td style=\"vertical-align:middle;\"><strong>Normal values</strong></td></tr><tr><td style=\"vertical-align:middle;\">FSH</td><td style=\"vertical-align:middle;\">3 mIU/mL</td><td style=\"vertical-align:middle;\">&gt;5 mIU/mL</td></tr><tr><td style=\"vertical-align:middle;\">LH</td><td style=\"vertical-align:middle;\">4 mIU/mL</td><td style=\"vertical-align:middle;\">&gt;5 mIU/mL</td></tr><tr><td style=\"vertical-align:middle;\">Prolactin</td><td style=\"vertical-align:middle;\">15 ng/mL</td><td style=\"vertical-align:middle;\">&lt;20 ng/mL</td></tr><tr><td style=\"vertical-align:middle;\">TSH</td><td style=\"vertical-align:middle;\">3.2 &#956;U/mL</td><td style=\"vertical-align:middle;\">0.5-5 &micro;U/mL</td></tr><tr><td style=\"vertical-align:middle;\">Testosterone</td><td style=\"vertical-align:middle;\">35 ng/dL</td><td style=\"vertical-align:middle;\">20-75 ng/dL</td></tr><tr><td style=\"vertical-align:middle;\">Dehydroepiandrosterone sulfate</td><td style=\"vertical-align:middle;\">1.0 mg/mL</td><td style=\"vertical-align:middle;\">0.6-3.3 mg/mL</td></tr><tr><td style=\"vertical-align:middle;\">Estradiol</td><td style=\"vertical-align:middle;\">7 pg/mL</td><td style=\"vertical-align:middle;\">&gt;10 pg/mL</td></tr><tr><td style=\"vertical-align:middle;\">&#946;-hCG</td><td style=\"vertical-align:middle;\">&lt;0.1</td><td style=\"vertical-align:middle;\"></td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s infertility?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"3039\" src=\"https://www.uworld.com/media/highresdefault/L24459.png\"  ></p><p>This patient most likely has <strong>hypogonadotropic hypogonadism</strong>.&nbsp; This condition occurs when severe stress, excessive weight loss (eg, eating disorder, excessive exercise), or chronic illness causes a <strong>decrease</strong> in the amplitude and frequency of <strong>GnRH pulses</strong> secreted by the hypothalamus.&nbsp; As a result, there is a decrease in pituitary LH and FSH production.&nbsp; Because of the <strong>low LH and FSH</strong> levels, ovarian <strong>estrogen production is low</strong>, and ovulation does not occur, leading to oligomenorrhea/amenorrhea and infertility.&nbsp; Physical examination is typically normal, although the patient may have a low BMI.</p><p>An underlying cause is not always initially apparent but can often be identified on further investigation.&nbsp; First-line treatment involves management of these causes (eg, reduce stress, gain weight via increased caloric intake and exercise reduction, manage any underlying chronic illness).</p><p><strong>(Choice B)</strong>&nbsp; Hypothyroidism can be a cause of anovulation and infertility; however, it is unlikely in this patient with a normal TSH.</p><p><strong>(Choice C)</strong>&nbsp; Although the use of triptans for acute abortive migraine treatment does not alter hormonal secretory patterns in the hypothalamus and pituitary, metoclopramide has the potential to cause hyperprolactinemia by blocking the dopaminergic inhibition of pituitary lactotrophs.&nbsp; However, this patient&#39;s intermittent use of metoclopramide and normal prolactin levels make this an unlikely cause of her amenorrhea and infertility.</p><p><strong>(Choice D)</strong>&nbsp; A pituitary adenoma can present with infertility and irregular menstrual cycles but also with galactorrhea (eg, prolactinoma) or symptoms suggesting a sellar mass (eg, headache, loss of peripheral vision).</p><p><strong>(Choice E)</strong>&nbsp; Polycystic ovary syndrome can present with irregular menses and infertility, but there is also evidence of insulin resistance (eg, acanthosis nigricans, obesity) and elevated testosterone (eg, acne, hirsutism).&nbsp; Estradiol levels are normal to increased.</p><p><strong>(Choice F)</strong>&nbsp; Primary ovarian insufficiency typically presents with oligomenorrhea/amenorrhea, infertility, menopausal symptoms (eg, hot flashes), elevated FSH levels, and decreased estradiol levels.</p><p><strong>Educational objective:</strong><br>Hypogonadotropic hypogonadism (low FSH and estradiol) causes irregular menses and infertility due to loss of pulsatile GnRH secretion precipitated by weight loss, stress, or chronic illness.&nbsp; First-line treatment involves management of any underlying causes.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 23429,
            "topic": "Amenorrhea",
            "titleId": 23429,
            "title": "Amenorrhea",
            "topicAttributeId": 330800,
            "topicAttribute": "Menstrual disorders and contraception",
            "correctAnswer": "1",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Hypogonadotropic hypogonadism",
                    "choiceNumber": 1,
                    "correctTaken": 12532,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypothyroidism",
                    "choiceNumber": 2,
                    "correctTaken": 131,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medication adverse effect",
                    "choiceNumber": 3,
                    "correctTaken": 1413,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pituitary adenoma",
                    "choiceNumber": 4,
                    "correctTaken": 685,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Polycystic ovary syndrome",
                    "choiceNumber": 5,
                    "correctTaken": 185,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Primary ovarian insufficiency",
                    "choiceNumber": 6,
                    "correctTaken": 1748,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "72",
                    "mediaDataId": 0,
                    "title": "Hypothalamic amenorrhea",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26849039",
                    "mediaDataId": 0,
                    "title": "Functional hypothalamic amenorrhoea: leptin treatment, dietary intervention and counselling as alternatives to traditional practice - systematic review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26849039",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 79,
            "notes": null,
            "peopleTaken": 16696,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 75,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 32,
            "questionId": 4766,
            "questionIndex": 4766,
            "questionText": "<p>A 19-year-old woman comes to the office for a routine physical examination.&nbsp; She feels well and has no concerns.&nbsp; The patient has had 2 sexual partners in the past 3 months and uses condoms for contraception.&nbsp; She has no significant medical history, takes no medications, and has no drug allergies.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 120/72 mm Hg, and pulse is 72/min.&nbsp; Pelvic examination shows normal external genitalia.&nbsp; The cervix has no lesions, abnormal discharge, or friability.&nbsp; On bimanual examination, the uterus is small and mobile and has no cervical motion or fundal tenderness.&nbsp; A urine pregnancy test is negative.&nbsp; A cervical swab sent for nucleic acid amplification testing is positive for <em>Chlamydia trachomatis</em> but negative for <em>Neisseria gonorrhoeae</em>.&nbsp; The patient is still asymptomatic.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31462\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Chlamydia &amp; gonorrhea in women</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors </strong></p></td><td><ul><li>Age &lt;25</li><li>High-risk sexual behavior</li></ul></td></tr><tr><td><p align=\"center\"><strong>Manifestations </strong></p></td><td><ul><li>Asymptomatic (most common)</li><li>Cervicitis</li><li>Urethritis</li><li>Perihepatitis (Fitz-Hugh&ndash;Curtis syndrome)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis </strong></p></td><td><ul><li>Nucleic acid amplification testing</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment </strong></p></td><td><ul><li>Empiric: ceftriaxone + doxycycline*</li><li>Confirmed chlamydia: doxycycline*</li><li>Confirmed gonorrhea: ceftriaxone</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications </strong></p></td><td><ul><li>Pelvic inflammatory disease</li><li>Ectopic pregnancy</li><li>Infertility</li><li>Pharyngitis</li></ul></td></tr><tr><td colspan=\"2\"><p>*Azithromycin in pregnancy.</p></td></tr></tbody></table></div><p><em>Chlamydia trachomatis</em> and <em>Neisseria gonorrhoeae</em> are common sexually transmitted infections with high prevalence, particularly in patients age 14-19.&nbsp; Women with these infections are commonly asymptomatic.&nbsp; The lack of symptoms (and subsequent lack of treatment) increases the risk for long-term reproductive complications, including pelvic inflammatory disease, tuboovarian abscess, and infertility or ectopic pregnancy due to tubal scarring.&nbsp; In addition, the frequent absence of symptoms contributes to high rates of transmission.&nbsp; Therefore, <strong>annual screening</strong> for chlamydia and gonorrhea is recommended in <strong>all sexually active women age &lt;25</strong> and women age &#8805;25 with risk factors (eg, multiple sexual partners, inconsistent condom use).</p><p>The <strong>nucleic acid amplification test</strong> (NAAT) is the <strong>gold standard</strong> screening and diagnostic test for both <em>C trachomatis</em> and <em>N gonorrhoeae</em> because of its high sensitivity (96%) and specificity (99%).&nbsp; Treatment is indicated for a positive NAAT result in the patient and the patient&#39;s sexual partners, even in the absence of symptoms <strong>(Choice D)</strong>.&nbsp; Confirmation testing is not required due to high test specificity <strong>(Choice E)</strong>.</p><p>First-line treatment for NAAT-confirmed <em>Chlamydia trachomatis</em> is <strong>doxycycline</strong>; azithromycin may be used in pregnant patients for whom doxycycline is a contraindication because of potential teratogenicity.</p><p><strong>(Choice A)</strong>&nbsp; Ceftriaxone and doxycycline are used for empiric treatment of symptomatic, acute cervicitis (eg, mucopurulent discharge, cervical friability) when NAAT results for gonorrhea and chlamydia are pending.&nbsp; This early empiric therapy covers both organisms to decrease complication rates.&nbsp; However, in patients with a single positive result, treatment of both infections is no longer required due to the high sensitivity and specificity of NAAT for both organisms.</p><p><strong>(Choice B)</strong>&nbsp; Dual therapy with ceftriaxone and azithromycin was once recommended for gonorrhea due to concern for increasing cephalosporin resistance of <em>N gonorrhoeae</em>.&nbsp; However, <em>N gonorrhoeae</em> has remained susceptible to ceftriaxone, particularly with an increased dose, but resistance to azithromycin has increased.&nbsp; Therefore, the recommendation for the treatment of gonorrhea (when chlamydia has been excluded on testing) is ceftriaxone monotherapy.</p><p><strong>Educational objective:</strong><br>Chlamydial infection diagnosed by nucleic acid amplification testing (NAAT) is treated with doxycycline to prevent long-term reproductive complications (eg, pelvic inflammatory disease, infertility).&nbsp; Concurrent treatment for gonorrhea with ceftriaxone is not indicated if the gonorrhea NAAT result is negative.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 8096,
            "topic": "Pelvic inflammatory disease",
            "titleId": 8096,
            "title": "Pelvic inflammatory disease",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "3",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Ceftriaxone and doxycycline",
                    "choiceNumber": 1,
                    "correctTaken": 6505,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ceftriaxone only",
                    "choiceNumber": 2,
                    "correctTaken": 1095,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Doxycycline only",
                    "choiceNumber": 3,
                    "correctTaken": 12113,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassurance and no treatment at this time",
                    "choiceNumber": 4,
                    "correctTaken": 307,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Repeat test for confirmation",
                    "choiceNumber": 5,
                    "correctTaken": 221,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "42",
                    "mediaDataId": 0,
                    "title": "Acute cervicitis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "637",
                    "mediaDataId": 0,
                    "title": "Chlamydia trachomatis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24622331",
                    "mediaDataId": 0,
                    "title": "Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae—2014.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24622331",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26042815",
                    "mediaDataId": 0,
                    "title": "Sexually transmitted diseases treatment guidelines, 2015.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26042815",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "33332296",
                    "mediaDataId": 0,
                    "title": "Update to CDC&#39;s treatment guidelines for gonococcal infection, 2020.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/33332296",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 38,
            "notes": null,
            "peopleTaken": 20241,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 60,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 33,
            "questionId": 2393,
            "questionIndex": 2393,
            "questionText": "<p>An 18-year-old nulligravid woman comes to the office for emergency contraception.&nbsp; The condom broke during sexual intercourse last night, and she does not want to become pregnant for at least several years.&nbsp; The patient and her longtime boyfriend have always used condoms, and their evaluations for sexually transmitted infections have been negative.&nbsp; Her last menstrual period was 2 weeks ago.&nbsp; The patient has no chronic medical conditions and takes no medications.&nbsp; She does not use tobacco, alcohol, or recreational drugs.&nbsp; Blood pressure is 122/80 mm Hg and pulse is 86/min.&nbsp; BMI is 27 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination is normal, and a pregnancy test is negative.&nbsp; Which of the following is the most effective emergency contraceptive method for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T32628\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"4\"><p align=\"center\"><strong>Emergency contraception</strong></p></td></tr><tr><td><p align=\"center\"><strong>Method</strong></p></td><td><p align=\"center\"><strong>Timing after<br>intercourse</strong></p></td><td><p align=\"center\"><strong>Efficacy</strong></p></td><td><p align=\"center\"><strong>Contraindications</strong></p></td></tr><tr><td><p align=\"center\"><strong>Copper-containing<br>intrauterine device</strong></p></td><td><p align=\"center\">0-120 hr</p></td><td><p align=\"center\">&gt;99%</p></td><td><ul><li>Wilson disease</li><li>Active pelvic infection</li><li>Severe uterine cavity distortion</li></ul></td></tr><tr><td><p align=\"center\"><strong>Progestin-releasing<br>intrauterine device</strong></p></td><td><p align=\"center\">0-120 hr</p></td><td><p align=\"center\">&gt;99%</p></td><td><ul><li>Breast cancer</li><li>Active pelvic infection</li><li>Severe uterine cavity distortion</li></ul></td></tr><tr><td><p align=\"center\"><strong>Ulipristal</strong></p></td><td><p align=\"center\">0-120 hr</p></td><td><p align=\"center\">98%-99%</p></td><td><ul><li>None</li></ul></td></tr><tr><td><p align=\"center\"><strong>Oral levonorgestrel</strong></p></td><td><p align=\"center\">0-72 hr</p></td><td><p align=\"center\">92%-98%</p></td><td><ul><li>None</li></ul></td></tr><tr><td><p align=\"center\"><strong>Oral contraceptives*</strong></p></td><td><p align=\"center\">0-72 hr</p></td><td><p align=\"center\">75%-89%</p></td><td><ul><li>None</li></ul></td></tr><tr><td colspan=\"4\"><p>*Combined estrogen/progestin oral contraceptive pills containing levonorgestrel or norgestrel.</p></td></tr></tbody></table></div><p>Patients with recent unprotected sexual intercourse or contraception failure (eg, broken condom) are at risk for unintended pregnancy and may be candidates for <strong>emergency contraception (EC)</strong>.</p><p>The <strong>copper-containing and 52-mg progestin-releasing intrauterine devices</strong> (<a href=\"2430\">IUDs</a>) are the <strong>most effective (&gt;99%)</strong> EC methods available.&nbsp; IUD insertion within 120 hours (5 days) after unprotected intercourse prevents pregnancy by impairing fertilization (by inducing intrauterine inflammation that is cytotoxic to sperm and ova) and preventing implantation.&nbsp; Age and parity are not contraindications to IUD insertion; therefore, an IUD is the most effective option for this nulligravid adolescent.</p><p>In addition, an IUD can be left in place to provide <strong>continued contraception</strong> for up to 7 years for the 52-mg progestin-releasing device and up to 10 years for the copper-containing device, but it may be removed sooner (ie, whenever the patient desires pregnancy), which leads to an immediate return of fertility.</p><p><strong>(Choice A)</strong>&nbsp; Combination oral contraceptive pills (eg, ethinyl estradiol plus levonorgestrel) are commonly used for precoital contraception but can also be used for EC by taking multiple pills simultaneously to achieve the progestin level required to delay ovulation.&nbsp; However, this method is less effective (47%-89%) and the pills contain estrogen, which typically causes intolerable side effects (eg, severe nausea).</p><p><strong>(Choices C and E)</strong>&nbsp; Levonorgestrel and ulipristal pills are EC methods that prevent pregnancy primarily by delaying ovulation.&nbsp; Although these medications are more accessible than an IUD, which requires a provider trained in its insertion, they are slightly less effective at pregnancy prevention than an IUD and do not offer the benefit of continued contraception.</p><p><strong>(Choice D)</strong>&nbsp; Medroxyprogesterone is a progestin-only contraceptive injection but is not typically used for EC.&nbsp; It inhibits hypothalamic secretion of GnRH, which decreases FSH and LH, thereby inhibiting ovarian follicle development.&nbsp; This patient already likely has a mature ovarian follicle (based on her last menstrual period); therefore, medroxyprogesterone would not work as EC.</p><p><strong>Educational objective:</strong><br>Emergency contraception can be used to prevent pregnancy within 3-5 days of unprotected intercourse and typically works by delaying ovulation or impairing implantation.&nbsp; Intrauterine devices (eg, copper-containing, progestin-releasing) are the most effective emergency contraceptive methods and may be offered to nulliparous women and adolescents.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 17805,
            "topic": "Contraception",
            "titleId": 17805,
            "title": "Contraception",
            "topicAttributeId": 330800,
            "topicAttribute": "Menstrual disorders and contraception",
            "correctAnswer": "2",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Combined ethinyl estradiol plus levonorgestrel pills",
                    "choiceNumber": 1,
                    "correctTaken": 598,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Copper-containing intrauterine device",
                    "choiceNumber": 2,
                    "correctTaken": 10043,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Levonorgestrel pills",
                    "choiceNumber": 3,
                    "correctTaken": 2886,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medroxyprogesterone injection",
                    "choiceNumber": 4,
                    "correctTaken": 291,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ulipristal pill",
                    "choiceNumber": 5,
                    "correctTaken": 2834,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "75",
                    "mediaDataId": 0,
                    "title": "Emergency contraception",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25254919",
                    "mediaDataId": 0,
                    "title": "Emergency contraception review: evidence-based recommendations for clinicians.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25254919",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26287787",
                    "mediaDataId": 0,
                    "title": "Practice bulletin no. 152: emergency contraception.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26287787",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28766313",
                    "mediaDataId": 0,
                    "title": "Interventions for emergency contraception.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28766313",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 33,
            "notes": null,
            "peopleTaken": 16652,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 60,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 34,
            "questionId": 17497,
            "questionIndex": 18954,
            "questionText": "<p>A 29-year-old woman comes to the emergency department due to vaginal spotting and discharge.&nbsp; She had a positive pregnancy test last week after missing her last menstrual period and estimates that she is at 5 weeks gestation.&nbsp; The patient has had increased vaginal discharge for the past 2 days but no pelvic pain or cramping.&nbsp; Today, she started having vaginal spotting, which prompted her to come to the emergency department.&nbsp; The patient had a spontaneous abortion 3 years ago that was treated with medication, but she has no chronic medical conditions.&nbsp; Temperature is 37.6 C (99.7 F), blood pressure is 100/60 mm Hg, and pulse is 90/min.&nbsp; The abdomen is soft, nontender, and without rebound or guarding.&nbsp; The cervix appears closed and without lesions, and there is bloody, yellow mucus at the external cervical os.&nbsp; The remainder of the physical examination is normal.&nbsp; Quantitative &#946;-hCG level is 5,200 IU/L and blood type is O, Rh positive.&nbsp; Ultrasound shows an intrauterine fetal pole with a positive fetal heartbeat.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32800\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Acute cervicitis </strong></p></td></tr><tr><td><p align=\"center\"><strong>Etiology </strong></p></td><td><ul><li>Infectious: <em>Chlamydia trachomatis, Neisseria gonorrhoeae</em></li><li>Noninfectious: foreign object, latex, douching&nbsp;</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation </strong></p></td><td><ul><li>Asymptomatic</li><li>Mucopurulent discharge &nbsp;</li><li>Postcoital/intermenstrual bleeding</li><li>Friable cervix &nbsp;&nbsp;</li></ul></td></tr><tr><td><p align=\"center\"><strong>Evaluation </strong></p></td><td><ul><li>Nucleic acid amplification testing &nbsp;</li><li>Wet mount microscopy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management </strong></p></td><td><ul><li>Empiric treatment: ceftriaxone + doxycycline*</li></ul></td></tr><tr><td colspan=\"2\"><p>*Ceftriaxone + azithromycin in pregnancy.</p></td></tr></tbody></table></div><p>This patient at 5 weeks gestation has <strong>first-trimester bleeding</strong>.&nbsp; A common cause is spontaneous abortion (particularly in patients with a prior spontaneous abortion), but there are many other etiologies of first-trimester bleeding that range from benign (eg, cervical polyp) to life threatening (eg, ectopic pregnancy, septic abortion).&nbsp; Therefore, initial evaluation is with speculum examination to determine the source of bleeding and with pelvic ultrasound to determine pregnancy location.&nbsp; This patient&#39;s nontender abdomen, closed cervix, and viable intrauterine pregnancy on ultrasound indicate that a spontaneous abortion is unlikely to be the cause of her bleeding.</p><p>In this patient, the vaginal spotting with associated <strong>mucopurulent endocervical discharge</strong> (eg, bloody, yellow mucus at the external os) is classic for <strong>acute cervicitis</strong>, which is cervical inflammation and <a href=\"2064\">friability</a> typically caused by a sexually transmitted infection (eg, gonorrhea, chlamydia).&nbsp; Acute cervicitis is diagnosed clinically and requires <strong>empiric antibiotic therapy</strong>.&nbsp; Nonpregnant patients are typically treated with ceftriaxone and doxycycline; however, because doxycycline is a potential teratogen, <strong>pregnant patients</strong> are treated with ceftriaxone and azithromycin.&nbsp; Because untreated, undertreated, or recurrent infection can ascend to the uterus and increase the risk of <strong>obstetric</strong> (eg, spontaneous abortion, preterm prelabor rupture of membranes) and <strong>neonatal</strong> (eg, conjunctivitis) <strong>complications</strong>, pregnant patients also require a <strong>test of cure</strong> after treatment.</p><p><strong>(Choice A)</strong>&nbsp; Anti-D immune globulin administration is administered to Rh-negative women after pregnancy-related bleeding (eg, spontaneous abortion, ectopic pregnancy) due to the risk of fetomaternal hemorrhage and possible Rh alloimmunization that can lead to hemolytic disease of the newborn in future pregnancies.&nbsp; This patient is Rh positive.</p><p><strong>(Choice B)</strong>&nbsp; Cervical biopsy is indicated in patients with suspected cervical cancer, which can cause vaginal spotting and mucopurulent discharge (particularly when there is associated tissue necrosis); however, patients typically have a visible cervical lesion, which is not seen in this patient.</p><p><strong>(Choices D, E, and F)</strong>&nbsp; Patients with spontaneous abortion can be treated with either medical (eg, mifepristone, misoprostol) or surgical (eg, suction curettage) management based on patient preference and hemodynamic status.&nbsp; Suction curettage is also indicated in patients with a septic abortion, which can present with mucopurulent cervical discharge; however, this diagnosis is unlikely in this patient with no other signs of infection (eg, afebrile, soft and nontender abdomen).</p><p><strong>Educational objective:</strong><br>Acute cervicitis can present with first-trimester bleeding and mucopurulent endocervical discharge.&nbsp; Pregnant patients with acute cervicitis require empiric treatment with ceftriaxone and azithromycin followed by a test of cure.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 8096,
            "topic": "Pelvic inflammatory disease",
            "titleId": 8096,
            "title": "Pelvic inflammatory disease",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "3",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Anti-D immune globulin administration",
                    "choiceNumber": 1,
                    "correctTaken": 2555,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cervical biopsy",
                    "choiceNumber": 2,
                    "correctTaken": 984,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Empiric antibiotic therapy",
                    "choiceNumber": 3,
                    "correctTaken": 11562,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Mifepristone",
                    "choiceNumber": 4,
                    "correctTaken": 969,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Misoprostol",
                    "choiceNumber": 5,
                    "correctTaken": 798,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Suction curettage",
                    "choiceNumber": 6,
                    "correctTaken": 745,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "42",
                    "mediaDataId": 0,
                    "title": "Acute cervicitis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "805",
                    "mediaDataId": 0,
                    "title": "Evaluation of vaginal discharge",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26042815",
                    "mediaDataId": 0,
                    "title": "Sexually transmitted diseases treatment guidelines, 2015.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26042815",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "33332296",
                    "mediaDataId": 0,
                    "title": "Update to CDC&#39;s treatment guidelines for gonococcal infection, 2020.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/33332296",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 82,
            "notes": null,
            "peopleTaken": 17613,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 66,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 35,
            "questionId": 11369,
            "questionIndex": 12524,
            "questionText": "<p>A 15-year-old girl is brought to the office due to prolonged, irregular menstrual periods.&nbsp; Menses occur at 2- to 4-month intervals and last for 7-10 days with heavy bleeding and passage of large clots.&nbsp; The patient&#39;s menstrual cycles are nonpainful, and she has no associated dizziness, fatigue, palpitations, or abnormal vaginal discharge.&nbsp; Menarche was at age 14, and her last menstrual period was a month ago.&nbsp; She has no other chronic medical conditions or previous surgeries.&nbsp; Blood pressure is 110/70 mm Hg and pulse is 72/min.&nbsp; Height and weight are at the 40th and 56th percentiles, respectively.&nbsp; The thyroid is without nodules.&nbsp; The skin has no discoloration or ecchymosis.&nbsp; Breast and pubic hair development are Tanner stage 5.&nbsp; External pelvic examination shows no lacerations, lesions, discharge, or bleeding.&nbsp; Hemoglobin is 10.1 g/dL.&nbsp; PT and aPTT are normal.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"5965\" src=\"https://www.uworld.com/media/highresdefault/L30865.jpg\"  ></p><p>During the first years after menarche, adolescents often have <strong>anovulatory cycles</strong> with <strong>heavy, irregular menstrual bleeding</strong> due to inadequate gonadotropin (eg, FSH, LH) secretion secondary to an immature <a href=\"2990\">hypothalamic-pituitary-ovarian axis</a>.</p><ul><li><p>In ovulatory cycles, a corpus luteum forms and produces progesterone after ovulation; progesterone induces differentiation of the proliferative endometrium into secretory endometrium, inhibiting further growth and stabilizing the endometrium.&nbsp; As the corpus luteum degenerates, the decline in progesterone levels leads to normal menses through a decrease in endometrial blood supply and shedding of the endometrial lining.</p></li><li><p>In contrast, anovulatory cycles do not produce progesterone (eg, no corpus luteum development) and there is no differentiation into secretory endometrium.&nbsp; Therefore, these patients have continued <strong>unopposed estrogen stimulation</strong>, resulting in uncontrolled <strong>proliferation</strong> (growth) <strong>of the endometrium</strong>.&nbsp; Bleeding occurs when the endometrial lining becomes too thickened and unstable, causing unpredictable and prolonged bleeding (eg, breakthrough bleeding).</p></li></ul><p>This adolescent patient has irregular, heavy bleeding that causes anemia, even 4 weeks after her last menstrual cycle.&nbsp; In such patients, <strong>progesterone</strong> treatment helps stabilize uncontrolled endometrial proliferation due to estrogen by causing differentiation into secretory endometrium.&nbsp; Cyclic progesterone causes controlled, predictable menstruation with less bleeding.</p><p><strong>(Choice A)</strong>&nbsp; Congenital anomalies of the reproductive tract (eg, M&uuml;llerian agenesis) typically present with primary amenorrhea rather than abnormal uterine bleeding.&nbsp; In patients with suspected anomalies, a pelvic MRI can be used to evaluate the structure of the reproductive tract.</p><p><strong>(Choice B)</strong>&nbsp; An <a href=\"9333\">endometrial biopsy</a> is an invasive procedure that can be used to diagnose endometrial hyperplasia, a condition that is rare in adolescents.&nbsp; An endometrial biopsy may be indicated in an adolescent with risk factors for hyperplasia (eg, obesity) or if symptoms do not improve with medical management.</p><p><strong>(Choice C)</strong>&nbsp; A hysteroscopy can be used to evaluate the endometrium for structural causes of abnormal bleeding (eg, <a href=\"4775\">endometrial polyp</a>), submucosal leiomyoma) and may be indicated if pharmacotherapy fails.</p><p><strong>(Choice D)</strong>&nbsp; A copper-containing intrauterine device is a long-acting, non-hormonal, reversible form of contraception that often causes longer, heavier menses.&nbsp; Therefore, it is not recommended in patients with heavy menstrual bleeding and anemia.</p><p><strong>(Choice E)</strong>&nbsp; Although anovulatory cycles are common in adolescents, providing only reassurance is inappropriate in patients bothered by menstrual cycle irregularity and in those with significant anemia.</p><p><strong>Educational objective:</strong><br>Adolescents often have anovulatory cycles with irregular, heavy menstrual bleeding due to an immature hypothalamic-pituitary-ovarian axis.&nbsp; Progesterone normalizes menstruation by stabilizing unregulated endometrial proliferation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 17488,
            "topic": "Abnormal uterine bleeding",
            "titleId": 17488,
            "title": "Abnormal uterine bleeding",
            "topicAttributeId": 330800,
            "topicAttribute": "Menstrual disorders and contraception",
            "correctAnswer": "6",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Order pelvic MRI",
                    "choiceNumber": 1,
                    "correctTaken": 99,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform endometrial biopsy",
                    "choiceNumber": 2,
                    "correctTaken": 43,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform hysteroscopy",
                    "choiceNumber": 3,
                    "correctTaken": 90,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Place copper-containing intrauterine device",
                    "choiceNumber": 4,
                    "correctTaken": 62,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Provide reassurance",
                    "choiceNumber": 5,
                    "correctTaken": 2917,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start oral progesterone therapy",
                    "choiceNumber": 6,
                    "correctTaken": 1794,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "54",
                    "mediaDataId": 0,
                    "title": "Evaluation of abnormal uterine bleeding",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26431240",
                    "mediaDataId": 0,
                    "title": "Evaluation and management of adolescents with abnormal uterine bleeding.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26431240",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22946701",
                    "mediaDataId": 0,
                    "title": "Abnormal uterine bleeding and dysfunctional uterine bleeding in pediatric and adolescent gynecology.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22946701",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 74,
            "notes": null,
            "peopleTaken": 5005,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 36,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 36,
            "questionId": 10876,
            "questionIndex": 12012,
            "questionText": "<p>A 32-year-old woman, gravida 5 para 5, comes to the office for follow-up from a breast biopsy that confirmed high-grade malignant features.&nbsp; Four weeks ago, the patient was incidentally found to have a breast mass during a routine pregnancy visit.&nbsp; The pregnancy ended in a miscarriage.&nbsp; She is coping with the recent pregnancy loss and the new diagnosis; she is otherwise feeling well with no vaginal bleeding or abdominal pain.&nbsp; Family history is significant for ovarian cancer in her mother, who died at age 50.&nbsp; Genetic testing reveals a mutation in the <em>BRCA2</em> gene.&nbsp; The patient is scheduled to begin chemotherapy and has been advised to avoid pregnancy.&nbsp; She took oral contraceptive pills during adolescence with no adverse effects.&nbsp; Breast examination shows a well-healing biopsy scar.&nbsp; A urine pregnancy test is negative.&nbsp; Which of the following is the best contraceptive option for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T34662\" style=\"overflow-x:auto;\"><table class=\"table-default-style\" style=\"width:342px\"><tbody><tr><td><p align=\"center\"><strong>Absolute contraindications to combined hormonal contraceptives</strong></p></td></tr><tr><td><ul><li>Migraine with aura</li><li>&#8805;15 cigarettes/day PLUS age &#8805;35</li><li>Hypertension &#8805;160/100 mm Hg</li><li>Heart disease</li><li>Diabetes mellitus with end-organ damage</li><li>History of thromboembolic disease</li><li>Antiphospholipid-antibody syndrome</li><li>History of stroke</li><li>Breast cancer</li><li>Cirrhosis &amp; liver cancer</li><li>Major surgery with prolonged immobilization</li><li>Pregnancy</li><li>Use &lt;3 weeks postpartum</li></ul></td></tr></tbody></table></div><p><strong>Cancer treatment</strong> with chemotherapy and/or radiation is <strong>highly teratogenic</strong>.&nbsp; Therefore, women undergoing treatment <strong>require effective contraception</strong>.&nbsp; The recommended method typically depends on contraceptive efficacy and the patient&#39;s desire for future fertility.&nbsp; For patients with certain medical conditions such as breast cancer, recommendations must also consider <strong>contraindications to hormonal contraception</strong> (ie, estrogen and/or progestin methods).</p><p>This patient with a <em>BRCA2</em> mutation has <strong>active breast cancer</strong>, which is an <strong>absolute contraindication</strong> to hormonal contraception because the proliferation of breast tissue can be sensitive to estrogen and progesterone levels.&nbsp; Malignant breast tumors, which are more commonly <strong>estrogen receptor&ndash;positive and/or progesterone receptor&ndash;positive</strong> in patients with <strong><em>BRCA </em> </strong>mutations, are at increased risk for proliferation with hormonal contraception use.</p><p>Therefore, the best option for this patient is a <strong>nonhormonal method</strong>, such as barrier contraception (eg, condoms, spermicide) or the <a href=\"2558\">copper-containing intrauterine device (IUD)</a>.&nbsp; The copper-containing IUD is hormone free, long term (effective for up to 12 years), reversible, and safe for insertion after most miscarriages.&nbsp; Although a potential adverse effect is heavy menses, it is usually preferable to barrier methods in women undergoing chemotherapy due to its higher efficacy (&gt;99%) compared to barrier methods, which are approximately 87% effective with typical use <strong>(Choice B)</strong>.</p><p><strong>(Choices A and C)</strong>&nbsp; Combined oral contraceptive pills (COCs) can decrease the risk for ovarian cancer, which is advantageous for <em>BRCA</em> mutation carriers who have a higher lifetime risk for ovarian cancer.&nbsp; However, because COCs and the contraceptive patch contain estrogen and progesterone, they are contraindicated in active breast cancer due to the risk for stimulating hormone receptor&ndash;positive tumor cells.&nbsp; In addition, exogenous estrogen is not recommended in patients with any type of malignancy due to an increased risk for thrombosis.</p><p><strong>(Choice E)</strong>&nbsp; The <a href=\"2448\">progestin-releasing IUD</a> is a highly effective (&gt;99%), long-acting reversible contraceptive that can prevent pregnancy for up to 8 years.&nbsp; Although its mechanism of action is most likely impairment of pregnancy implantation via localized progesterone effect (ie, endometrial thinning), there is a theoretical risk for systemic progesterone absorption.&nbsp; Therefore, it is currently not recommended in active breast cancer.</p><p><strong>Educational objective:</strong><br>Hormonal contraception (ie, estrogen and/or progestin methods) is contraindicated in patients with active breast cancer due to the risk for stimulating estrogen receptor&ndash;positive and/or progesterone receptor&ndash;positive tumor cells.&nbsp; These patients can safely use the copper-containing intrauterine device, which is preferable to other hormone-free methods (eg, condoms and spermicide) due to its high efficacy (&gt;99%).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 17805,
            "topic": "Contraception",
            "titleId": 17805,
            "title": "Contraception",
            "topicAttributeId": 330800,
            "topicAttribute": "Menstrual disorders and contraception",
            "correctAnswer": "4",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Combined oral contraceptive pills",
                    "choiceNumber": 1,
                    "correctTaken": 200,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Condoms and spermicide",
                    "choiceNumber": 2,
                    "correctTaken": 133,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Contraceptive patch",
                    "choiceNumber": 3,
                    "correctTaken": 34,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Copper-releasing intrauterine device",
                    "choiceNumber": 4,
                    "correctTaken": 3592,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Progestin-releasing intrauterine device",
                    "choiceNumber": 5,
                    "correctTaken": 1090,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "53",
                    "mediaDataId": 0,
                    "title": "Contraception",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26447268",
                    "mediaDataId": 0,
                    "title": "Medical eligibility criteria for contraceptive use.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26447268",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27467196",
                    "mediaDataId": 0,
                    "title": "U.S. medical eligibility criteria for contraceptive use, 2016.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27467196",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28080000",
                    "mediaDataId": 0,
                    "title": "Selected practice recommendations for contraceptive use.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28080000",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 71,
            "notes": null,
            "peopleTaken": 5049,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 37,
            "questionId": 10245,
            "questionIndex": 11063,
            "questionText": "<p>A 78-year-old woman is brought to the emergency department due to urinary incontinence.&nbsp; The patient has a history of Alzheimer dementia and has been living in a nursing home for the past 3 years.&nbsp; At baseline, she requires assistance for most daily activities but is able to alert the nursing home staff when she needs to use the bathroom.&nbsp; For the past week, the patient has had urinary incontinence, which she has never experienced before; she has also been less active and now spends most of the day sleeping.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 130/70 mm Hg, and pulse is 76/min.&nbsp; On examination, the patient is somnolent but responsive to voice.&nbsp; She is disoriented but has a normal gait and no focal neurologic deficits.&nbsp; The abdomen is soft and nontender.&nbsp; Genitourinary examination shows thin, pale vaginal mucosa with ill-defined labia minora.&nbsp; There is mild anterior vaginal wall prolapse.&nbsp; The remainder of the physical examination is unremarkable.&nbsp; Which of the following is the best next step in managing this patient&#39;s urinary incontinence?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T94692\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Urinary incontinence: major causes in older adults</strong></p></td></tr><tr><td style=\"width: 15%;\"><p align=\"center\"><strong>Reversible</strong><br>(often acute)</p></td><td><p><strong>D</strong>elirium: decreased awareness<br><strong>I</strong>nfection (urinary tract): bladder irritation<br><strong>A</strong>trophic vaginitis: urethral irritation<br><strong>P</strong>harmacologic: variable mechanisms (eg, anticholinergics, diuretics)<br><strong>P</strong>sychiatric: decreased motivation (eg, depression)<br><strong>E</strong>xcess urine output: polyuria (eg, diabetes mellitus)<br><strong>R</strong>educed mobility (ie, functional): inability to reach toilet (eg, restraints)<br><strong>S</strong>tool (constipation/impaction): urethral or bladder compression</p></td></tr><tr><td><p align=\"center\"><strong>Persistent</strong></p></td><td><ul><li><strong>Urologic causes</strong><ul style=\"list-style-type:circle;\"><li>Stress: pelvic muscle weakness (eg, multiparity)</li><li>Urgency: detrusor overactivity</li><li>Mixed: both stress &amp; urgency</li><li>Overflow: detrusor underactivity or urethral obstruction (eg, BPH)</li></ul></li><li><strong>Neurologic causes</strong><ul style=\"list-style-type:circle;\"><li>Urge: detrusor overactivity from impaired CNS inhibition (eg, dementia, Parkinson disease, normal pressure hydrocephalus)</li><li>Urge &plusmn; overflow: mechanism varies by lesion location (eg, multiple sclerosis, spinal cord injury, stroke)</li></ul></li></ul></td></tr><tr><td colspan=\"2\"><p><strong>BPH</strong> = benign prostatic hyperplasia.</p></td></tr></tbody></table></div><p>This older patient has <strong>acute urinary incontinence</strong>.&nbsp; New-onset incontinence should prompt <strong>investigation for reversible causes</strong>, which include <strong>D</strong>elirium, urinary tract <strong>I</strong>nfection (UTI), <strong>A</strong>trophic vaginitis, <strong>P</strong>harmacology (eg, anticholinergics), <strong>P</strong>sychiatry (eg, depression), <strong>E</strong>xcess urine (eg, diabetes mellitus), <strong>R</strong>educed mobility, and <strong>S</strong>tool symptoms (eg, constipation) (mnemonic: <strong>DIAPPERS</strong>).</p><p>Etiology can often be identified by history and physical examination.&nbsp; Because UTI is a common cause of urinary incontinence, <strong>urinalysis with urine culture</strong> should be obtained for most patients.&nbsp; This is particularly true for <strong>older patients</strong>, who may lack typical UTI symptoms/signs (eg, dysuria, fever) or cannot provide a reliable history (eg, <strong>dementia</strong>).&nbsp; Positive urine cultures require assessment for asymptomatic bacteriuria versus true infection.&nbsp; This patient&#39;s positive cultures would likely represent true infection given that UTI could explain both her new-onset incontinence and delirium (eg, increased somnolence).</p><p>If reversible causes are not found, further testing includes evaluation for stress incontinence (eg, Valsalva maneuver with full bladder) and overflow incontinence (eg, postvoid residual).&nbsp; Urodynamic testing is usually unnecessary unless there is diagnostic uncertainty (eg, mixed incontinence) or consideration for surgical intervention <strong>(Choice E)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Beta-3 adrenergic agonists (eg, mirabegron) promote detrusor relaxation and are effective for urge incontinence (ie, overactive bladder).&nbsp; However, pharmacotherapy is typically not initiated until reversible causes are excluded and the incontinence type is clarified.</p><p><strong>(Choice B)</strong>&nbsp; CT scan of the head can evaluate for neurologic causes of urinary incontinence (eg, stroke, normal pressure hydrocephalus [NPH]).&nbsp; Despite this patient&#39;s altered mental status, she has no focal neurologic findings to suggest acute stroke.&nbsp; Although urinary incontinence and dementia are cardinal features of NPH, this patient&#39;s lack of gait dysfunction (typically the most prominent feature) makes NPH unlikely.</p><p><strong>(Choice C)</strong>&nbsp; Long-term urinary catheter placement is typically reserved for patients with chronic urinary incontinence (or retention) who cannot manage intermittent self-catheterization.&nbsp; It is inappropriate for this patient&#39;s acute urinary incontinence and would likely exacerbate her delirium.</p><p><strong>(Choice F)</strong>&nbsp; Vaginal estrogen cream is effective for atrophic vaginitis (eg, pale, thin mucosa), which is common in postmenopausal patients.&nbsp; Although atrophic vaginitis is a reversible cause of urinary incontinence, it would not explain this patient&#39;s acute onset and associated delirium.</p><p><strong>Educational objective:</strong><br>Acute urinary incontinence should prompt investigation for reversible causes.&nbsp; Because urinary tract infection is a common reversible cause, urinalysis with urine culture is appropriate for most patients.&nbsp; This is particularly true in older patients who may lack typical signs/symptoms or cannot provide a reliable history (eg, dementia).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 1315,
            "topic": "Urinary incontinence",
            "titleId": 1315,
            "title": "Urinary incontinence",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "4",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Beta-3 adrenergic agonist therapy",
                    "choiceNumber": 1,
                    "correctTaken": 411,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "CT scan of the head",
                    "choiceNumber": 2,
                    "correctTaken": 350,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Long-term urinary catheter",
                    "choiceNumber": 3,
                    "correctTaken": 332,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urinalysis and urine culture",
                    "choiceNumber": 4,
                    "correctTaken": 5467,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urodynamic studies",
                    "choiceNumber": 5,
                    "correctTaken": 769,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vaginal estrogen cream",
                    "choiceNumber": 6,
                    "correctTaken": 837,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "9636332",
                    "mediaDataId": 0,
                    "title": "Diagnostic evaluation of urinary incontinence in geriatric patients.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/9636332",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "33392535",
                    "mediaDataId": 0,
                    "title": "Association of dementia diagnosis with urinary tract infection in the emergency department.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/33392535",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "35338229",
                    "mediaDataId": 0,
                    "title": "Prevalence of and factors associated with atypical presentation in bacteremic urinary tract infection.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/35338229",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 76,
            "notes": null,
            "peopleTaken": 8166,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 67,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 38,
            "questionId": 11271,
            "questionIndex": 12426,
            "questionText": "<p>A 40-year-old woman comes to the emergency department due to abdominal pain for the past 2 weeks.&nbsp; The pain has become worse over the past day and is not relieved by ibuprofen.&nbsp; The patient has a fever but no nausea, vomiting, diarrhea, or dysuria.&nbsp; She has no chronic medical conditions or previous surgeries.&nbsp; Her last menstrual period was 2 weeks ago; menses are regular and last 5 days, with painful cramping and heavy bleeding on the first day.&nbsp; The patient is sexually active with a male partner and uses condoms for contraception.&nbsp; She does not use tobacco, alcohol, or illicit drugs.&nbsp; Temperature is 38.8 C (101.8 F), blood pressure is 100/60 mm Hg, and pulse is 92/min.&nbsp; The abdomen has diffuse tenderness to deep palpation that is worse in the right lower quadrant.&nbsp; There is no rebound or guarding.&nbsp; Pelvic examination reveals a small, mobile, tender uterus and an enlarged, tender right adnexal mass.&nbsp; Leukocyte count is 22,000/mm<font size=\"2\"><sup>3</sup></font>.&nbsp; Urine pregnancy test is negative.&nbsp; Pelvic ultrasonography reveals a large, thick-walled, multiloculated mass filled with debris obliterating the right adnexa.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T32055\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Pelvic inflammatory disease</strong></p></td></tr><tr><td><p align=\"center\"><strong>Symptoms</strong></p></td><td><ul><li>Lower abdominal pain</li><li>Abnormal bleeding</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk<br>factors</strong></p></td><td><ul><li>Multiple sexual partners</li><li>Age 15-25</li><li>Previous pelvic inflammatory disease</li><li>Inconsistent barrier contraception use</li><li>Partner with sexually transmitted infection</li></ul></td></tr><tr><td><p align=\"center\"><strong>Physical<br>examination</strong></p></td><td><ul><li>Fever &gt;38.3 C (&gt;100.9 F)</li><li>Cervical motion, uterine, or adnexal tenderness</li><li>Mucopurulent cervical discharge</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Inpatient: IV broad-spectrum antibiotics</li><li>Outpatient: PO broad-spectrum antibiotics</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Tuboovarian abscess</li><li>Infertility</li><li>Ectopic pregnancy</li><li>Perihepatitis</li></ul></td></tr></tbody></table></div><p>This patient with fever, abdominal pain, and a multiloculated, complex adnexal mass most likely has a <strong>tuboovarian abscess</strong> (TOA).&nbsp; TOA typically occurs in sexually active, reproductive-age women as a complication of <strong>pelvic inflammatory disease</strong>, a polymicrobial infection of the upper genital tract (ie, uterus, fallopian tubes).</p><p>Patients with TOA can initially have diffuse lower abdominal pain plus <strong>uterine tenderness</strong> that gradually (over days to weeks) worsens and localizes to one side, causing <strong>unilateral adnexal tenderness</strong> with an associated mass.&nbsp; Because of the worsening infection, patients often develop <strong>high fever</strong> and leukocytosis.&nbsp; When the infection extends to the fallopian tube, it creates an inflammatory exudate, purulent fluid, and tubal wall thickening, which conglomerate into a <strong>complex adnexal mass</strong>, or pyosalpinx (ie, infected fallopian tube), visible on <strong>pelvic ultrasound</strong>.&nbsp; Treatment is with intravenous broad-spectrum antibiotics.</p><p><strong>(Choice A)</strong>&nbsp; An appendiceal abscess can cause fever, pain, and a mass in the right lower quadrant.&nbsp; However, patients typically have periumbilical pain that migrates to the right lower quadrant with associated nausea, vomiting, and anorexia.</p><p><strong>(Choice B)</strong>&nbsp; Endometriosis can present with abdominal pain and an adnexal mass (eg, endometrioma) that is typically described as having a ground-glass appearance on ultrasound.&nbsp; However, high fever, uterine tenderness, and leukocytosis are not typically present.</p><p><strong>(Choice C)</strong>&nbsp; A mature cystic teratoma may present with abdominal pain (due to mass effect or acute torsion) but does not cause fever and leukocytosis.&nbsp; Ultrasound typically reveals an ovarian cyst with solid components, hyperechoic nodules, and calcifications.</p><p><strong>(Choice D)</strong>&nbsp; Ovarian serous cystadenocarcinomas are the most common type of ovarian cancer.&nbsp; They can cause abdominal pain and inflammation (eg, fever, leukocytosis) due to ovarian necrosis; however, patients do not typically have both uterine and adnexal tenderness.</p><p><strong>(Choice E)</strong>&nbsp; Although ovarian torsion can cause abdominal pain and fever due to ovarian necrosis, the initial onset of pain is typically sudden and unilateral rather than diffuse.&nbsp; Ultrasound typically shows an adnexal mass with absent Doppler flow.</p><p><strong>Educational objective:</strong><br>A tuboovarian abscess is a complication of pelvic inflammatory disease, a polymicrobial infection of the upper genital tract.&nbsp; Patients typically have fever, diffuse abdominal pain that gradually worsens on one side, and both uterine and adnexal tenderness.&nbsp; Ultrasound typically shows a complex multiloculated adnexal mass with thick walls and internal debris.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 8096,
            "topic": "Pelvic inflammatory disease",
            "titleId": 8096,
            "title": "Pelvic inflammatory disease",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "6",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Appendiceal abscess",
                    "choiceNumber": 1,
                    "correctTaken": 510,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometriosis",
                    "choiceNumber": 2,
                    "correctTaken": 257,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Mature cystic teratoma",
                    "choiceNumber": 3,
                    "correctTaken": 3044,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ovarian serous cystadenocarcinoma",
                    "choiceNumber": 4,
                    "correctTaken": 1146,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ovarian torsion",
                    "choiceNumber": 5,
                    "correctTaken": 368,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Tuboovarian abscess",
                    "choiceNumber": 6,
                    "correctTaken": 11385,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "43",
                    "mediaDataId": 0,
                    "title": "Pelvic inflammatory disease",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31524362",
                    "mediaDataId": 0,
                    "title": "Pelvic inflammatory disease: diagnosis, management, and prevention.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31524362",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26062637",
                    "mediaDataId": 0,
                    "title": "Ultrasonography of adnexal causes of acute pelvic pain in pre-menopausal non-pregnant women.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26062637",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 76,
            "notes": null,
            "peopleTaken": 16710,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 68,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 39,
            "questionId": 11349,
            "questionIndex": 12502,
            "questionText": "<p>A 21-year-old woman is brought to the emergency department due to a day of persistent vomiting, diarrhea, and high fever.&nbsp; The patient also has had a severe headache unrelieved by acetaminophen.&nbsp; She has no hematemesis or hematochezia.&nbsp; The patient spent the past 3 months in Southeast Asia and returned yesterday after 36 hours of plane travel and airport layovers.&nbsp; She has no chronic medical conditions or previous surgeries.&nbsp; The patient does not use tobacco or recreational drugs.&nbsp; She is currently on day 5 of her menstrual period.&nbsp; Temperature is 39.4 C (102.9 F), blood pressure is 80/40 mm Hg, and pulse is 124/min.&nbsp; Physical examination shows a diaphoretic woman with dry mucous membranes.&nbsp; There is no nuchal rigidity.&nbsp; An erythematous macular rash covers the entire body, including the palms and soles.&nbsp; Which of the following microorganisms is most likely responsible for this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T31755\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\" style=\"margin-left:.1in;\"><strong>Staphylococcal toxic shock syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risks</strong></p></td><td><ul><li>Tampon use</li><li>Nasal packing</li><li>Surgical/postpartum wound infection</li></ul></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li><em>Staphylococcus aureus</em></li><li>Exotoxin release acting as superantigens</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br>features</strong></p></td><td><ul><li>Fever &gt;38.9 C (102 F)</li><li>Hypotension</li><li>Diffuse macular rash involving palms &amp; soles</li><li>Desquamation 1-3 weeks after disease onset</li><li>Vomiting, diarrhea</li><li>Altered mentation without focal neurologic signs</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Supportive therapy (fluid replacement)</li><li>Removal of foreign body (eg, tampon)</li><li>Antibiotic therapy (eg, vancomycin, cefepime, clindamycin)</li></ul></td></tr></tbody></table></div><p>This patient with fever, signs of shock (eg, hypotension, tachycardia), and a diffuse erythematous rash likely has <strong>toxic shock syndrome</strong> (TSS).&nbsp; TSS typically occurs when an exotoxin-producing strain of <em>Staphylococcus aureus</em> proliferates in a <strong>retained foreign body</strong> (eg, tampon, nasal/wound packing) or a wound infection (eg, surgical, post-partum); this patient likely developed TSS due to prolonged <strong>tampon use</strong> during her travel home from Southeast Asia.</p><p>Certain <em>S aureus</em> exotoxins (eg, TSS toxin-1) act as superantigens, proteins that bypass normal antigen processing and bind directly to the surface of class II major histocompatibility complexes.&nbsp; Superantigens indiscriminately activate T cells, leading to the massive release of inflammatory cytokines.&nbsp; Manifestations of TSS typically arise <strong>rapidly</strong> over 1-2 days and include fever, shock, a <strong>widespread macular rash</strong> that eventually desquamates (usually after 1-2 weeks), and multiorgan failure (eg, decreased urine output, altered mentation).&nbsp; Treatment includes supportive care (eg, intravenous fluids), removal of the foreign body (if still present), and empiric antibiotic therapy (vancomycin, cefepime, and clindamycin).</p><p><strong>(Choice A)</strong>&nbsp; Disseminated gonococcal infection (DGI) can cause a pustular rash.&nbsp; A widespread macular rash is not seen.&nbsp; In addition, most patients with DGI who have a rash also have tenosynovitis and migratory polyarthralgia.&nbsp; Furthermore, shock is uncommon.</p><p><strong>(Choice B)</strong>&nbsp; <em>Rotavirus</em> can cause traveler&#39;s diarrhea.&nbsp; In adults, this typically presents with mild gastroenteritis (eg, watery diarrhea, dry mucous membranes).&nbsp; However, <em>Rotavirus</em> does not cause rash, and shock would be very uncommon.</p><p><strong>(Choice C)</strong>&nbsp; <em>Shigella</em> gastroenteritis causes fever, bloody diarrhea, and abdominal cramping but not rash.</p><p><strong>(Choice E)</strong>&nbsp; Secondary syphilis, caused by <em>Treponema pallidum</em>, can present with a maculopapular rash involving the palms and soles.&nbsp; Patients may also develop a low fever, malaise, and epitrochlear adenopathy.&nbsp; However, patients typically have an indolent course, and shock would be very uncommon.</p><p><strong>Educational objective:</strong><br>Toxic shock syndrome (TSS) is usually due to the elaboration of <em>Staphylococcus aureus</em> exotoxin.&nbsp; Most cases are associated with a retained foreign body (eg, tampon, nasal packing) or a skin/soft-tissue infection.&nbsp; TSS typically presents with fever, shock, and a diffuse, red, macular rash involving the palms and soles.&nbsp; Treatment includes fluid replacement, removal of the foreign body (if present), and empiric antibiotic therapy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 8882,
            "topic": "Toxic shock syndrome",
            "titleId": 8882,
            "title": "Toxic shock syndrome",
            "topicAttributeId": 330601,
            "topicAttribute": "Genitourinary tract infections",
            "correctAnswer": "4",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "<em>Neisseria gonorrhoeae</em>",
                    "choiceNumber": 1,
                    "correctTaken": 1057,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<em>Rotavirus</em>",
                    "choiceNumber": 2,
                    "correctTaken": 562,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<em>Shigella</em>",
                    "choiceNumber": 3,
                    "correctTaken": 1070,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<em>Staphylococcus aureus</em>",
                    "choiceNumber": 4,
                    "correctTaken": 7159,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<em>Treponema pallidum</em>",
                    "choiceNumber": 5,
                    "correctTaken": 3877,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27",
                    "mediaDataId": 0,
                    "title": "Staphylococcal toxic shock syndrome",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28646955",
                    "mediaDataId": 0,
                    "title": "Toxic shock syndrome - the seven Rs of management and treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28646955",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24889583",
                    "mediaDataId": 0,
                    "title": "Lesson of the month 2: toxic shock syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24889583",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 51,
            "notes": null,
            "peopleTaken": 13725,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 52,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 40,
            "questionId": 4283,
            "questionIndex": 4283,
            "questionText": "<p><u><strong>Patient Information</strong></u><br><strong>Age:</strong> 19 years<br><strong>Gender:</strong> F, self-identified<br><strong>Race/Ethnicity:</strong> unspecified<br><strong>Site of Care:</strong> office</p><p><u><strong>History</strong></u><br><strong>Reason for Visit/Chief Concern:</strong> amenorrhea</p><p><strong>History of Present Illness:</strong></p><ul><li>5 months of amenorrhea</li><li>previously had regular menses every 28 days with 4-5 days of bleeding</li><li>menarche at age 14</li><li>no headaches, visual disturbances, heat intolerance, palpitations, hot flashes, or night sweats</li></ul><p><strong>Past Medical History:</strong></p><ul><li>no chronic medical conditions</li></ul><p><strong>Medications:</strong></p><ul><li>no current medications</li></ul><p><strong>Allergies:</strong></p><ul><li>no known drug allergies</li></ul><p><strong>Family History:</strong></p><ul><li>noncontributory</li></ul><p><strong>Psychosocial History:</strong></p><ul><li>national gymnastics champion; attends the local university</li><li>has never been sexually active</li><li>does not use tobacco, alcohol, or recreational drugs</li></ul><p><u><strong>Physical Examination</strong></u></p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"text-align: center;\"><strong>Temp</strong></td><td style=\"text-align: center;\"><strong>Pulse</strong></td><td style=\"text-align: center;\"><strong>Resp</strong></td><td style=\"text-align: center;\"><strong>BP</strong></td><td style=\"text-align: center;\"><strong>O</strong><font size=\"2\"><sub><strong>2</strong></sub></font>&nbsp;<strong>Sat</strong></td><td style=\"text-align: center;\"><strong>Ht</strong></td><td style=\"text-align: center;\"><strong>Wt</strong></td><td style=\"text-align: center;\"><strong>BMI</strong></td></tr><tr><td style=\"text-align: center;\">36.7 C<br>(98.1 F)</td><td style=\"text-align: center;\">54/min</td><td style=\"text-align: center;\">&ndash;</td><td style=\"text-align: center;\">110/60<br>mm Hg</td><td style=\"text-align: center;\">98% on<br>room air</td><td style=\"text-align: center;\">165 cm<br>(5 ft 4 in)</td><td style=\"text-align: center;\">&ndash;</td><td style=\"text-align: center;\">19 kg/m<font size=\"2\"><sup>2</sup></font></td></tr></tbody></table><ul><li>Appearance: in no acute distress; muscular appearing</li><li>HEENT: mild facial acne; no thyromegaly or facial hair</li><li>Cardiac: regular rhythm; normal S1 and S2</li><li>Breast: sexual maturity rating (Tanner stage) 5 development</li><li>Abdominal: soft, nontender; no palpable masses</li><li>Pelvic: normal external genitalia, vagina, and cervix; small, mobile uterus; no adnexal masses on bimanual examination</li></ul><p><u><strong>Diagnostic Studies</strong></u></p><ul><li>Urine pregnancy test: negative</li><li>TSH and prolactin levels: within normal limits</li></ul><p><u><strong>Question:</strong></u>&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T31519\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Exercise-induced hypothalamic amenorrhea</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><ul><li>Strenuous exercise</li><li>Relative calorie deficiency</li><li>Stress fracture</li><li>Amenorrhea</li><li>Infertility</li></ul></td></tr><tr><td><p align=\"center\"><strong>Hormone levels</strong></p></td><td><ul><li>&#8595; GnRH</li><li>&#8595; LH &amp; FSH</li><li>&#8595; Estrogen</li></ul></td></tr><tr><td><p align=\"center\"><strong>Long-term consequences</strong></p></td><td><ul><li>&#8595; Bone mineral density</li><li>&#8593; Total cholesterol</li><li>&#8593; Triglycerides</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Increased calorie intake</li><li>Estrogen</li><li>Calcium &amp; vitamin D</li></ul></td></tr></tbody></table></div><p>This conditioned athlete has <strong>secondary amenorrhea</strong> likely due to functional <strong>hypothalamic amenorrhea</strong> (eg, hypogonadotropic hypogonadism), which is commonly seen in women with the athlete&#39;s triad: amenorrhea, osteoporosis, and insufficient caloric intake.</p><p>Female athletes who exercise intensively are thought to have a <strong>relative caloric deficiency</strong> (even those with normal BMI) secondary to insufficient calorie replenishment compared to the amount of energy expended.&nbsp; Low energy stores (ie, low body fat) in muscular athletes (as seen in this patient) also alter multiple peripheral metabolic hormones (ie, low leptin, high ghrelin), which affects GnRH secretion.&nbsp; These combined effects suppress the hypothalamic-pituitary-ovarian axis with <strong>decreased</strong> levels of <strong>GnRH</strong>, a subsequent <strong>decrease</strong> in <strong>LH secretion</strong>, and ultimately <strong>estrogen deficiency</strong>.</p><p>These patients are at increased risk for conditions associated with estrogen deficiency, including infertility and decreased bone mineral density (eg, osteopenia).</p><p><strong>(Choices A and B)</strong>&nbsp; Androgenic steroid use and congenital adrenal hyperplasia present with virilization (eg, male pattern baldness, deepening voice, clitoromegaly) and hypertension.&nbsp; Patients who use androgenic steroids also exhibit aggressive behavior and mood disorders, which are not seen in this patient.</p><p><strong>(Choice D)</strong>&nbsp; Ovarian fibrothecoma, a type of ovarian sex cord&ndash;stromal tumor, may secrete androgens but more commonly secretes estrogen.&nbsp; This patient has no evidence of excess androgen (eg, hirsutism) or estrogen (eg, breast tenderness) secretion and no adnexal mass.</p><p><strong>(Choice E)</strong>&nbsp; Patients with polycystic ovary syndrome have signs of androgen excess (eg, severe nodulocystic acne on the chest and back), obesity, and enlarged ovaries on examination.&nbsp; This patient has mild acne, but her normal BMI and pelvic examination make this diagnosis less likely.</p><p><strong>(Choice F)</strong>&nbsp; Patients with primary ovarian insufficiency typically have vasomotor symptoms (eg, hot flashes, night sweats) and vaginal atrophy associated with amenorrhea.&nbsp; Primary ovarian insufficiency is typically associated with a concomitant autoimmune disorder or Turner syndrome.</p><p><strong>Educational objective:</strong><br>Secondary amenorrhea is relatively common in female athletes and results from hypothalamic amenorrhea (eg, GnRH deficiency).&nbsp; The subsequent decreased LH secretion and estrogen deficiency result in amenorrhea and decreased bone mineral density.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 23429,
            "topic": "Amenorrhea",
            "titleId": 23429,
            "title": "Amenorrhea",
            "topicAttributeId": 330800,
            "topicAttribute": "Menstrual disorders and contraception",
            "correctAnswer": "3",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Androgenic steroid use",
                    "choiceNumber": 1,
                    "correctTaken": 3013,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Congenital adrenal hyperplasia",
                    "choiceNumber": 2,
                    "correctTaken": 68,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypothalamic amenorrhea",
                    "choiceNumber": 3,
                    "correctTaken": 11426,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ovarian fibrothecoma",
                    "choiceNumber": 4,
                    "correctTaken": 70,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Polycystic ovary syndrome",
                    "choiceNumber": 5,
                    "correctTaken": 221,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Primary ovarian insufficiency",
                    "choiceNumber": 6,
                    "correctTaken": 1161,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "72",
                    "mediaDataId": 0,
                    "title": "Hypothalamic amenorrhea",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22283375",
                    "mediaDataId": 0,
                    "title": "Neuroendocrine control of ovulation.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22283375",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 15,
            "othersAvgTimeSpent": 58,
            "notes": null,
            "peopleTaken": 15959,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 72,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 15,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": null,
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 1,
            "name": "UNUSED"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}